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Plant viruses have been highlighted among material research due to their well-defined 
structures in nanoscale, mono-dispersity, stability, and chemical functionalities. Each of 
the thousands coated protein subunits on a viral nanoparticle can be homogenously 
modified, chemically, and genetically with a functional ligand leading to a high-density 
and spatial distribution of ligands on each particle (multivalency). Many reports from our 
group have clearly shown that virus coated substrates induced the acceleration of bone 
marrow stromal cells differentiation into bone cells. We hypothesized that this 
phenomenon could rely on the multivalency that the viral nanoparticle has to offer. 
Moving to a more clinical relevant application, we fabricated three-dimensional (3D) 
biopolymeric scaffolds with functionalized rod-like Tobacco mosaic virus (TMV) for 
tissue engineering. The virus-functionalized hydrogel materials were developed and 
characterized. The first three chapters present in vitro and in vivo data based on the 
sponge-like preformed hydrogel functionalized with the cellular recognition peptide, 
arginine-glycine-aspartic acid (RGD), through an incorporation of RGD mutant of TMV 
(TMV-RGD1). Chapter 6 describes the development of an in situ crosslinking injectable 
hydrogel using cysteine-addition mutant of TMV (TMV-1Cys). 
First chapter includes the fabrication method for TMV-incorporated porous 
alginate hydrogel, in vitro stem cell culture in 3D, and in vitro bone differentiation of 
stem cell in the hydrogel. TMV-RGD1 was non-covalently incorporated to introduce the 
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biofunctionality into the hydrogel. This hydrogel was a preformed scaffold in which stem 
cells were seeded after the gel was fabricated. Cell attachment, viability were then 
characterized to assure the presence and accessibility of the RGD peptide on the virus 
scaffold. Osteogenic differentiation of bone marrow stromal cells was assessed in the 
composite hydrogels. The virus and its mutant modification with bio-adhesive peptide 
(RGD) significantly improved cell attachments and afforded a higher level of calcium 
depositions in comparison to the unmodified hydrogel. The TMV-functionalized 
hydrogel scaffolds were also used to study cartilage differentiation of bone marrow 
stromal cells in chapter 5. In chapter 2, in vivo biocompatibility studies of the hydrogel 
scaffolds, functionalized with wild-type and RGD-mutant TMV, showed no systemic 
toxicity and insignificant immune response against virus-modified hydrogel implants in 
the BALB/c mice. Chapter 3 confirms the in vivo biocompatibility of the hydrogel 
scaffolds with TMV and its RGD-mutant when bone marrow stromal cells were 
incorporated in the implants. Moreover, the implanted hydrogels guided the bone 
regeneration and could consequently repaired cranial defects in laboratory rats, as 
presented in chapter 4.  
In chapter 6, cys-mutant of TMV was used to covalently link the virus particles 
with methacrylated polymer backbone through Michael addition reaction in the injectable 
hydrogel. In this system, physical properties of the hydrogel; for example, gelation time 
and gel moduli could be finely tuned via the degree of methacrylation and/or the addition 
of the virus. This in situ crosslinking method and the resulting hydrogel was 
cytocompatible for encapsulation and cultivation of bone marrow stromal cells. 
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Taken together, this dissertation articulates the application of using virus 
nanoparticles in functionalization and development of hydrogels as biomaterials for 3D 
cell culture and differentiation, as well as bone substitute matrix. These findings 
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POROUS ALGINATE HYDROGEL FUNCTIONALIZED WITH TOBACCO MOSAIC VIRUS AS 




1.1.1 Hydrogels as biomaterials for tissue engineering 
The key challenges in making off-the-shelf tissue-engineered organs include providing 
sufficient oxygen and nutrient exchange to engineered tissue constructs with pore size 
larger than 100 μm, selecting a suitable cell type, and creating advance architecture of 
matrix to support the tissue.
1-3
 Hydrogels, as three dimensional (3D) scaffolds mimicking 
the natural extracellular environment of cells, have great potential for tissue engineering 
applications. A carefully designed hydrogel system can offer the ideal support
4
 for 
microvasculature and tissues, as well as the possible equilibration to high, tissue-like 
water content.
5
 The presence of water and the porous structure allows for the influx of 
low molecular weight solutes and nutrients crucial for cell viability, as well as the 
transport of cellular waste out of the hydrogel.
6, 7
 In addition, different functional groups 
can be attached to the hydrogel skeleton to impart desirable physical, chemical, and cell 
responsive properties to serve different biomedical applications.
8-10
 
                                                 
1
 The content in this chapter was modified from Luckanagul J, Lee LA, Nguyen QL, Sitasuwan P, Yang X, 
Shazly T, Wang Q. Biomacromolecules 2012;13:3949-58 with permission of publisher (Appendix A). 
Copyright (2012) American Chemical Society. 
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1.1.2 Roles of virus particles in extracellular matrix designed to control cell behavior 
Despite extensive work with peptide conjugates in hydrogels, there are limited studies 
showing the functionalization of hydrogels with multivalent (multipoint contact) 
materials. Past studies have shown that complex toxins (e.g., heptavalent protective 
antigen from anthrax), immune complexes, and surface receptor clusters that reflect the 
multivalent interactions between the host cell surface receptors and the binding agents are 
important for cell dynamics.
11-13
 To modulate the cellular responses, ligands specific to 
cell surface receptors are crucial, but studies also suggest that ligand density, the spatial 
presentation of ligands, and the physical and mechanical properties of the hydrogels all 
play critical roles.
8-10, 14, 15
 Based on previous studies, coating 2D substrates with TMV 
demonstrated enhanced osteogenic differentiation potentials.
16
 The results from these 
earlier studies indicated that the surface coating with viral particles was essential to 
accelerate differentiation from 21 to 14 days and supplementing the media with virus 
particles failed to induce a similar enhanced differentiation.
17
 While the interaction 
between TMV, substrate, and mesenchymal stem cells on 2D substrates appears critical 
for such an accelerated differentiation process, it is not known whether these similar 
events can be translated to 3D scaffolds. Tobacco mosaic virus (TMV) is a rod-like plant 
virus consisting of 2130 identical protein subunits arranged helically around a genomic 
single-RNA strand. A TMV particle is roughly 300 nm long and 18 nm in diameter, with 
a 4 nm cylindrical cavity along the central core.
18, 19
 TMV particles are multifaceted 
nanosized building blocks, given its well-defined structure, genetic and chemical 
modalities, and relative simplicity in its purification process. It has been used as a 
primary building block to generate a programmable scaffold by chemical or genetic 
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modification to decorate polyvalent functional motifs or peptide ligands with defined 
density and distance between ligands.
20-23
 For example, TMV can be modified to display 
certain functional units that promote cell adhesion, proliferation, and differentiation. In a 
previous study the classical RGD (arginine−glycine−aspartic acid) peptide sequences 
with different flanking sequencing were genetically engineered on the surface of the 
TMV coat proteins to bind to the integrin receptors with differential adhesion strengths.
24
 
A chemical modification approach can also be used to display phosphates or similar RGD 
ligands via sequential modification of the tyrosine residue with a diazonium salt followed 
by Cu(I)-catalyzed azide−alkyne cycloaddition reaction.
23, 25
 Here, we generated a 3D 
scaffold that incorporates the virus particles without affecting the virus’s quaternary 
structures in the porous hydrogels. The assembly of the porous hydrogel with the viral 
particles required no covalent linkages between the alginate and TMV particles. A 
genetically modified TMV particle was also used to enhance the cell loading capacity 
within the hydrogels, and as a proof-of-concept, mesenchymal stem cells were seeded 
and induced to osteogenic lineage. 
 
1.1.3 Alginate as a hydrogel forming biopolymer 
Alginate is a linear polysaccharide copolymer of (1−4)-linked β-D-mannuronic acid (M) 
and α-L-guluronic acid (G) monomers that has been widely used in a variety of medical 
applications. The choice for alginate hydrogel was due to its ability to form highly porous 
hydrogels under mild conditions as well as its low toxicity and biodegradability.
26-28
 
Alginate gels are formed when divalent cations (i.e., Ca
2+
) cooperatively interact with 





alginate has limited bioactivity, meaning that the saccharide units do not specifically 
interact with cell surface receptors.
9
 Covalent modifications of alginates to circumvent 
this limitation have been well established via carbodiimide-mediated peptide coupling at 
the carboxylic groups of which the activation step is nonselective to both G and M 
residues. However, the covalent modification of G content reduces cross-linking sites, 
thereby interfering with gelation.
30
 The modification of alginates could be realized by 
incorporating large biomacromolecules, such as the virus particles, to generate embedded 
functionalities without forming covalent modifications to the sugar backbone. In this 
study, we prepared 3D porous hydrogels that can be functionalized by incorporating the 
viral nanoparticles to enhance mesenchymal stem cell attachment, proliferation, and 
differentiation. Given the mild synthetic conditions, we envision a range of functional 
groups could be incorporated using virus libraries or other macromolecular assemblies in 
these porous hydrogels. 
 
1.2 RESULTS AND DISCUSSION 
From the previous work, we have observed a significant shift in utilization of virus as 
bionanoparticle scaffold to direct stem cell response.
31
 We have previously demonstrated 
that TMV coated surfaces strikingly accelerated BMSCs bone differentiation in 
comparison to conventional tissue culture polystyrene.
32
 Moreover, when a phosphate 
group was chemically introduced to the TMV coat protein, the osteogenic differentiation 
of BMSCs was more evident, as indicated by greater increase in osteocalcin mRNA 
expression level.
25
 We proposed that the structural features of TMV played a role in the 
improvement of stem cell differentiation. Continued efforts by Sitasuwan et al. indicated 
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that an enhanced BMP2 expression at both mRNA and protein levels within 8 h of 
osteoinduction was only for BMSCs cultured on TMV-coated surfaces and not when 
TMV was supplemented in media.
17
 These findings have suggested the potential of 
applying TMV as a scaffold to modulate the BMP2 regulation during early osteogenic 
differentiation and potential osteogenic inducer for stem cells. In this regard, the 
development of 3D matrices was deemed essential to determine similar enhanced 
differentiation events observed with BMSCs on 2D scaffolds. In this study, we present an 
economical, convenient, and versatile method of producing a fuctional 3D culture system 
by incorporating the TMV particles. Our work is considered a pilot study and the first 
reported method of noncovalent incorporation of TMV particles in 3D porous hydrogels. 
 
1.2.1 Synthesis and characterization of porous alginate hydrogels  
TMV was introduced into the hydrogel by adding the noninfectious virus particles during 
the formation of gas templated, porous alginate hydrogels (PAH; Figure 1.1). The porous 
alginate hydrogel was fabricated following the report by Barbetta et al., which provided 
physical and mechanical parameters for potential use as 3D culture system.
28
 This 
process did not require covalent modification or further purification, which reduced 
concerns for protein deformation during covalent chemical conjugations and eliminated 
the need to engineer reactive sites to incorporate the biological molecules in the 
hydrogels. The initial homogeneous mixture of alginate in bicarbonate solution with low 
concentration of surfactant (Pluronic F-108) is reacted with a mild acid (citric acid) to 
generate CO2 in situ (Figure 1.1A). After the formation of the initial gas templated foamy 







Figure 1.1. Synthetic procedure of generating virus functionalized porous composite hydrogels. Functionalization of composite 
hydrogels for use in stem cell cultures can be achieved through direct mixing of virus solution to the foamy mixture of alginate. (A) 
Alginate mixture comprised of low viscosity alginate, Pluronic F108, and sodium bicarbonate with an equivalent amount of citric acid 
to generate gas template foamy mixture. (B) TMV was added 5 min before the foamy mixture was frozen and lyophilized. The 




flash frozen then cross-linked. Additional dialysis and lyophilization steps provided the 
final PAH functionalized with the virus particles. Developing 3D scaffolds for tissue 
engineering, such materials need to have a range of macropores and proper size of 
interconnecting channels that allow penetration of gas, nutrient and cellular infiltration.
33, 
34
 Previous studies revealed that a pore size and an interconnecting channel of 100−300 
and 40 μm, respectively, are essential for the cell survival and proliferation.
28, 35
 In this 
porous alginate hydrogel, macropores were generated by in situ gas (CO2) generating 
system composed of NaHCO3 and citric acid, suspended and stabilized by surfactant 
(pluronic F108) with the help of high viscosity from 5% alginate until the mixture was 
freeze-dried and cross-linked. PAH has provided a coarse structure for 3D cell housing 
but lack the biofunctionalities in general. We fine-tuned the PAH by physically mixing 
TMV particles during PAH synthesis. As a proof of concept, genetically engineered 
TMV that precisely display integrin binding ligands, which we called TMV-RGD1,
36, 37
 
was incorporated into the hydrogel mixture in the same way as TMV. The resulting 
modified-PAH hydrogel successfully displayed RGD peptide sequences as indicated by 
enhance cell attachment and cell viability. Similar to wild-type TMV, this RGD mutant 
could be manufactured by the infected tobacco plants and easily purified in a very similar 
procedure as wild-type TMV with high yields.
24, 37, 38
 The economical production of the 
mutant TMV particles and the potential virus-based combinatorial functionalization of 
3D material may prove to be useful for expanded material development. 
The incorporation of the virus particle, its structural integrity, and its effects upon 
the overall PAH formation (pore deformations, swelling property, and mechanical 
property) was initially assessed by ESEM. The low magnification images obtained by 
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ESEM revealed similar macropores and interconnecting channels ranging between 10 and 
500 μm for both PAH (Figure 1.2A) and TMV-PAH (Figure 1.2C). These similarities 
suggest that the addition of the virus did not hinder pore formation. The overall 
architecture of the pores for PAH (Figure 1.2A) appeared to be more compact when 
compared to the pores observed for TMV-PAH (Figure 1.2C). At a higher magnification, 
PAH indeed shows smaller pores and denser networks (Figure 1.2B) than TMV-PAH, 
whereas larger spherical pores (100−500 μm) were visible in TMV-PAH (Figure 1.2D). 
These images indicate that the overall hydrogel formation (macropores and 
interconnecting channels) is not hindered by the incorporation of the virus, which, 
instead, can further facilitate the formation of large, well-defined pores. It is possible that 
the addition of TMV stabilizes the interface between gas/liquid phase.
39
 TMV particles 
could help trapping larger hydrophobic gas pockets upon the generation of CO2 to better 
mediate the interfacial tension between aqueous and gas phases. 
To verify this simple incorporation method and to confirm that the incorporated virus still 
maintains its original rod-like structure, the existence of TMV intact particles in the 
hydrogels after the entire synthesis process was observed under TEM. Addition of a 
chelator, EDTA, was sufficient to de-crosslink the PAH and subsequently release the 
viral particles to the solution. This de-crosslinking step was used to determine whether 
the same amount of virus could be recovered from PAH, and whether the viral particles 
were still structurally intact. The recycled TMV particles (Figure 1.2E) is similar in size 
and shape under TEM in comparison to the TMV particles prior to incorporation (Figure 
1.2F). UV−vis absorbance at 260 nm of the de-crosslinked TMV-PAH solution indicated 





Figure 1.2. (A-D) Scanning electron micrographs of hydrogels and TMV particles: (A) 
and (B) PAH at different magnifications; (C) and (D) TMV-PAH at different 
magnifications. The images of TMV-PAH reveal larger macropores and interconnecting 
channels than PAH. Transmission electron micrographs of (E) intact TMV particles 
released from TMV-PAH after decrosslinking with EDTA, and (F) purified native TMV 
particles in buffer. Scale bars are 500 microns for (A) and (C), 100 microns for (B) and 
(D) and 200 nm for (E) and (F). 
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(based on 0.1% TMV solution having an absorbance of 3 at 260 nm). A defining physical 
characteristic of hydrogels is their swelling property that provides an aqueous 
environment comparable to soft tissue. Both PAH and TMV-PAH hydrated 6−7 times 
their original dry weight and was fully hydrated within 2 min (Figure 1.3A, B). A slight 
increase in swelling ratio was observed during the 4-week incubation, which could 
indicate a possible onset of the degradation of the scaffold, although such an observation 
was not accompanied by a significant change in macroscopic dimension of the scaffold 
(Figure 1.3C). Despite the lack of covalent conjugation of TMV to the alginate hydrogel, 
the virus was stably integrated into the hydrogel. The amount of TMV released from 
TMV-PAH into the aqueous solution was measured and it confirmed that most TMV 
particles were entrapped in the hydrogel matrices even upon long-term incubation in 
solution. The release profile derived from fluorescein-modified virus particles suggests 
that dye modified TMV is slowly released from the hydrogel to a maximum 13% of its 
original concentration after 24 h in solution and plateaued thereafter (Figure 1.3D). This 
release profile may be reflective of any residual small dye molecules, broken particles, or 
weakly embedded particles on the outer surface that are released to the solution. Future 
studies probing this initial release profile with long-term release kinetics would be of 
interest for time-controlled drug or biologics delivery platforms.  
The mechanical properties of stem cell microenvironments are well-recognized as 
essential determinants of differentiation fate. The mechanical factors that promote certain 
stem cell fates can vary dramatically, with as much as 300-fold difference in elastic 
modulus between matrices that favor soft brain tissue (0.1 kPa) and decalcifying bone 
(>30 kPa).
40





Figure 1.3. Swelling property and stability of porous alginate hydrogels. (A) Both PAH 
and TMV-PAH can absorb water and swell to the maximum within 2 min. (B) Total 
masses of hydrogels soaked in water over time (fold increase of initial dry weight) are 
constant and similar of both PAH (without TMV) and TMV-PAH (with TMV). (C) 
Photographs of PAH soaked in water for 1 day, 14 days, and 28 days. (D) TMV releasing 




properties of PAH was assessed through unconfined compression testing. Regardless of 
the irreversible water loss from the hydrated specimens during compression, stress versus 
strain curves demonstrated that incorporation of virus in PAH induce a shift from a linear 
to nonlinear mechanical response (Figure 1.4). The incremental elastic moduli extracted 
from average stress−strain curves indicate that virus-modified materials are stiffer in the 
lower strain regions (0−0.05), but more compliant at the higher strains (0.1−0.15; Table 
1.1). These observations in mechanical properties may be explained by corresponding 
effects on material pore architecture (Figure 1.2A−D), in which TMV inclusion caused an 
increase in pore size. It is plausible that the alginate bulk is mechanically reinforced by 
the inclusion of TMV particles (resulting in increased stiffness at low strains), but the 
macroporous architecture begins to collapse at higher strains causing a reduction in 
material stiffness. 
In thermal analysis, while modulated differential scanning calorimetry (MDSC) 
data supported the incorporation of virus particles into PAH, we showed that TMV did 
not significantly impact the thermostability of original PAH, as indicated by 
thermogravimetric analysis (TGA). As there were no covalent modifications on the 
polymer chain structure, alginate still maintained their own properties and dominates as a 
bulk material. The results showed similar decomposition profiles from TGA as well as 
heat flow profiles obtained from MDSC in all three types of hydrogels (Figure 1.5). The 
initial weight loss from TGA appeared to be water loss since the hydrogels are highly 
hygroscopic. However, the major decomposition point started at 235−240 °C referring to 
the decomposition of alginate, which is consistent with previous report.
41
 There were 





Figure 1.4. The mechanical response of PAH, TMV-PAH, and RGD-PAH to unconfined 
compression. PAH exhibited linear behavior, while both forms of virus modified PAHs 
(TMV-PAH and RGD-PAH) induced nonlinearity at high strains (>0.1). Values 
expressed are means (n=3) ± S.D. 
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Table 1.1. Incremental elastic moduli of PAH, TMV-PAH, and RGD-PAH in two 
compressive strain ranges (0-0.05 and 0.1-0.15). Values expressed are means (n=3) ± 
S.D. 
 
Strain range  Incremental  Modulus (kPa)  
 PAH TMV-PAH RGD-PAH 
0-0.05  103.92±23.10  183.01±13.09  146.56±7.49  





Figure 1.5. TGA (Termogravimetric analysis) characterization of porous composite 
hydrogels. The porous composite hydrogels (A) PAH, (B) TMV-PAH, and (C) RGD-
PAH have similar weight-loss decomposition profiles
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hydrogels. The thermal decomposition of TMV could not be observed from this 
experiment, which is possible that the virus were decomposed in the same temperature 
range as alginate. MDSC showed very broad endothermic peaks of the overall heat flow 
profiles from all three types of hydrogels due to the dominance of amorphous 
characteristic of hydrogels. The peak shift showing a combination of heat profiles from 
PAH and TMV alone was observed on TMV-PAH, which was similar to the profile of 
RGD-PAH. This could indicate some interaction occurring between virus particles and 
PAH (Figure 1.6). 
 
1.2.2 Cell attachment and cell viability in 3D virus-incorporated hydrogels 
A number of studies have been done on modifying hydrogel scaffolds with peptide 
sequence by peptide-polymer conjugation in order to probe substantial cell recognitions. 
As the concept of multivalency effect in which intracellular cell machinery is believed to 
be under integrative control of cell microenvironment by means of ligand density and 
ligand orientation through oligomerized cell-surface receptors, the major threat of peptide 
modifications is the lack of control over the spatial distribution of ligands displayed on 
modified polymer in 3D system.
42
 Distinctively, we suggested the opportunity of using 
virus nanoparticle to introduce the multivalency of ligands in 3D system. Our previous 
experiment showed that the cell binding ligands on TMV-RGD1 mutant were exposed 
and accessible for the cells.
37
 To demonstrate the potential use in cell cultures, cell 
attachment, and viabilities were determined for the three types of hydrogels. Despite the 
arrest in metabolic activity from a slow differentiation that might occur without the 





Figure 1.6. MDSC (Modulated Differential Scanning Calorimetry) characterization of 
porous composite hydrogels. (A) An overlay total heat flow profile of PAH, TMV-PAH 
and TMV alone showed the temperature shift on TMV-PAH as a combination of PAH 
and TMV alone. (B) RGD-PAH showed similar total heat flow profiles with TMV-PAH.
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BMSCs culture because they survived and were able to grow in the PAH either with or 
without the viral particles. In cell attachment assay, RGD-PAH (96 ± 1%) had 
significantly higher cell attachment after 8 h of incubation than PAH (85 ± 3%). The 
incorporation of TMV did not provide any significant improvement to cell attachment 
when compared to the control (85 ± 1%; Figure 1.7A). Based on the metabolic assay with 
CTB reagent, the cell viabilities in all three different types of hydrogels were determined 
for days 8 and 14 cultures and normalized to metabolic rates of cells in PAH (Figure 
1.7B). The results indicate that BMSCs survived in both virus modified PAHs (TMV- 
and RGD-PAH) and the cells cultured on RGD-PAH continued to have the highest 
metabolic activity (Figure 1.7B). However, there was no further increase in metabolically 
active viable cells from day 8 to day 14. One possible explanation is that the change in 
metabolic activity of cells due to the differentiation also occurred slowly without 
osteogenic induction supplements in TMV-PAH and RGD-PAH. This explanation was 
supported by the previous report from our group, which tested on a TMV-coated 
substrate.
17
 Despite the lower attachment numbers and cell numbers for PAH and TMV-
PAH samples, the cells could penetrate deeply into the hydrogel, as indicated by ESEM 
analysis (Figure 1.8). The morphology of the cells was visualized by ESEM in which the 
BMSCs adhered and spread out for both PAH (Figure 1.8A) and TMV-PAH (Figure 






Figure 1.7. Cell attachment and viability in different types of porous composite 
hydrogels. Cell attachment was observed from counting the floating cells in the media 
after initial cell seeding for 8 h. (A) Percent attachment of BMSCs in each type of 
hydrogels. Values expressed are mean (n = 3) ± S.D. (B) CellTiter Blue
®
 metabolic 
activity assay of BMSCs culture in different types of hydrogels at different time points. 
Values expressed are mean (n=3) ± S.D. of RFU that were normalized against PAH for 






Figure 1.8. Scanning electronic micrographs of cell inside the hydrogels, showing the 




1.2.3 Osteogenic differentiation of BMSCs in 3D virus-incorporated hydrogels 
For the application point of view, our previous works provided a solid background of 
bone tissue development improved by TMV and other plant viruses. The 2D studies 
demonstrated that substrates coated with plant viruses supported BMSCs growth and 
accelerated cell differentiation.
32
 TMV decorated with phosphates caused an increased 
calcium sequestration and higher expression levels of genes related to osteogenesis.
16
 
Plus, the concept of diversity in differentiation ability of BMSCs has been well 
established in the past years. In particular, their osteogenic differentiation potential has 
become one of the most widely studied topics in bone regeneration. Large extent of 
research has shown promising results when using osteoblasts differentiated from BMSCs 
in bone regenerative processes.
43, 44
 The differentiation studies in our 3D devices were 
directed to the osteogenic lineage of BMSCs in osteogenic supplemented media. The 
differentiation of seeded BMSCs toward the osteogenic lineage was explored by 
analyzing several cell differentiation markers.  
First, the activity of alkaline phosphatase (ALP), an early osteoblastic marker that 
reflects not only the stage of cell differentiation but also represents the percentage of 
committed osteoprogenitor cells, was evaluated. The activity of this enzyme increases 
during synthesis of the extracellular matrix, which corresponds to the beginning of cell 
differentiation.
45, 46
 The ALP activity was initially assessed at days 3, 7, and 14 upon 
culturing in the osteogenic medium (Figure 1.9A). Low levels of enzyme activity were 
detected for all three samples for day 3 cultures, followed by marked increases in ALP 
activities on days 7 and 14. The incorporation of the virus did not appear to hinder the 





Figure 1.9. Osteogenesis assays of BMSC in porous composite hydrogels. (A) ALP 
activity assay was performed on day 3, 7, and day 14 of osteogenic culture. Values 
expressed are mean (n=3) ± S.D., 
≠/
*paired equal variance Student t-test, p < 0.05. (B) 
Calcium deposition quantified by ICP-OES on day 6 after background subtraction from 
control samples with no cells. Values expressed are mean (n=3) ± SEM, *paired equal 
variance Student t-test, p < 0.05. (C) Thin sections of hydrogels stained with Alizarin red 
on day 14 cultures, scale bar = 2 mm.
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measured among the three groups from day 3 to day 14. Interestingly, RGD-PAH seemed 
to accelerate an early osteogenesis of BMSCs as the ALP activity was significantly 
higher among three samples on day 3. However, on day 7, the unexpected higher level of 
ALP activity was observed for PAH compared to the virus-functionalized PAH. Based on 
the comparison of the three matrices cultures, ALP activity was found to be the same 
trend, showing an increase in the enzyme activity from day 3 to day 14 in all three 
hydrogels as the development of bone tissue. Essentially, the incorporation of TMV-
RGD1 was shown to promote an early stage differentiation by significantly elevated ALP 
activity observed on day 3 compared to those from PAH and TMV-PAH.  
Although the ALP activity’s result from day 7 showed otherwise, the following 
calcification analysis from ICP-OES showed the significant increase in mineralization in 
RGD-PAH that was already occurred on day 6. Calcium deposition in three types of 
hydrogels with BMSC osteogenic culture was quantified by ICP-OES (Figure 1.9B). The 
average amounts of calcium deposited in both TMV-PAH and RGD-PAH after 
background subtraction from control samples without cells were higher than in PAH 
(Figure 1.9B). All three types of hydrogels with BMSCs osteogenic culture were stained 
with Alizarin red giving intense red color (Figure 1.9C). Although calcium is used as a 
cross-linking agent, PAH without cells stained lighter pink with the dye (see Appendix 
B). A higher calcium level of osteogenic culture in TMV- and RGD-PAH could be a 
consequence of the high calcium binding affinity of TMV.
47, 48
 This issue was taken into 
account as the calcium produced by differentiating cells could be sequestered more in 




Hydroxyapatite is a major mineral component of calcified tissue (bone and teeth). 
Its composition is a crystalline form of calcium (Ca) and phosphorus (P), with the 
formula Ca10(PO4)6(OH)2.
49
 To further confirm the presence of Ca and P in the stem cell 
impregnated hydrogels, elemental analysis for the two samples were determined. The 
results indicate deposition of calcium phosphate around the cell areas with higher Ca 
levels detected for both PAH with and without TMV (Table 1.2). In PAH, the amount of 
P was less as nondetected in the scaffold. 
As BMSCs undergo the phase of the maturation and ECM remodeling, 
osteocalcin is considered as the most specific marker of mature osteoblasts. Osteocalcin 
is a calcium binding protein, gets accumulated in mineralized bone, and binds actively to 
hydroxyapatite crystals promoting bone crystal growth.
31
 It actively controls the process 
of ossification, ECM remodeling, and maturation. We observed this biomarker via 
immunostaining, which exhibited the intense localization of osteocalcin within 13 days of 
osteogenic induction culture in all three composite hydrogels. Figure 1.10 illustrated the 
accumulation of osteocalcin after day 10 (PAH) and day 13 (TMV-PAH and RGD-PAH) 
and confirmed that virus incorporation into 3D matrices did not impair the differentiation 
potential of BMSC into osteogenic lineage.  
Also, the results from calcium deposition studies including Alizarin red staining, 
quantification of calcium deposited in the hydrogels by ICP-OES, and elemental analysis 
using EDX confirmed that differentiated BMSCs underwent mineralization process in 
composite porous hydrogels under BMP-2 free osteogenic induction. However, unlike 
what others have reported on similar work with RGD peptide modification in hydrogel 
systems,
50
 the results herein did not show a dramatic increase in ALP activity on early 
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Table 1.2. Mineralization assay by EDX (Elemental analysis) of BMSC osteogenic 
culture on day 17 in PAH, TMV-PAH, and RGD-PAH showed peak intensity for calcium 
and phosphorous around the cell in all three samples. 
 
                    Elements Around cells  Scaffold  
PAH  P  9.55  N/D*  
Ca  69.15  56.75  
TMV-PAH  P  15.45  17.05  
Ca  283.6  160.65  
   RGD-PAH P 23.00 18.00 






Figure 1.10. Confocal images of differentiated BMSCs in 3D composite hydrogels 
stained for nucleus (blue), actin (green) and osteocalcin (red). Scale bar = 50 microns. 
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BMSC differentiation when more biofunctionality was added through TMV-RGD. The 
possible explanation could be the limited concentration of RGD peptide that was exposed 
in the hydrogel due to the fairly low percentage (0.1%) of TMV-RGD incorporated in the 
hydrogel. Yang et al. demonstrated that RGD can promote ALP and osteocalcin 
production of BMSCs, however, in a dose-dependent manner, in peptide covalently 
incorporated poly(ethylene glycol) diacrylate hydrogel.
51
 Therefore, the optimum 
concentration of TMV and TMVRGD can be further explored to improve the BMSC 
osteogenesis in this system 
Moving forward in a tissue engineering direction, a near future study will be 
focusing on the improvement of hydrogel synthesis regarding uniformity in size and 
shape of hydrogels, essentially for further in vivo studies, including biocompatibility and 
in vivo bone formation. Besides, with the unique nature of TMV, we can potentially bring 
other specific ligands to 3D porous composite hydrogel with multivalency directing the 
stem cell differentiation in other lineages.
16
 In addition, there are opportunities to develop 
this virus-based combinatorial hydrogel functionalization for better therapeutic outcome, 
for example, conjugation of growth factors and other small molecules to promote stem 
cell differentiation or vascularization, as well as endogenous stem cell recruitment 





We have successfully synthesized the alginate-based porous composite hydrogels 
functionalized with biomacromolecules and demonstrated their advantage as vehicles to 
support the 3D stem cell culture and differentiation. We have shown that TMV surface 
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can be accessible in 3D porous hydrogels as shown by significant improvement in cell 
attachment after functionalization by TMV-RGD1. Moreover, the incorporation of TMV 
and its RGD mutant can facilitate bone differentiation of BMSCs. This study is 
considered a proof-of-concept for utilizing virus particle to display functionalities onto 
the 3D alginate porous hydrogel. Together with further biocompatibility and bone 
formation studies in vivo, this system could be even more applicable for tissue 
engineering biocompatible matrix. This attractive approach could not only allow for the 
localization, delivery, and differentiation of stem cells but also contribute the advantage 
of simplicity in matrix modifications. 
 
1.4 EXPERIMENTAL SECTION 
All chemicals were obtained from commercial suppliers and used as received unless 
otherwise noted. Wild-type TMV (TMV) and its RGD-mutant (TMV-RGD1) were 




1.4.1 Synthesis of virus-incorporated porous alginate hydrogels 
The synthesis of gas template solid foam was based on the methodology reported by 
Barbetta et al.
28
 Briefly, 5% w/v low viscosity sodium-alginate (Protanal
®
 LF 10/60 FT, 
30-60 mPas for 1%, kindly provided by FMC Biopolymer UK Ltd.) was dissolved in 2% 
w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 solution. Molar equivalent 
of citric acid with respect to NaHCO3 was added to the mixture while stirring. Stirring 
was continued for 15 min to allow CO2 to fully develop. Afterward, the foamy alginate 
solution was flash frozen in liquid nitrogen and freeze-dried. The resulting solid foam 
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was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based 
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid 
foam was freeze-dried, resulting in porous alginate hydrogel (PAH). For the TMV 
modified PAH (TMV-PAH), or mutant TMV-RGD1 modified PAH (RGD-PAH), 0.1% 
w/v of virus was added to the solution 10 min after adding citric acid. The mixture was 
stirred for another 5 min.  
TMV-PAH was de-crosslinked and dissolved in 0.5 M EDTA, and the solution 
was analyzed under transmission electron microscopy (TEM) (Hitachi H-8000 
microscope) on 300 mesh copper grids coated with carbon and stained with 2% uranyl 
acetate. The absorbance at 260 nm was measured by UV-Vis spectroscopy to confirm the 
concentration of TMV in de-crosslinked alginate solution. 
 
1.4.2 Environmental scanning electron microscopy 
Environmental scanning electron microscopy (ESEM) images and elemental analysis by 
EDX were obtained by FEI Quanta 200 electron microscope. Freeze dried samples were 
cut to about 2 × 2 × 2 mm
3
 cubes and mounted on aluminum stubs with carbon tape. For 
ESEM, samples were observed under a low vacuum with 30 kV of electron acceleration, 
a spot size of 4-6, and a 6-10 mm working distance. The same condition was used for 
EDX except the work distance was fixed at 10 mm and at least 3 areas were analyzed. 
Cell morphology in hydrogels was visualized by ESEM. Day 8 cultured hydrogel 
samples were prepared following the biological preparation procedure for ESEM. In 
brief, the samples were fixed in 2.5% glutaraldehyde in 0.1 M cacodylated buffer (pH 
7.4) overnight at 4⁰C and post-fixed in 1% OsO4 in cacodylated buffer for 1 h at 4⁰C in 
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dark. The samples, after being washed 3 times with cacodylated buffer, were frozen in 
liquid N2 and lyophilized. The lyophilyzed samples were mounted on aluminum stubs 
using a carbon tape.  
 
1.4.3 Swelling property of PAH 
Swelling property of PAH was determined by the final weight divided by the initial 
weight of the hydrogel. The initial weights (2-3 mg) of freeze dried PAH and TMV-PAH 
were recorded (µ0). Hydrogels were immersed in water, and then the weights after 
hydration of hydrogels were recorded over time (µƒ). Surrounding water was drained and 
blotted out with Whatman filter paper from hydrated hydrogels before weighing. The 
study was continued for 4 weeks to observe the stability of the hydrogels. The swelling 
ratio was defined as μƒ/μ0. 
 
1.4.4 TMV releasing profile 
TMV releasing profile was observed for the stability of TMV-PAH. Fluorescently labeled 
TMV (TMV-Fl) was prepared by carbodiimide coupling reaction (see Appendix C for the 
MALDI-TOF analysis of the fluoresceinamine internal modification of wild-type TMV 
and TMV-Fl emission spectrum) according to the reported protocol
20
 and incorporated in 
alginate hydrogels as previously described. Firstly, the standard curve (Appendix C) of 
fluorescent intensity from different concentration of TMV-Fl was generated. The reading 
was measured at 490/530 nm (Ex/Em). Each TMV-PAH (3 × 3 × 2 mm
3
) was submersed 
in 1 mL 100 mM CaCl2 Tris-buffered saline (TBS) pH 7.4. From each sample, 100 μL of 
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buffer solution was collected and replaced by the same volume of fresh buffer at different 
time points.  
 
1.4.5 Mechanical testing  
The mechanical properties of porous alginate hydrogels before and after the inclusion of 
TMV or TMV-RGD1 were compared via unconfined compression testing. Disk-shaped 
samples (3 mm height, 1.5 mm radius) of each material were maintained in TBS until the 
time of testing. Each hydrated material sample was placed between flat platens of a 
mechanical testing system (Bose Electroforce 3200 series instrument) and immediately 
subjected to displacement-controlled compression of 0.45 mm (displacement rate of 1 
mm min
-1
) without neither water submersion fixture nor water replacement during 
compression. Sample deformation and load were continuously recorded (50 measurement 
sec
-1
) by the system software (Wintest), and subsequently processed to generate true 
stress versus strain curves. Material incremental moduli were calculated based on average 
data linearization in two strain regions (0-0.05 and 0.1-0.15) to provide a basis for 
assessing the effect of TMV or TMV-RGD1 inclusion on the mechanical properties of 
PAH. 
 
1.4.6 DSC and TGA tests 
Modulated differential scanning calorimetry (MDSC) measurements on dry PAH, TMV-
PAH, and RGD-PAH were carried out using a TA Q2000-DSC thermal analyzer (TA 
Instruments, New Castle, DE, USA). Hydrogel samples and TMV alone (5-10 mg, with 
0.1 mg accuracy) were packed down and sealed in aluminum solid pans, and an empty 
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pan was used as reference. The pans were heated at a scan rate of 3°C/min according the 
following program: equilibrated at 0°C, modulated at ±1°C every 60 sec, kept isothermal 
for 5 min, and then heated to 220°C. Reversible and non-reversible heat flow signals 
were separated from the total heat flow signals. The peak melting temperature was 
determined from the reversing heat flow signal. 
Thermogravimetric analysis (TGA) was carried out using a SDT 2960 
Simultaneous DTA-TGA thermogravimetric analyzer (TA Instrument). The sample was 
heated from room temperature to 700°C at a rate of 5°C/min under Helium gas flow. 
Prior to analysis, the samples were thoroughly dried in a vacuum for overnight. 
 
1.4.7 Bone Marrow Stem Cells (BMSCs) isolation and culture  
Primary BMSCs were isolated from the bone marrow of young adult 160-180 g male 
Sprague-Dawley rats (Charles River Laboratories). The procedures were performed in 
accordance with the guidelines for animal experimentation by the Institutional Animal 
Care and Use Committee, School of Medicine, University of South Carolina. Cells were 
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS)), kept at 37°C in a CO2 incubator with 
5% CO2 : 95% air and passaged no more than seven times after isolation.  
 
1.4.8 Cell seeding and attachment studies 
Lyophilized PAH, TMV-PAH, and RGD-PAH were cut to 3 × 3 × 2 mm
3 
cubes.  In each 
set of experiment, six hydrogels per type of sample were used for these studies. 
Hydrogels were sterilized in 70% ethanol for 15 min, ethanol was drained on sterile filter 
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paper and the hydrogels were further sterilized under UV-light for 60 min in laminar 
airflow hood. Hydrogels were then saturated in complete primary media at 37°C for 60 
min, blotted excess media with sterile filter paper, and placed in 12-well non-adhesive 
plate (6 hydrogels in each well). BMSCs were harvested from 80% confluent culture 
flask using 0.25% trypsin/EDTA for 5 min and counted and re-suspended in complete 
primary media. 1.4 × 10
3
 BMSCs were seeded per one volume of hydrogel. Rat BMSCs 
loaded hydrogels were initially incubated with 200 μL of complete primary media in each 
well to prevent hydrogels from drying out. After 6 h of an initial incubation, hydrogels 
were completely submersed in 1 mL of complete primary media in each well. The 
hydrogels seeded with rBMSCs were cultured at 37°C and 5% CO2.  
Attachment percentages were determined for different types of hydrogels on day 
1 after cell seeding by counting floating cells in each well with a hematocytometer. Three 
separate experiments were carried out in this study. 
Attachment percentage   
total seeding cell number floating cell number
total seeding cell number
 
 
1.4.9 Cell viability 
CellTiter-Blue
®
 (CTB) cell viability assay (Promega) after day 8 and day 14 of culture 
was performed for each type of hydrogel. The culture media in each well was replaced by 
1 mL of pre-warmed media containing 10% CTB and incubated for 1 h at 37°C and 5% 
CO2. The media containing CTB was used without cells as negative controls. The 
measurement of the CTB product was taken at two time points. First, to detect the cells 
that attached to the outer surface of hydrogel, the solution was collected and replaced 
with 1 mL of culture media. The incubation was continued for another 2 h to allow 
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diffusion of the fluorescent product from the inner part of hydrogel. After 2-hour 
incubation, the media solution was collected again and replaced with 1 mL of culture 
media in each well to continue cell culture. The 1:1 mixture of solution from first 
collection and second collection was measured for fluorescence intensity at 560/590 nm 
(Ex/Em) using SpectraMax M2 Multi-Mode microplate reader (Molecular Devices). 
Also, three separate experiments were conducted with each type of sample, which 
comprised of 6 hydrogels. 
 
1.4.10 Osteogenic culture  
After 1 day of cell seeding, complete primary media was replaced by osteogenic media 
consisting of DMEM supplemented with 10% FBS, 10 mM sodium β-glycerol phosphate, 
l-ascorbic acid (50 μg/mL), 10
−2
 μM dexamethasone, penicillin (100 units/mL), 
streptomycin (100 μg/mL), and amphotericin B (1 μg/mL). The osteogenic media was 
changed every 2 days. The culture was incubated at 37°C and 5% CO2. 
 
1.4.11 Alkaline phosphatase (ALP) and mineralization assays 
Alkaline phosphatase (ALP) activity was determined using pNPP (p-nitrophenyl 
phosphate) assay (Sigma Diagnostics). After 3, 7 and 14 days, the hydrogels with cells 
were pre-washed with TBS then incubated with pNPP solution at room temperature for 
2.5 h. Absorbance was read using a M2 SpectraMax plate reader at 405 nm indicating 
ALP activity levels. The enzyme activity was calculated from Beer-Lambert law as 
follow, 
Enzyme activity ( moles/min/ g)   
V ( L)    D405nm (cm
 1
)

















) is the absorbance at 405 nm divided by the light-
path length (cm). V is the final assay volume (100 μL). 
Alizarin Red S (ARS) staining for Ca
2+
 was performed on day 14 cultures. The 
hydrogels with cells were washed 3 times with TBS and fixed in 10% buffered formalin 
overnight and sliced into 1 mm thick samples. The sections were then stained with 0.1% 
solution of ARS (Sigma-Aldrich) pH 4.1-4.5 for 30 min, washed with 1:1 xylene:acetone 
solution and placed with toluene mounting solution on glass slides. Control experiments 
without cells were conducted for PAH, TMV-PAH, and RGD-PAH. 
Calcium concentrations were quantified using Varian 720-ES ICP-OES 
(Inductively Coupled Plasma - Optical Emission Spectrometer) elemental analysis. 
Standards were created using 0-0.4 mg/L calcium standard solutions. PAH, TMV-PAH 
and RGD-PAH with similar size and weight were seeded with BMSCs and cultured with 
osteogenic supplement media until day 6. Samples were washed with sterile Milli-Q 
water and completely lysed with dissolving solution (0.1% HNO3, 0.01% TritonX-100, in 
100 mM sodium citrate). The dissolved samples were diluted to fit the range of the 
standard curve. Approximately 4 mL of each diluted sample was fed into the instrument 
per run. The experiment was performed in triplicates. Control experiments without cells 
were also performed for PAH, TMV-PAH, and RGD-PAH in the same manner. 
 
1.4.12 Immunostaining 
Immunostaining was performed to observe the presence of osteocalcin. rBMSCs culture 
in PAH, TMV-PAH, and RGD-PAH were terminated after culturing 10 days for PAH 
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and 13 days for TMV-PAH and RGD-PAH hydrogels in osteogenic media. Hydrogels 
were washed three times with 100 mM cacodylated buffer and then fixed in 2.5% 
glutaraldehyde in cacodylated buffer overnight. The fixed samples were then 
permeablized for 15 min in TBST (0.05% Tween20) and blocked in 2% w/v bovine 
serum albumin (BSA, Sigma–Aldrich) in TBS for 20 min with gentle agitation at room 
temperature. After blocking, the hydrogels were incubated for 2 h with primary antibody 
targeting the osteospecific protein osteocalcin (Santa Cruz Biotechnology). Secondary 
antibody detection Alexa Fluor
®
 546 (Molecular Probes, Invitrogen) was used for 
osteocalcin at 1:100 dilutions in blocking buffer for 1 h at room temperature. In the end, 
the hydrogels were washed with TBS and counter-stained with DAPI (nuclear staining) 
and FITC-Phalloidin (actin staining). Images of the stained samples were obtained using 
Olympus IX81 with DSU confocal mode under 20x oil lens (NA = 0.85). Exposure times 






IN VIVO COMPATIBILITY AND DEGRADABILITY OF TOBACCO MOSAIC VIRUS  
INCORPORATED HYDROGELS AS SCAFFOLDS FOR TISSUE ENGINEERING 
3.1 INTRODUCTION 
3.1.1 Virus and virus-like nanoparticles in tissue engineering 
Virus nanoparticles are now gaining great interest from different interdisciplinary fields 
especially in material science as nanoscale building blocks. The major advantage of virus 
nanoparticles is that they can easily be produced in gram quantities with high uniformity 
in laboratory. Viral capsids can be in different sizes, shapes and arrangements. They are 
exceptionally robust in that their surface modifications are amendable by genetic and/or 
chemical approaches, thereby presenting different types of functionalities.
54, 55
 The use of 
chemical ligands can be complemented by the genetic engineering of virus coat proteins 
that offer multivalency of specific peptides.
24, 56
 Moreover, spatial display of signaling 
molecules or peptides can be obtained at the nanometer scale leading to the 
programmable designs for quantitative investigations of cell behaviors.
57, 58
 Among viral 
nanoparticles, plant viruses are considered safer than human pathogen-derived viruses 
such as adenovirus in terms of handling, processing, and downstream medicinal 
applications.
59
 These properties make the plant viruses attractive tools for biomedical 
applications including drug delivery and tissue engineering.
60, 61
 
Our group had introduced the use of plant viruses as scaffolding materials to 
probe cellular behaviors. Some of the previous publications focused on the enhanced
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bone regeneration from bone marrow stromal cells (BMSCs) using Tobacco mosaic virus 
(TMV) and its mutants.
16, 17, 25
 Along the same line, our attempt has translated into a three 
dimensional (3D) model using alginate, a well-known biologically inert natural polymer, 
as the TMV-functionalized 3D hydrogel’s base-material. The 3D porous alginate 
hydrogels (PAH) functionalized with wild-type TMV (TMV-PAH) and its RGD mutant 
(RGD-PAH) have been developed. This proof-of–concept study indicated that the 
integration of biofunctionality in 3D hydrogel could be simply achieved by the 
incorporation of viral nanoparticles which carry the functional units therefore maintain 
the ability to regulate cell behavior in the hydrogel environment. As shown in our study, 
RGD-PAH gel had increased cell loading capacity with higher alkaline phosphatase 
activity in early-stage osteogenesis of BMSCs in comparison to the control hydrogels 
(PAH and TMV-PAH). We suggested that TMV can be used as a platform to provide a 





2.1.2 In vivo toxicity and degradation of plant viruses in biomedicine  
In vivo properties, especially any potential toxic effect needs to be taken into 
account, when developing novel materials for biomedical applications. There have been 
many studies that reported the in vivo characteristics including biodistribution and 
toxicity of different types of viral nanoparticles used in biomedicine.
62-67
 For example, 
spherical plant viruses, cowpea mosaic virus (CPMV) and cowpea chlorotic mottle virus 
(CCMV), as well as filamentous bacteriophage M13, showed a broad biodistribution 
throughout the body, albeit predominantly in the liver and the spleen.
63-66
 Blood clearance 
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kinetics, biodistribution, and histopathology of rod-shaped TMV were also observed by 
Wu et al, 2013. The study demonstrated that radio-iodinated TMV was accumulated 
mostly in the spleen and the liver of BALB/c mice and U87MG tumor-bearing mice with 
no overt toxicity. About 97% of TMV particles were eliminated from the blood 
circulation by the reticulo-endothelial system (RES) within 40 minutes after intravenous 
(IV) administration of ∼1 μg TMV per animal.67 Liver and spleen are parts of the RES 
that play a critical role in removing antigens, including structured proteinaceous 
nanoparticles, from circulation through mononuclear phagocyte system (MPS).
62, 68, 69
 
Similarly, Steinmetz group studied pharmacokinetic properties of TMV in two different 
shapes, 300 x 18 nm rods and 54 nm spheres. The rapid clearance of TMV was confirmed 
in both shapes (rods had longer blood circulation) with blood and tissue biocompatibility. 
Moreover, PEGylation of TMV could create the stealth layer shielding TMV from 
recognition of RES leading to the longer circulation of the nanoparticle in blood stream.
62
 
However, the immune responses for TMV were not addressed.
62, 67
 These studies 
suggested that, even though, the animal’s physiologic system recognizes the viral 
nanoparticles as foreign bodies, these do not necessarily reflect the systemic toxicity.  
Antigenicity of TMV has been well established for more than 50 years.
70, 71
This 
rod-like virus has been used extensively as a model system for studying various aspects 
of virus-antibody interactions. TMV, when administered with adjuvant, gives very high 
immunogenicity in vivo at doses as low as micrograms immunization per kilogram in 
rabbits and mice.
72-74
 TMV has allowed immunologists to study and develop a system 
that can enhance immune response to pathogenic antigens for vaccine applications.
75, 76
 
Gilleland group constructed the genetically modified chimeric TMV by inserting 
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sequences representing peptide of outer membrane protein F of Pseudomonas aeruginosa 
between amino acids Ser154 and Gly155 of the TMV coat protein and observed the 
immunoprotection to the bacteria in a mouse model of chronic pulmonary infection.
77
 
Nevertheless, the systemic toxicity and immunogenicity of TMV as a functional material 
in implanted polymeric hydrogels for tissue engineering in animals or human has not 
been reported. 
In our study, we focused on the toxicity of the hydrogels modified with TMV and 
its mutant in animal model. We studied the potential of using the TMV-functionalized 
PAH in stem cell bone tissue engineering in vivo by two means. First, the 
biocompatibility and possible toxic effects of the subcutaneously implanted hydrogels 
were investigated. The antigenicity of TMV in the hydrogel implant was also evaluated. 
Second, the biodegradability of hydrogels was observed at the endpoint of the animal 
study to further characterize this plant virus-hydrogel system regarding the suitability of 
its application for tissue engineering. 
 
3.2 RESULTS AND DISCUSSION 
3.2.1 In vivo Biocompatibility of Plant Virus as Biomaterial for Tissue Engineering 
Our recent discoveries suggested that TMV, as nanoparticle platform, offered a high 
density of biofunctional ligands that were able to probe different cellular responses 
including the induction of rapid bone differentiation in both 2D and 3D environments.
16, 
25, 36, 37, 55, 78
 As reported in our previous paper,
37
 we have developed a 3D system of 
TMV-functionalized macroporous alginate hydrogel that could facilitate bone 
differentiation of BMSC in vitro. By incorporating RGD mutant of TMV to the hydrogel, 
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cell loading capacity increased by at least 12% and the stem cells expressed greater 
alkaline phosphatase activity after osteogenic induction. However, questions regarding 
the in vivo toxicity of TMV-modified hydrogel were still unanswered.
37
 In this chapter, 
we performed careful studies mainly focusing on the in vivo biocompatibility of the 
hydrogels functionalized with wild-type TMV and its RGD mutant (Figure 2.1).  
TMV is an RNA virus that typically infects plants and considered non-pathogenic 
in human. Meanwhile, the virus could highly induce the adaptive immune response in 
mammal.
79, 80
 Because of its well-known immunogenicity in mammal, we here evaluated 
whether TMV, after being incorporated in the 3D biocompatible polymeric hydrogel 
scaffold, could still cause serious toxicity and/or physical symptoms derived from 
specific immune response in animal model. The animals were closely observed for the 
entire experimental period. The surgical wound heeled within 1 week. Grossly, all mice 
were normally active in eating, drinking, and grooming with no observable hair loss, skin 
wounds on implanted sites, and aggressive behavior.  The body weight of mice with 
PAH, TMV-PAH, and RGD-PAH implanted were comparable to the mock group 
(without any implant) as shown in Figure 2.2.  
 The blood samples from each group of mice in 2 and 4 post-operative weeks were 
analyzed for total blood count. All animals had blood cell numbers counted in the normal 
ranges (values shown under the bottom x-axis, Figure 2.3). The host inflammatory 
responses after the surgery were evaluated by white blood count including total white 
blood cell (WBC), lymphocyte (LYM), monocyte (MON), and neutrophil (NEU) counts. 
In this study, these parameters in all mice were shown to fall in the normal range after 





Figure 2.1. Schematic diagram depicted the synthetic procedure virus functionalized 
composite hydrogel for implantation. Functionalization of composite hydrogels can be 
achieved through direct mixing of virus solution to the foamy mixture of alginate. (A) 
TMV particles after purification in 0.1 M potassium phosphate buffer was added and 
dispersed into the foamy solution B. Scale bar is 200 nm (B) Alginate mixture comprised 
of low viscosity alginate, Pluronic F108, sodium bicarbonate with an equivalent amount 
of citric acid to generate gas templated foamy mixture. The mixture was molded, frozen 
and lyophilized. The lyophilized sample was crosslinked with CaCl2, then lyophilized. 
(C) The resulting hydrogel was 6.35 mm in diameter and 2 mm in height. (D) After 
hydrated by sterile PBS overnight, the hydrogel was subcutaneously implanted at the 






Figure 2.2. Animal growth rates were normal in all mice after implantation of different 
types of hydrogels. The actual body weight at each time point was normalized with the 
weight prior to the operation. The mouse weight was monitored along the experimental 
period of 28 days. All the hydrogel implanted mice were healthy and growing normally 
according to the mock control. Values expressed are means (n = 6, for day 2 – 14 and n = 
3, for day 21 - 28) ± SD. Mock control data analyzed from 2 mocks on the first 2 weeks, 





Figure 2.3. Total blood analysis of mice implanted with porous composite hydrogels. 
The hematology was essentially normal in all animals. The total blood counts were 
performed at 2 time points (2 and 4 post-operative weeks). The histograms showed the 
numbers of total white blood cells (WBC), lymphocyte (LYM), monocyte (MON), NEU 
(neutrophil), red blood cell (RBC), hemoglobin (HGB), platelet (PLT), and mean platelet 
volume (MPV). The normal range of each parameter for mice was indicated in the boxes 
below the histograms. Values expressed are means (n = 6, for day 2 – 14 and n = 3, for 
day 21 - 28) ± SD. Mock control data analyzed from 2 mocks on the first 2 weeks, but 1 
mock after week 2. 
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 Other blood parameters that indicate animal health and significant loss of blood 
such as red blood cell (RBC) and hemoglobin (HGB) were shown to be normal in all 
animals as well. Even though platelet count (PLT) from every sample was lower than the 
normal range, as well as the corresponding mean platelet volume (MPV) was shown to be 
high, this result was consistent with the mock control in both time points (Figure 2.3). 
The explanation could be an error caused by the automated blood counter instrument that 
might have counted some aggregates of platelets from each blood sample showing less 
numbers of PLT and increased number of MVP. The normal spleen weight between 3.0 ± 
0.17 and 3.6 ± 0.14 g/kg of total body weight from each animal observed at the end of the 
experiment indicated that there were no chronic and/or major inflammatory and toxicity 




 Histological sections of the explants were stained with H&E staining and 
evaluated the infiltration of inflammatory cells, fibroblast, and new blood vessels into the 
hydrogels. No significant differences were detected between each gel condition within 
the same time point. Macrophages and lymphocytes were seen in the tissue around the 
gel disks at both time points. At week 2, there were some inflammatory cells observed in 
the peripheral area with 1.0 - 2.0 average score range, as well as the histological scores 
from week 4 that fell between 1.0 - 1.7. Average scores of 0.3-1.0 indicated mild 
inflammation observed in the center of the hydrogels from week 2, while they slightly 
increased with no statistical significance (p > 0.05, ANOVA) to 1.0 - 2.0 at week 4. Very 
few fibrosis was found in all explants (average score = 0.3) at week 2. However, 
fibroblasts accumulated given statistically higher scores on week 4 (p < 0.05, ANOVA). 
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Table 2.1. Average spleen weights of experimental mice at 8 week endpoint. Healthy 
mice have normal spleen weight in the range between 0.085 - 0.112 g (calculated from 30 
g of total body weight).
33
 Values expressed are means (n = 3) ± SD.  
 







 New capillaries for which process required oxygenation of transplanted tissues
82
 
were present in all types of hydrogels from both time-points at average score of 1.0 - 1.3 
(Figure 2.4). Inflammatory cell infiltration, fibrosis and neovascularization indicated the 
normal wound healing progress and emphasized that the macro-porous structure of these 
hydrogels allowed cell invasion in vivo.
27, 83
 
The fact that TMV causes humoral immune response in animals and is 
consequently used as antigen expression system in vaccine has been extensively 
reported.
79, 80
 Since in specific immune response a serious systemic reaction can be 
induced sequentially from the antigen-antibody complex, we investigated the 
immunogenicity of TMV-incorporated hydrogels supporting bone differentiation of stem 
cell. From the ELISA assay, we found that TMV and its RGD mutant within the 
hydrogels led to non-significant induction of specific anti-TMV Immunoglobulin G (IgG) 
produced in mice. ELISA revealed lower anti-TMV antibody titers in mouse sera 
collected from the animals implanted with TMV-PAH and RGD-PAH hydrogels in 
comparison to the sera from mice that were challenged by native TMV solution (intra-
muscular injection) in the same amount of virus presented in the hydrogels (Figure 2.5). 
This data suggested that there were only limited amount of TMV antigen released from 
the hydrogels into the circulation system. The result also emphasized in vivo safety of this 
virus-based combinatorial 3D material for tissue engineering.  
 
3.2.2 In vivo Biodegradability of Hydrogels  
Biodegradability of materials is one of the requirements for an ideal material applicable 





Figure 2.4. Histopathology analysis of hydrogel explants. Histological scoring of three 
types of hydrogel explants showed similar degree of inflammation from both peripheral 
and central areas, fibrosis, and vascularization within each time point of 2 and 4 weeks. 
There were mild to moderate inflammation (average scores 1 - 2) from all the hydrogels. 
The average fibroblast scores in all types of hydrogel slightly increased from week 2 to 







Figure 2.5. Anti-TMV serum titers from mice implanted with different hydrogels. The 
immune response to TMV in the implant materials was smaller in comparison to the 
intramuscular injection of native TMV. Comparative serological analysis of the immune 
response to each type of hydrogels was carried out by ELISA after 4 post-operative 
weeks. Serum endpoint dilutions for anti-TMV immune response in mice implanted by 
TMV-PAH and RGD-PAH were lower than ones challenged by single shot of native 
TMV at the same amount presented in the hydrogels (11 µg). Values expressed are means 
± SEM with each scatter plot represents each animal.
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after the new functional tissue has been developed in the patient. Moreover, the 
degradation of the scaffold must closely follow the extracellular matrix (ECM) synthesis 
and macroscopic tissue development. Thus, the rate of degradation of biomaterial 
scaffolds is desired to correspond with the development of a type of tissue that they 
replaced.
84, 85
 Here, we tested the hydrogel degradation by measuring the hydrogel size 
reduced after 4 weeks of implantation and determining the number of hydrogel explants 
that could be recovered after 8 weeks. Table 2.2 shows that out of 10 samples for each 
group of hydrogel implant, 4, 6, and 6 of PAHs, TMV-PAHs, and RGD-PAHs, 
respectively, were completely degraded within 8 post-operative weeks. Moreover, the 
explants were significantly smaller than the starting hydrogels before implantation. 
Figure 2.6 represents the photographs of the native hydrogel (Figure 2.6A) and the 
different hydrogel explants (Figure 2.6B-D). The corresponding dot plot demonstrates the 
volume reduction calculated from dimensions of each hydrogel explant. Approximately 
half volume of hydrogels degraded during 4 post-operative weeks regardless of hydrogel 
type (Figure 2.6 plots). The degradation of these hydrogels could be attributed to the 
biodegradation of alginate hydrogel, the bulk forming materials used in the study. There 
were two possible degradation events involving: 1) loss of calcium ion (crosslinker) by 
diffusion into the surrounding medium and subsequent dissolution; and 2) 
depolymerization of polymer backbone via β-elimination caused by alkaline 
hydrolysis.
86-88
 Also, Pluronic F108 surfactant might have aided in facilitating faster 
biodegradation of scaffold as reported by Nsereko and Amiji in which the chitosan alone 
and chitosan with Pluronic surfactant were compared.
89
 In that report, they showed
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Table 2.2. Numbers of hydrogel implants recovered from sacrificed mice after 8 post-
operative weeks. 
 










Figure 2.6. In vivo degradability of porous composite hydrogels. Photographs illustrated 
irregular shaped hydrogel explants with size reductions. (A) The hydrogel figure before 
implant. (B-D) The images of typical explants of PAH, TMV-PAH, and RGD-PAH, 
respectively. The bottom scattered plots indicated the volume reduction of each explant. 
Values expressed are means (n = 3) ± SD. 
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a significant increase in lysozyme degradation profile of the chitosan hydrogel with 
Pluronic F108 and concluded that the higher porosity of hydrogel resulted from the 
incorporation of surfactant.
89
 However, in our study, we did not observe differences in 
the in vivo degradation of each hydrogel. The detailed degradation profiles of the 
materials will need to be further explored. 
 
3.3 CONCLUSION 
TMV, as the plant virus nano-scaffolding material, is a versatile tool from natural source 
for biomedical applications. We hereby conclude that TMV-functionalized porous 
alginate hydrogel implant is biocompatible in mice. The antigenicity of TMV could be 
suppressed when immobilized within hydrogels. The hydrogels were degraded in the 
physiological condition, which is one of the important criteria when developing a 
scaffold for tissue engineering. This virus-based hydrogel system can be further 
developed to have a better-controlled biodegradation profile for a less-invasive route of 
administration (injectable form). Overall, our result highlights the feasibility of 
incorporating viral nanoparticles in biomaterials for in vivo regenerative medicine 
applications. 
 
3.4 EXPERIMENTAL SECTION 
All chemicals were obtained from commercial suppliers and used as received unless 
otherwise noted. Wild-type TMV (TMV) and its RGD mutant (TMV-RGD) were isolated 






3.4.1 Synthesis of Virus-Incorporated Porous Alginate Hydrogels  
The incorporation of TMV and its mutant (TMV-RGD) in porous alginate hydrogel was 
based on previously reported methods.
37
 Briefly, 5% w/v low viscosity sodium alginate 
(Protanal LF 10/60 FT, 30 − 60 mPas for 1%, kindly provided by FMC Biopolymer UK 
Ltd.) was dissolved in 2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 
solution. Molar equivalent of citric acid with respect to NaHCO3 was added to the 
mixture while stirring at 500 rpm using overhead stirrer, 115V. Stirring was continued for 
15 min at room temperature to allow CO2 to fully develop. For the PAH modified with 
TMV (TMV-PAH), or PAH modified with mutant TMV-RGD (RGD-PAH), 0.1% w/v of 
virus was added to the solution 10 min after adding citric acid. The mixture was stirred 
for another 5 min.  Afterward, the foamy alginate solution was cast in 6.35 mm (0.25 
inches) diameter, 2 mm thick aluminum mold and freeze-dried. The resulting solid foam 
disc was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based 
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid 
foam was freeze-dried, resulting in porous alginate hydrogel (PAH) for implantation in 
animal study (Figure 2.1).  
 
3.4.2 Animals, Lethality Test and Animal Treatments 
The procedures were performed in accordance with the guidelines for animal 
experimentation by the Institutional Animal Care and Use Committee, School of 
Medicine, University of South Carolina. NIH guidelines (or for non-U.S. residents 
similar national regulations) for the care and use of laboratory animals (NIH Publication 
#85 - 23 Rev. 1985) have been observed. Twelve-week-old male BALB/c mice were 
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housed at 22 ± 2 °C with a 12-h light/ dark cycle and fed standard rodent chow and water 
ad libitum. Mice were randomly assigned to experimental groups. For in vivo 
biocompatibility tests, each group of animal (3 groups implanted by PAH, TMV-PAH, 
and RGD-PAH) consisted of 6 mice excepted the positive control group for anti-TMV 
antibody ELISA that consisted of 3 mice and the non-treatment control (mock) that 
consisted of 2 mice. A total of 10 mice per each group were used to determine the 
number of hydrogel explants that could be recovered after 8 post-operative weeks.  Disk-
shaped hydrogels were implanted subcutaneously to assess biocompatibility. Briefly, 
under anesthesia with 2-3% Isoflurane in oxygen, a small dorsal incision (~ 1 cm) was 
made to create a subcutaneous pocket to place the implant along the back of the animal. 
The skin was closed with surgical sutures. The animals were closely monitored (at least 
once per week) for signs of distress or abnormal behaviors and measured body weight for 
the entire experimental period. In the implanted groups, 3 animals in each group were 
sacrificed at week 2 after implantation and another 3 animals were sacrificed at week 4 at 
the end of experiment by cervical dislocation. The implanted animals and mocks were 
bled via retro-orbital bleeding through the anti-coagulant coated glass capillaries every 2 
weeks for blood count assay. The serum samples for ELISA were obtained after 
centrifugation (2,000 g, 15 min, 4 °C) of blood samples collected from every animal just 
before euthanization and stored at - 80 °C. The implant hydrogels were recovered after 
the sacrifice of each animal. The size reduction of implanted hydrogels was measured on 
the explants from week 4 using Vernier Caliper in terms of diameter and height with a 
subsequent volume calculation. The implanted hydrogels with the surrounding tissues 
were then preserved in 10% neutral buffered formalin individually in the tissue blocks for 
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further paraffin embedding and histological assays. The liver, lung, brain, heart, and 
spleen of all mice were isolated and weighted.  
 
3.4.3 Antibody challenge for ELISA positive control 
Administration of TMV in the positive control group was performed by intramuscular 
injection of 11 µg TMV, which was calculated to match the average amount of TMV 
presented in each implant hydrogel. TMV in phosphate-buffered saline (pH 7.4) were 
sterile filtered before injecting into the animals. 
 
3.4.4 Hematological assay 
Complete Blood Count (CBC) was preceded right after each blood withdrawal. The 
blood sample of 10 - 50 µL was transferred into 1 mL BD Microtainer Tube with 
Dipotassium EDTA. Each tube was subjected to the automated blood counter machine, 
model VetScan HM5 Hematology System. The numbers of total white blood cell (WBC), 
neutrophil (NEU), monocyte (MON), lymphocyte (LYM), red blood cell (RBC), 
hemoglobin (HGB), platelet (PLT), and mean platelet volume (MPV) were recorded and 
analyzed according to the calibrated instrumental protocol, which indicated the normal 
range of each parameter specifically for mice. 
 
3.4.5 Paraffin Embedding and Histological Assays 
The formalin preserved implanted hydrogels/tissues and organs of all mice were 
embedded in paraffin blocks individually with proper orientations.  Tissue sections (5 
µm) were prepared and stained with hematoxylin and eosin (H&E). Based on the amount 
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of inflammatory cells (basically lymphocytes, neutrophils, macrophages, and so on) 
observed within the center or peripheral areas of implants, the degree of tissue 
inflammation was scored as 0, 1, 2, and 3 (normal; none, rarely seen; 1 to 5 per ×40 
objective field, slightly increased; 5 to 20 per ×40 objective field, and obviously 
increased; > 20 per ×40 objective field). Based on the degree of fibrous/connective 
tissues and capillary blood vessels observed within the center or peripheral areas of 
implants, the tissue fibrosis and vasculization were scored as 0, 1, 2 and 3 (none, rarely 
seen; ≤ 2 vessels/  40 field, slightly increased; 3 - 10/ ×40, and obviously increased; > 10 
vessels/ × 40, respectively). Histological images were taken by using a Nikon microscope 
and an Olympus digital camera. 
 
3.4.6 Enzyme-Linked Immunosorbent Assay (ELISA) 
ELISA was performed no later than 3 months after the sera were collected. In order to 
coat wells with TMV as an antigen, high protein-binding conical bottom 96-well plate 
was used. TMV (10 µg/mL, 100 mL) in Phosphate Buffer Saline (PBS) were added to the 
microwells and incubated for 1 h at room temperature, followed by three PBS washes. 
Blocking for non-specific binding was performed by adding 100 µL of 1% bovine serum 
albumin (BSA) and incubating for 30 min at room temperature, followed by three PBS 
washes. Binding was performed by adding 100 µL of serially diluted antiserum into 
microwells and incubating for 1 h at room temperature, followed by thorough washes. 
HRP conjugate anti-mouse IgG (Cayman Chemical Company) diluted at 1:20000 ratio 
was added and incubated for 30 min at room temperature. Tetramethyl Benzidine (TMB 
Plus, Amresco) and 1 M H2SO4 were added in sequence to the wells according to the 
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manufacturer’s protocol, and the binding efficiency was monitored by measuring 




BIOCOMPATIBILITY STUDY OF BMSCS INCORPORATED TMV ALGINATE HYDROGELS 
3.1 INTRODUCTION 
3.1.1 Bone marrow stromal cells in tissue engineering 
Bone marrow stromal cells (BMSCs), also sometimes referred to as mesenchymal stem 
cells (MSCs), are broadly used for regenerative medicine applications.
90, 91
 These cells 
have two important innate abilities. First, MSCs can differentiate into distinctive end-
stage cell types, such as those that fabricate specific mesenchymal tissues including bone, 
cartilage, muscle, bone marrow stroma, tendon/ligament, fat, dermis, and other 
connective tissues. Second, MSCs, themselves, secrete a broad spectrum of bioactive 
macromolecules that can aid restructuring microenvironments in sites of tissue injury.
92
 
Although, numerous preclinical studies have established the therapeutic potential of 
MSCs in tissue engineering and as cellular protein factory for delivery of cytokines and 
anticancer agent,
93
 to date, MSC immunosuppressive and immunoprivilege properties 
remain controversial.
94-97
 Most of the evidence for MSC immunoprivilege and 
immunosuppression has been obtained using adaptations of the lymphocyte 
transformation assays (LTA) and mixed lymphocyte reaction (MLR), respectively. The 
reliability and sensitivity of these assays is dependent upon the optimization of the assay 
conditions, and different conditions have yielded conflicting outcomes in some 
instances.
98
 There were some studies reported that MSCs may also behave as
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nonprofessional antigen-presenting cells (APCs).
99, 100
 An enhancement of lymphocyte 




3.1.2 Virus-functionalized alginate hydrogel scaffolds 
In Chapter 1, we have shown that the porous alginate hydrogels (PAH) could be 
functionalized with tobacco mosaic virus (TMV) and demonstrated their advantage as 
vehicles to support the 3D stem cell culture and differentiation. TMV, as the plant virus 
nano-scaffolding material, is a versatile tool from natural source for biomedical 
applications. In summary, the 3D porous alginate hydrogels (PAH) functionalized with 
wild-type TMV (TMV-PAH) and its RGD mutant (RGD-PAH) were developed. We have 
also emphasized that TMV surface can be accessible in 3D porous hydrogels as shown by 
significant improvement in cell attachment after functionalization by cell binding motif, 
RGD, via the mutation of TMV. Moreover, the incorporation of TMV and its RGD 
mutant can facilitate bone differentiation of BMSCs. We reported (Chapter 2) that the 
virus is biocompatible in the form of porous hydrogel implant using BALB/c mice as the 
in vivo study model. The antigenicity of virus could be suppressed when immobilized and 
slowly released from the bulk hydrogels. The hydrogels were degraded in the 
physiological condition, which is one of the important criteria when developing a 
scaffold for tissue engineering. 
 Here, we further characterized the in vivo properties of this hydrogel system by 
focusing on the potential of using the TMV-functionalized PAH to incorporate BMSCs in 
bone tissue engineering. The key objective of this study was to rule out the 
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biocompatibility and possible toxic effects of the subcutaneously implanted hydrogels 
when BMSCs were co-delivered with serum-free osteogenic supplemented media. 
 
3.2 RESULTS AND DISCUSSION 
3.2.1 Ex vivo bone marrow stromal cells loading 
To investigate the potentiality of the virus-functionalized hydrogel in stem cell bone 
tissue engineering application, isolated murine BMSCs from the host strain (BALB/c 
mouse) were loaded in the hydrogel and primarily induced with non-BMP2 osteogenic 
induction media before implant. The isolated BMSCs were cultured and expanded in 
vitro. After cells were seeded in the hydrogels, the in vitro parallel study of call metabolic 
activity showed that cells were viable in the hydrogels (Figure 3.1). Moreover, RGD 
mutant of TMV embedded in the hydrogels clearly enhanced cell adhesion. The results 
were consistent with the in vitro report in which significantly higher metabolic activity of 
the BMSCs, isolated from Sprague-Dawley rats, in RGD-TMV functionalized hydrogel 
was shown (Chapter 1). 
 
3.2.2 Immunogenicity of virus in the hydrogel seeded with osteogenic induced BMSCs 
Previously in Chapter 2, we demonstrated the remarkable decrease in immunogenicity of 
TMV incorporated in the hydrogel in BALB/c mice implanted with the materials alone 





Figure 3.1. CellTiter Blue metabolic activity assay of mBMSCs cultured in different 
types of hydrogels at different time points, in vitro. Values expressed are mean (n = 3) ± 




elicited in the presence of 1) co-delivered cells or 2) other biological entities due to an 
adjuvant effect. Although MSCs have been widely reported to have immunomodulatory 
capacity and an immunoprivileged status,
101-103
 for example, strong evidence suggested a 
delay in B cell maturation and antibody production by MSCs in mice
104, 105
 and human 
cell culture,
106, 107
 their interaction in vivo is still not well known.
108
 Here, we studied the 
immune response to TMV particles in TMV-PAH and RGD-PAH seeded with mouse 
BMSCs and saturated with osteogenic induction media. The hydrogels were first soaked 
in the osteogenic induction media before cell loading. Then the cell-loaded scaffolds 
were implanted under the skin of the animal. The animals implanted with bare hydrogels 
(hydrated with PBS), without cells and osteogenic media, were used as control groups for 
all type of hydrogels. The blood samples collected at the end of the experiment (8 post-
implantation weeks) were subjected to ELISA assay. Figure 3.2 showed no differences in 
anti-TMV titers comparing the controls (no cells) and the hydrogels seeded with BMSCs 
in osteogenic media. Moreover, regardless of co-delivered cells and media supplements, 
the ELISA showed negligible immune responses to TMV and TMV-RGD imbedded in 
the hydrogels. Despite the differences in serum collection time points, this data was 
consistent with the previous experiment reported in Chapter 2 (sera collected at week 4). 
Therefore, the result here confirmed that the release of TMV particles happened very 






Figure 3.2. Anti-TMV serum titers from mice implanted with different hydrogels seeded 
with BMSCs. Comparative serological analysis of the immune response to the hydrogels 
co-delivered with BMSCs and the blank hydrogels was carried out by ELISA after 8 
post-operative weeks. Serum endpoint dilutions for anti-TMV immune response in mice 
implanted by TMV-PAH and RGD-PAH with osteogenic-induced BMSCs were very low 
with no statistical significances in comparison to the response elicited by the hydrogel 
alone. Values expressed are means ± SEM. 
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3.2.3 Histological study 
Histological sections of the explants were stained with H&E staining and evaluated the 
infiltration of inflammatory cells, fibroblast, new blood vessels, and tissue/cell growth in 
the hydrogels after 8 weeks. For every parameter, no significant differences were 
detected between each type of hydrogel implant, PAH, TMV-PAH, and RGD-PAH, 
seeded with BMSCs ex vivo. The average histological scores revealed that there were 
mild to moderate inflammatory cells, fibroblast, and neovascularization at the 
implantation site (Figure 3.3). However, very rare foam cells were observed within some 
of the PAH explants, and none were found in TMV-PAH and RGD-PAH (Figure 3.3). It 
has also been observed that there were few cell growths in the hydrogels possibly from ex 
vivo seeded BMSCs; however, no substantial difference in the degree of cell growths 
were observed among different hydrogel types. This result was inconsistent with the 
study of cell adhesion study in vitro, which RGD-PAH could attract more cells into the 
scaffold. This contrary could be justified as following. First, the vascular networks in 
subcutaneous pocket/tissue are too poor in their natural state to allow the growth and 
function of tissue graft.
109
 Second, the time of implantation was much longer than the 
incubation time of in vitro study. The new extracellular matrix might be generated by the 
physiological system through the wound healing events in animal body, and overcame 
the influence from the implant material (RGD-PAH) in cell recruitment. Third, the 
release of TMV particles due to the degradation of implant materials led to the loss of 
scaffold functionality over time (Chapter 2). Moreover, the same set of histopathological 
parameters was assessed comparing between the hydrogels with and without BMSCs. In 







Figure 3.3. Histological score given to hydrogel explants of ex vivo BMSC-loaded hydrogels compared implant cell growth, 
peripheral inflammation, central inflammation, implant foam cell, fibroblast, and vascularization on PAH, TMV-PAH, and RGD-









Figure 3.4. For each type of hydrogel implant, histological score compared implant cell growth, peripheral inflammation, central 
inflammation, implant foam cell, fibroblast, and vascularization on BMSC-loaded and naked implants. Each plot represents the 
response from each animal with mean ± SD shown as a bar. Grey bars are for the scaffolds without cells. Black bars are for the 
scaffolds with cells. 
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inflammations (both peripheral and central), implant foam cells, and vascularization 
when comparing the blank scaffolds with the cell-seeded scaffolds. To our surprise, bare 
TMV-PAH induced higher central inflammation and foam cells than the scaffold with co-
delivered cells. However, only one animal was used for the control TMV-PAH implant 
here. To further test for statistical importance of this data, the animal number should be 
increased.  
 Some studies suggested that MSCs have antifibrotic properties. Moodley et al. 
reported that locally administered human umbilical cord MSCs reduced fibrosis of 
bleomycin-induced lung injury in mice by decreasing collagen concentration at the 
injured site.
110
 Leung et al. showed that the presence of MSCs can suppress abnormal 
deposition of collagen I in the nucleus pulposus of intervertebral disc degeneration 
rabbits, modulating profibrotic mediators MMP12 and HSP47, thus reducing collagen 
aggregation and maintaining proper fibrillar properties and function.
111
 Here, only the 
RGD-PAH implants exhibited the significant suppression of fibrosis when BMSCs were 
present. There were no differences in fibrosis between the blank hydrogels and the 
hydrogels seeded with BMSCs for PAH and TMV-PAH implants. Likewise, the presence 
of BMSCs caused no differences in vascularization in any types of implants. The cell 
growths in the cell-loaded implants were compared with the blank implants among each 
hydrogel type. To our surprise, RGD-PAH showed distinct result to other types of 
hydrogels. The RGD-PAH without pre-loaded BMSCs exhibited comparable/slightly 
higher implant cell growth than the hydrogel with initial cell seeding. The possibility 
could be that the available RGD peptide presented in blank RGD-PAH recruited MSCs 
that travel through the peripheral blood
112




The TMV incorporated porous alginate hydrogel scaffolds were evidenced for the 
biocompatiblity as ex vivo 3D supports for BMSCs and as in vivo cell delivery and tissue 
development platforms. The cell-loaded implants caused insignificant changes in the 
immunogenicity of TMV particles. Overall, mild to moderate inflammatory responses 
were observed due to the injury triggered by normal wound healing and implantation of 
foreign materials with no major differences in degrees of inflammation between the 
BMSC seeded hydrogel and the control in both virus-functionalized hydrogels and PAH 
alone. Hence, this virus functionalized hydrogel system is considered a promising 
candidate as safe and easy incorporating biofunctional material well-suited for stem cell 
delivery and tissue regeneration. This study is one of the underlying platforms for the 
development of viral nanoparticle based biomaterials in tissue engineering and 
regenerative medicine. 
 
3.4 EXPERIMENTAL SECTION 
All chemicals were obtained from commercial suppliers and used as received unless 
otherwise noted. Wild-type TMV (TMV) and its RGD mutant (TMV-RGD) were isolated 






3.4.1 Synthesis of Virus-Incorporated Porous Alginate Hydrogels  
The incorporation of TMV and its mutant (TMV-RGD) in porous alginate hydrogel was 
based on previously reported methods.
37
 Briefly, 5% w/v low viscosity sodium alginate 
(Protanal LF 10/60 FT, 30−60 mPas for 1%, kindly provided by FMC Biopolymer UK 
Ltd.) was dissolved in 2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 
solution. Molar equivalent of citric acid with respect to NaHCO3 was added to the 
mixture while stirring at 500 rpm using overhead stirrer, 115V. Stirring was continued for 
15 min at room temperature to allow CO2 to fully develop. For the PAH modified with 
TMV (TMV-PAH), or PAH modified with mutant TMV-RGD (RGD-PAH), 0.1% w/v of 
virus was added to the solution 10 min after adding citric acid. The mixture was stirred 
for another 5 min.  Afterward, the foamy alginate solution was cast in 6.35 mm (0.25 
inches) diameter, 2 mm thick aluminum mold and freeze-dried. The resulting solid foam 
disc was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based 
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid 
foam was freeze-dried, resulting in porous alginate hydrogel (PAH) for implantation in 
animal study. 
 
3.4.2 Bone Marrow Stem Cells (BMSCs) Isolation and in vitro Expansion 
Primary BMSCs were isolated from the bone marrow of young adult male BALB/c mice. 
The procedures were performed in accordance with the guidelines for animal 
experimentation by the Institutional Animal Care and Use Committee, School of 
Medicine, University of South Carolina. Cells were maintained in complete primary 
media (Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 20% fetal 
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bovine serum (FBS)), kept at 37 °C in a 5% CO2 incubator and passaged no more than 
six times after isolation. 
 
3.4.3 Cell Seeding and in vitro Cell Viability 
For each experimental group of animals, 4 hydrogels of PAH, 3 hydrogels of TMV-PAH 
and 2 hydrogels of RGD-PAH were prepared for ex vivo cell seeding. All hydrogels were 
sterilized in 70% ethanol for 15 min, ethanol was drained on sterile filter paper and the 
hydrogels were further sterilized under UV-light for 60 min in laminar airflow hood. For 
experimental group, hydrogels were then saturated in serum-free osteogenic media at 37 
°C for 60 min, blotted excess media with sterile filter paper, and placed in 12-well 
nonadhesive plate (six hydrogels in each well). The control hydrogels (no cells) were 
saturated with sterile PBS instead of osteogenic supplemented media. Serum-free 
osteogenic media contained high-glucose DMEM supplemented with 10 mM sodium β-
glycerol phosphate, L-ascorbic acid (50 μg/mL), 10
−2
 μM dexamethasone, 1  ITS, FGF 
(1 ng/mL), TGFβ (1 ng/mL), EGF (1 ng/mL), penicillin (100 units/mL), streptomycin 
(100 μg/mL), and amphotericin B (1 μg/mL). BMSCs were harvested from 80% 
confluent culture flask using 0.25% trypsin/EDTA for 5 min and counted and 
resuspended in complete primary media. A total of 30 × 10
3
 BMSCs were seeded per one 
volume (cm
3
) of hydrogel. BMSCs loaded hydrogels were initially incubated with 100 
μL of serum-free osteogenic media in each well to prevent hydrogels from drying out. 
After 6 h of an initial incubation, hydrogels were completely submersed in 1 mL of 
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serum-free osteogenic media in each well. 12 h after cell seeding, cell loaded hydrogels 
were then implanted to the animals. 
 For the in vitro cell viability assay, the hydrogels were prepared and seeded with 
mouse BMSCs by the same procedure with the implant hydrogels. The hydrogels seeded 
with BMSCs were cultured at 37 °C and 5% CO2. CellTiter-Blue (CTB) cell viability 
assay (Promega) after days 2 and 6 of culture was performed for each type of hydrogel. 
The culture media in each well was replaced by 1 mL of prewarmed media containing 
10% CTB and incubated for 1 h at 37 °C and 5% CO2. The media containing CTB was 
used without cells as negative controls. The measurement of the CTB product was taken 
at two time points. First, to detect the cells that attached to the outer surface of hydrogel, 
the solution was collected and replaced with 1 mL of culture media. The incubation was 
continued for another 2 h to allow diffusion of the fluorescent product from the inner part 
of hydrogel. After 2 h incubation, the media solution was collected again and replaced 
with 1 mL of culture media in each well to continue cell culture. The 1:1 mixture of 
solution from first collection and second collection was measured for fluorescence 
intensity at 560/590 nm (Ex/Em) using SpectraMax M2 Multi-Mode microplate reader 
(Molecular Devices). Also, 3 separate experiments were conducted with each type of 
sample, which is comprised of 4 hydrogels. 
 
3.4.4 Animals, Lethality Test and Animal Treatments 
The procedures were performed in accordance with the guidelines for animal 
experimentation by the Institutional Animal Care and Use Committee, School of 
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Medicine, University of South Carolina. NIH guidelines (or for non-U.S. residents 
similar national regulations) for the care and use of laboratory animals (NIH Publication 
#85 - 23 Rev. 1985) have been observed. Twelve-week-old male BALB/c mice were 
housed at 22 ± 2 °C with a 12-h light/ dark cycle and fed standard rodent chow and water 
ad libitum. Mice were randomly assigned to experimental groups. Each group of animal 
(3 groups implanted by PAH, TMV-PAH, and RGD-PAH) consisted of 6 mice. Disk-
shaped hydrogels were implanted subcutaneously. Briefly, under anesthesia with 2 - 3% 
Isoflurane in oxygen, a small dorsal incision (~ 1 cm) was made to create a subcutaneous 
pocket to place the implant along the back of the animal. The skin was closed with 
surgical sutures. The animals were closely monitored (at least once per week) for signs of 
distress or abnormal behaviors and measured body weight for the entire experimental 
period. All animals were sacrificed at week 8 after implantation by cervical dislocation. 
The serum samples for ELISA were obtained after centrifugation (2,000 g, 15 min, 4 °C) 
of blood samples collected from every animal just before euthanization and stored at -80 
°C. The implant hydrogels were recovered after the sacrifice of each animal. The 
implanted hydrogels with the surrounding tissues were then preserved in 10% neutral 
buffered formalin individually in the tissue blocks for further paraffin embedding and 
histological assays. The liver, lung, brain, heart, and spleen of all mice were isolated and 
weighted.  
 
3.4.5 Paraffin Embedding and Histological Assays 
The formalin preserved implanted hydrogels/tissues and organs of all mice were 
embedded in paraffin blocks individually with proper orientations.  Tissue sections (5 
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µm) were prepared and stained with hematoxylin and eosin (H&E). Based on the amount 
of inflammatory cells (basically lymphocytes, neutrophils, macrophages, and so on) 
observed within the center or peripheral areas of implants, the degree of tissue 
inflammation were scored as 0, 1, 2, and 3 (normal; none, rarely seen; 1 to 5 per × 40 
objective field, slightly increased; 5 to 20 per ×40 objective field, and obviously 
increased; > 20 per × 40 objective field). Implant cell growth and foam cells were also 
scored with the criteria applied to inflammatory cells. Based on the degree of 
fibrous/connective tissues and capillary blood vessels observed within the center or 
peripheral areas of implants, the tissue fibrosis and vasculization were scored as 0, 1, 2 
and 3 (none, rarely seen; ≤ 2 vessels/   40 field, slightly increased; 3-10/ × 40, and 
obviously increased; > 10 vessels/ × 40, respectively). Histological images were taken by 
using a Nikon microscope and an Olympus digital camera. 
 
3.4.6 Enzyme-Linked Immunosorbent Assay (ELISA) 
ELISA was performed no later than 3 months after the sera were collected. In order to 
coat wells with TMV as an antigen, high protein-binding conical bottom 96-well plate 
was used. TMV (10 µg/mL, 100 mL) in Phosphate Buffer Saline (PBS) were added to the 
microwells and incubated for 1 h at room temperature, followed by three PBS washes. 
Blocking for non-specific binding was performed by adding 100 µL of 1% bovine serum 
albumin (BSA) and incubating for 30 min at room temperature, followed by three PBS 
washes. Binding was performed by adding 100 µL of serially diluted antiserum into 
microwells and incubating for 1 h at room temperature, followed by thorough washes. 
HRP conjugate anti-mouse IgG (Cayman Chemical Company) diluted at 1:20000 ratio 
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was added and incubated for 30 min at room temperature. Tetramethyl Benzidine (TMB 
Plus, Amresco) and 1 M H2SO4 were added in sequence to the wells according to the 
manufacturer’s protocol, and the binding efficiency was monitored by measuring 




BONE REGENERATION IN RATS WITH CRANIAL DEFECT BY IMPLANTATION OF TMV 
FUNCTIONALIZED ALGINATE HYDROGEL SCAFFOLDS 
4.1 INTRODUCTION 
4.1.1 Rat cranial segmental bone defect model 
There are extensive needs for clinical bone replacement from patients with bone loss after 
resection of tumors, bone loss after trauma, and voids created as a result of fractures. 
Even though bone has a good healing capacity compared to other tissues, the regeneration 
potential is limited in the case of large defects such as after tumor resection, major 
fractures, hip implant revision, or impaired healing capacity of the host.
113, 114
 In such 
cases, the use of bone grafts, derivates, or bone substitutes are indicated to promote 
healing and regeneration.
114-116
 Current clinical methods of treating skeletal defects are 
autograft and allograft bone transplantation. Autograft bone (bone transplanted from one 
part of the body to another in the same individual) provides an environment that bone 
cells like to grow and to make bone tissue. However, the supply of autograft bone is 
limited. Allograft bone (bone from one person to another including those from cadaveric 
and living related) has slower rate of healing compared to autograft bone and the 
possibility of disease transfer. Therefore, material scientists introduced the concept of 
tissue engineering using biocompatible artificial materials that offer an unlimited supply 





The translation of many therapeutics, including pharmaceuticals, medical devices 
and medical strategies, into clinics requires an animal testing. Despite ethical concerns 
and efforts to develop alternatives to animal experimentation, standardized animal 
models are crucial components in translational sciences and medical technology 
development.
118-121
 For bone tissue engineering, a number of small animal models exist. 
Many species have been used for animal models of bone defects, including mice, rats, 
rabbits, dogs, pigs, sheep and goats, but much of the research has focused on rodent 
models because of reproducibility, throughput and economic considerations. The rat 
calvarium or cranium allows for a reproducible defect that can be generated quickly and 
does not require fixation for stabilization of the skeleton, as is generally required with 
femoral defects.
122, 123
 However, as an anatomical site experiencing less loading than long 
bones, the functional testing of a bone regeneration strategy intended to withstand 
biomechanical forces is not feasible in the calvarial defect.
124
 Thus, taking into 
consideration the objective of the biomaterial or bone regeneration strategy, the rat 
calvarial defect can serve as a rapid, high throughput method for in vivo evaluation of 
bone regeneration. The rat cranial segmental bone defect is a versatile model allows for 
evaluation of biomaterials and bone tissue engineering approaches within a reproducible, 
non-load-bearing orthotopic.
125
 For critical defects, i.e. defects that would not fully heal 
spontaneously, or even to accelerate or guide the repair process, the use of bioactive 
scaffolding material could be of great advantage. Suitable materials can, in fact, fill the 







4.1.2 TMV nanoparticle-functionalized porous alginate hydrogel 
The goal of this study is to assess the potential for plant virus/polymer hydrogels as 
materials capable of enhancing bone formation/regeneration. The hydrogel is composed 
of Tobacco mosaic virus (TMV) as protein templates with a mixture of a natural hydrogel 
forming polymer that is biocompatible and biodegradable, sodium alginate (sugar-based 
polymer derived from algae/seaweed). Alginate has been well established as a hydrogel 
forming polymer that is used extensively in biomedical applications. However, alginate 
itself cannot guide cells towards bone differentiation, unless complex mixtures of protein 
materials (i.e. growth factors, cell binding sequences) are incorporated. Therefore, we 
rationalized that TMV can supplement the polymer backbone to promote bone formation. 
There are two rationales for using the plant virus. One, the plant virus cannot infect 
mammalian cells. Historically and at present, there have been no reports of TMV 
infections in mammals. Even in the case that the plant virus was to enter the mammalian 
cells, it does not have the proper material to replicate itself inside the mammalian cells.
36, 
126-128
 The virus solution can further be purified to be pathogen-free by sterile filtration. 
Second, a large number of functionalities (cell anchorage sites, growth factors) can be 
placed on the virus at the nanometer scale.
23, 24
 The ability to place specific functional 
groups (cell anchorage sites, growth factors) at nanometer scales within the hydrogel has 
been an important direction for tissue engineering.
 23, 24 23, 24 23, 24 23, 24 23, 24 23, 24
 Currently, 
the preparation of complex hydrogels is a tedious process that involves multiple steps to 
position the cell anchorage sites and growth factors within the hydrogel. By incorporating 
cell-binding ligands on the external surface of TMV, we have shown that TMV can act as 
nanometer sized building blocks that the plant virus act as nanometer sized materials that 
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can support mesenchymal stem cells and dramatically improve the transformation of cells 
into bone-like cells in vitro.
16, 17, 37
 We did not observe any decrease in cell survival even 
with very high doses of TMV. Additionally, from our previous studies reported in 
Chapter 2 for biocompatibility (subcutaneous) of TMV and its mutant (TMV-RGD) 
incorporated alginate hydrogel scaffold in mice, we did not observe any serious immune 
responses in comparison with the control group (mice subcutaneously implanted with 
alginate-alone scaffold). Therefore, the proposed hydrogel will possibly provide a new 
way to prepare biomaterials for bone repairing applications.  
 
4.2 RESULTS AND DISCUSSION 
4.2.1 Surgical recovery of animals 
The survival surgery of cranial bone defect creation with subsequently hydrogel 
implantation was carried out. Mean surgery time was 10 minutes (SD = 4). One out of the 
21 animals did not gain consciousness and died after the surgery. Animal’s weight was 
measured immediately after the cranial defect survival surgery on each animal to monitor 
post-surgery weight loss. Figure 4.1A showed that all rats lost less than 5% of its initial 
weight measured before the operation. Blood loss during surgical procedure was also 
estimated to be less than 1 mL in all rats. The animals were closely monitored within the 
first 6 hours after and weighed every day for the first post-operative week and at least 
once every consecutive week, continuously for the entire experimental period. 
Postoperatively, the rats recovered quickly, gaining their baseline weight and returning to 







Figure 4.1. Animal post-operative care and monitoring. (A) All experimental animals only lost less than 5% of their original weights 
after the surgery. The dot plot represented each animal with mean shown as a bar (n = 6, for PAH and TMV-PAH and n = 7, for RGD-
PAH). (B) The rats recovered quickly, the surgical wound healed completely and the suture material fell off spontaneously within 2 
weeks. (C) All rats maintained their normal  growth rates for the entire experimental period. Values expressed are means (n = 6, for 
PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD. 
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surgical wound heeled within 1.5 weeks without post-surgical bleeding or wound 
infection. The surgical suture fell off spontaneously from the surgical site after the wound 
healed completely (Figure 4.1B). From gross observations after cranial defect operation 
and implantation, all animals were normally active in eating, drinking, and grooming 
with no observable hair loss and aggressive behavior. The growth rate was evaluated by 
body weight of rats at each time point normalized with their original weight before 
implantation with PAH, TMV-PAH, and RGD-PAH. Comparing to the normal growth 
rate of Sprague Dawley rats.
129
 All experimental animals grew normally with no weight 
loss as shown in Figure 4.1C.  
 
4.2.2 Systemic inflammatory and immunogenic responses 
Complete blood count was analyzed from whole blood samples from each group of rats at 
every week for 4 weeks, and then every other week until termination after 10 post-
operative weeks. Figure 4.2 and 4.3 showed different blood counts in normalization to the 
initial numbers that were analyzed from whole blood collected from a 8-week old normal 
Sprague Dawley rat. The host inflammatory responses after the surgery were evaluated 
by white blood count including total white blood cell (WBC), lymphocyte (LYM), 
monocyte (MON), and neutrophil (NEU) counts. Overall, all animals had slightly low 
WBC, LYM, and NEU comparing to the normal rat. However, the comparison had no 
statistical difference for each parameter in each time point except for PAH group. Rats 
implanted with PAH had significant lower WBC at week 1, 3, 8, and 10, and LYM at 





Figure 4.2. White blood count analysis of all rats with bone substitute implants. The total 
blood counts were monitored at 8 time points (day 4, week 1, 2, 3, 4, 6, 8 and 10, post-
operatively). The histograms showed the numbers of total white blood cells (WBC), 
Lymphocyte (LYM), Monocyte (MON), NEU (neutrophil) normalized with the values 
measured from non-treated rat. Each bar indicated min to max with mean as the middle 
horizontal bar (n = 6, for PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD. From t-
test analysis comparing control (non-treatment) and experimental value, the filled bars 






Figure 4.3. Hematology analysis of all rats with bone substitute implants. The total blood 
counts were monitored at 8 time points (day 4, week 1, 2, 3, 4, 6, 8 and 10, post-
operatively). The histograms showed the numbers of red blood cell (RBC), hemoglobin 
(HGB), platelet (PLT), and mean platelet volume (MPV) normalized with the values 
measured from non-treated rat. Each bar indicated min to max with mean as the middle 
horizontal bar (n = 6, for PAH and TMV-PAH and n = 7, for RGD-PAH) ± SD. From t-
test analysis comparing control (non-treatment) and experimental value, the filled bars 
represented statistical significance, p < 0.05. Red dots represented outliers. 
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rats was comparable with value shown in normal rat’s blood (no significant difference, 
multiple t-test). There were also no significant differences in all white blood counts when 
compared between each group of hydrogel implant. There were 2 outliers on day 4 white 
blood counts: one, from RGD-PAH implanted group expressed increased numbers of 
LYM and the corresponding WBC; another, from PAH implanted group exhibited high 
NEU and its corresponding WBC. However, both rats had white blood counts leveled out 
to the values comparable to all other rats after 1 post-operative week (Figure 4.2).  
 Other blood parameters that indicate animal health and significant loss of blood 
such as red blood cell (RBC), hemoglobin (HGB), platelet count (PLT), and mean 
platelet volume (MPV) were shown to be comparable to the values measured from non-
treated rat’s blood in all animals that were implanted with different types of hydrogels. 
Even though there were some outliers appeared at different time points for each 
parameter, those outliers seemed to obtain only temporal changes in particular blood 
counts that returned to the normal values at the later time point (Figure 4.3).  
Organ weight can be the most sensitive indicator of an effect of drug toxicity, as 
significant differences in organ weight between treated and control animals may occur in 
the absence of any morphological changes.
130
 The spleen and liver are main target organs 
for various nanomaterials in the circulatory system, because these organs are part of the 
reticulo-endothelial system (RES) that has removing foreign agents from the circulation 
as one of its functions. 
131-133
 In this study, we utilized viral nanoparticles in providing 
biofunctionality to hydrogel to create extracellular matrix preferable for cell attachment 
and growth. It was critical to evaluate the spleen enlargement that might occur from the 
immunogenic and/or elimination reaction of the body towards viral nanoparticles 
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presented in the hydrogel implants. Figure 4.4 showed that the spleen weights measured 
after the animal sacrifice (at the age of 22 weeks) were not significantly different among 
all groups. The corresponding mean spleen weight of all rats was 1495 ± 236 mg/kg of 
total body weight, which was not statistically different from the value reported in the 
literatures (p > 0.05, t-test). The mean normal spleen weight of male Sprague Dawley rat 
± SD calculated from a generalized Michaelis–Menten (GMM) model, used to fit organ 
weights versus age in a previous study reported by Schoeffner et al., equaled to 1029 ± 
191 mg/kg of total body weight.
134-136
 From each animal observed at the end of the 
experiment, there were no chronic and/or major inflammatory and toxicity reactions in 
the RES that could cause the spleen enlargement in any group of animals. 
In chapter 2, we have discussed the immunogenicity of TMV in the hydrogels 
implanted subcutaneously at lower back of BALB/c mice. The assay showed non-
significant induction of specific anti-TMV Immunoglobulin G (IgG) produced in mice. 
Here, with the distinct rat cranial defect model, we re-evaluated the humoral immune 
reaction causing by TMV and its RGD mutant in the hydrogels after the bone defect 
replacement by TMV-PAH and RGD-PAH. From the ELISA assay, we found that TMV 
and its RGD mutant within the hydrogels led to average anti-TMV titer at peak time 
(week 8) below 1000. ELISA revealed higher anti-TMV antibody titers in rat sera 
collected from the animals implanted with TMV-PAH than those implanted with RGD-
PAH hydrogels (Figure 4.5A). This observation might be due to the experimental design. 
The ELISA was performed based solely on wild-type TMV (used as antigen coated on 
ELISA plate). This could lead to the lower sensitivity in titer detection for the RGD-PAH 





Figure 4.4. Rat spleen weight at 10 week endpoint. Values expressed are means (n = 6, 









Figure 4.5. Immune response to TMV (Anti-TMV titer) in the rats with bone substitute implant materials. Comparative serological 
analysis of the immune response to each type of hydrogels was carried out by ELISA at different time points including  2, 4, 6, 8, and 
10 post-operative weeks. TCID50 was shown as a titer for each plot. (A) Values expressed are means (n = 6, for TMV-PAH and n = 7, 
for RGD-PAH) ± SEM. (B) Each rat responded differently in terms of the titer level and the progression of anti-TMV IgG production. 
Each line connected the values analyzed from the same rat at different time points.
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TMV wild-type and TMV-RGD1 share the same structure, the assay could have been 
optimized using different coating for ELISA on sera collected from different groups of 
animals. TMV-RGD1 mutant could have been used as the coating antigen to detect the 
titer for the rats in RGD-PAH group. Another possibility could be the difference of 
release profile between the wild-type TMV and the RGD mutant that escaped from the 
hydrogel scaffold into the circulation. The detailed studies on in vivo bioavailability and 
fate of both types of TMV releasing from the hydrogels would be carefully designed and 
preceded. Figure 4.5B shows that 3 out of 6 animals implanted with TMV-PAH 
expressed anti-TMV antibody as early as week 2, and the titers were continued to 
increase to reach their maximum within week 8. Among 7 rats implanted with RGD-
PAH, 4 rats produced antibodies against TMV. However, the initial time points that the 
titers were first detected varied from week 2 to week 8. Interestingly, the titers decreased 
after week 8 in all rats that showed positive immune response from ELISA. This data 
suggested that there were only limited amount of TMV antigen released from the 
hydrogels into the circulation system. The result also emphasized in vivo safety of this 
TMV-based combinatorial 3D material for tissue engineering. 
 
4.2.3 Local inflammatory responses towards hydrogel implant 
Histological sections of the explants were stained using Masson’s trichrome staining 
method and evaluated the inflammation, fibrosis and connective tissue formation, and 
vascularization in the hydrogels. No significant differences were detected between each 








Figure 4.6. Histopathological analysis of bone substitute hydrogel implants. Histological scoring of three types of hydrogels in tissue 
excises showed different degree of inflammation, fibrosis, and vascularization after 10 week of implantation. Values expressed are 




inflammation and fibrosis comparing to the control PAH (t-test, p < 0.05), yet obtained 
slightly higher scores than TMV-PAH with no statistical significance. Similarly, the 
average scores evaluated based on both histopathological parameters for TMV-PAH were 
slightly higher, but not significant, than those for PAH control. The same score trend 
among three types of hydrogels was observed with the vasculature analysis, but the 
differences were not statistically significant (t-test, p > 0.05), as well. The descriptive 
statistics of each histopathological variable was demonstrated in Table 4.1. There were 
inflammatory cells observed in the following hydrogel implants with average scores of 
1.2 (PAH), 1.8 (TMV-PAH), and maximum 2.0 (RGD-PAH). The average scores of 2.0, 
2.6, and 3.0 for PAH, TMV-PAH, and RGD-PAH, respectively, were given to the extent 
of connective and fibrous tissue (min - max = 0 - 3) formed in the hydrogels. 
Interestingly, every sample from RGD-PAH group scored maximum for inflammation 
and fibrosis variables, and gained a minimum of 2 scored for vasculature. The average 
scores for new blood vessels formed in each type of hydrogel (min - max = 0 - 3) are 1.7 
for PAH, 2.4 for TMV-PAH, and 2.8 for RGD-PAH. Based on histological analysis of 
bone excises at the defect area, the animals that were treated with hydrogels incorporated 
with TMV and its RGD mutant tended to induce more physiological reactions towards 
implant materials including inflammatory cells infiltration, fibrosis, and 
neovascularization. One possible explanation could be that TMV might be able to induce 
more cytokine production from the migrating cells at the implantation site that could lead 
to more inflammatory cells recruited. The previous report by Sitasuwan et al. suggested 
that some cytokine-induced neutrophil chemoattractant-1 (CINC-1), CINC-2, 






Table 4.1. Descriptive statistics of variables according to the type of hydrogel implant. 
 
Variable Hydrogel Implant n Average SEM 
95% CI of mean 
Min Max Lower Upper 
Inflammatory PAH 6 1.2 0.3 0.4 2.0 0 2 
 
TMV-PAH 5 1.8 0.2 1.2 2.4 1 2 
 
RGD-PAH 5 2.0 0 2.0 2.0 2 2 
Fibrous/Connective Tissue PAH 6 2.0 0.5 0.7 3.3 0 3 
 
TMV-PAH 5 2.6 0.4 1.5 3.7 1 3 
 
RGD-PAH 5 3.0 0 3.0 3.0 3 3 
Vasculature PAH 6 1.7 0.4 0.6 2.8 0 3 
 
TMV-PAH 5 2.4 0.4 1.3 3.5 1 3 
RGD-PAH 5 2.8 0.2 2.2 3.4 2 3 
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(VEGF) were detected from the conditioned media for the bone marrow stromal cells 
grown on TMV coated substrate.
36
 CINC-1 and MIP-3α recruit neutrophils and 
monocytes that result in the induction osteogenesis.
137
 Cytokines and growth factors 
secreted by infiltrated inflammatory cells including neutrophils, monocyte-derived 
macrophages, and lymphocytes are the molecular messengers that promote inflammatory 
events, such as neutrophil and macrophage recruitment, as well as wound healing events, 
such as connective tissue synthesis and vasculature. 
27, 83, 138, 139
 Moreover, the RGD 
peptide introduced by the incorporation of TMV-RGD1 into the hydrogel implant could 
induce even more material-host interaction. Even though, it has not been conclusive 
whether RGD can regulate in vivo cell adhesion to biomaterials as it does in vitro.
140
 Our 
observation was consistent with many reports in RGD-functionalized materials 
promoting materials and surrounding cells interaction in vivo. For example, Shu et al. 
reported that the inclusion of covalently attached RGD peptides onto hyaluronan-based 
hydrogels could enhance the formation of fibrous tissue in vivo, with increased 
production of procollagen by the fibroblasts in the newly formed fibrous tissue at 4 weeks 
after animal treatment.
141
 However, the future study with larger animal numbers should 
be performed in order to confirm these results and obtain more statistically significant 
analyses. 
 
4.2.4 Bone healing analysis 
The new bone formation after the hydrogel implantation was evaluated by two methods; 
1) micro computed tomography (microCT) and 2) histological analysis of tissue excises 
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using Masson’s trichrome staining technique. Microcomputed tomography (MicroCT) is 
an X-ray–based imaging method that offers access to the 3D microarchitecture of bone. A 
computer combines a stack of virtual cross-sections, interpolating sections along different 
planes, to inspect the internal structure of the object. A quantitative 3D 
histomorphometric evaluation (i.e., determination of the volume of bone mass and of the 
microarchitecture indices of the newly formed bone) can then be performed on a cubic 
volume or on an irregularly shaped volume of interest.
142, 143
 Here, we scanned the 
regenerated bone tissue excises and quantified the new bone formed in each type of 
hydrogel implants using the microCT scanner. First, measurement of the angle for 
rotation and reconstruction of the 2D images were performed to ensure that all parts of 
the samples were scanned properly. All 2D constructs were shown in Appendix D. Figure 
4.7 showed that RGD-PAH samples gave the most average bone volume following with 
TMV-RGD. PAH samples had the least mean bone volume quantified by microCT. 
Nevertheless, with statistical t-test analysis, the regenerated bone volume differences 
among three types of hydrogels lacked of significance. Therefore, more replicate samples 
may be investigated to make this conclusion definitive. 
 The same samples were then subjected to histopathological analysis. Masson’s 
trichrome is to show the bone and non-mineralized osteoid seen in blue (aniline blue) and 
red (biebrich-scarlet), respectively. Figure 4.8 illustrated the representative image from 
each type of hydrogel sample corresponding to the bone density rank that obtained 
highest frequency (rat number) within each hydrogel type. The insets of Figure 4.8 
depicted descriptive statistical analysis showing the frequency of each level of bone 





Figure 4.7. Bone regeneration in critical size defect areas with porous hydrogel bone 
substitutes. The bone volume regenerated in each type of hydrogel was quantified using 
micro computed tomography (microCT). Values expressed are means (n = 6, for PAH 




                                                 
2








Figure 4.8. Histological analysis of regenerated bone at defect sites filled with hydrogel implants. Histological sections cut coronally 
through the defect after 10 weeks of implantation. The sections are stained with Masson’s trichrome and imaged at × 40 magnification. 
The regenerated bone was characterized by the presence of a collagen-rich matrix stained blue. The inset pie charts represented the rat 
numbers that developed different degree of bone regeneration at the defect site. 
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of Figure 4.8 corresponded to the sample that was stained dense bone tissue (weighted 
60% of total rats treated with RGD-PAH). Figure 4.8 showed that the rats that received 
RGD-PAH implants had more probability to regenerate higher density of bone. 
Following by the group that was treated with TMV-PAH, 60% of the animals in this 
group could regenerate few or medium bone tissue. The group with PAH alone had the 
most probability in having none or rarely seen bone formation. This analysis suggested 
that by incorporating TMV particle into the hydrogel scaffold, the bone regeneration 
could be enhanced. Moreover, TMV-RGD1 mutant further improved the new bone 
formation bridging the cranial bone defects. This result also corresponded to the 
histological analysis from previous section. Among combinations of hydrogel types, 
Pearson’s statistical correlation test showed correlations between bone tissue formation in 
the hydrogel implants and two isolated histopathological variables including 
fibrous/connective tissue (correlation coefficient; r = 0.6) and neovascularization (r = 
0.6). This study suggested, in consistence with many other studies, that RGD, when 
attached to the implanted scaffolding materials, played an important role in cell 





The viral particle functionalized PAHs were comparatively investigated in terms of 
inflammation and healing of confined critical size cranial bone defects in rats. In vivo, 
TMV- and RGD- PAH permitted the healing of critical size defects in the cranial 
segmental bone of rats, as did the PAH control gel, but, unlike the latter, RGD-PAH 
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improved bone remodeling and maturation. The hydrogels elicited neither a systemic 
inflammatory reaction, nor a severe immunogenic adverse effect. Therefore, virus-based 
combinatorial porous alginate hydrogel is potentially useful as bone replacement material 
in reconstructive orthopaedic surgery, being a readily available biomaterial able to 
improve bone healing and maturation. However, more animal research with other model 
of bone defects (e.g., tibia and femur) and other higher animal may be needed before 
translation to clinic. 
 
4.4 EXPERIMENTAL SECTION 
All chemicals were obtained from commercial suppliers and used as received unless 
otherwise noted. Wild-type TMV (TMV) and its RGD mutant (TMV-RGD) were isolated 




4.4.1 Synthesis of Virus-Incorporated Porous Alginate Hydrogels.  
The incorporation of TMV and its mutant (TMV-RGD) in porous alginate hydrogel was 
based on previously reported methods.
37
 Briefly, 5% w/v low viscosity sodium alginate 
(Protanal LF 10/60 FT, 30 − 60 mPas for 1%, kindly provided by FMC Biopolymer UK 
Ltd.) was dissolved in 2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 
solution. Molar equivalent of citric acid with respect to NaHCO3 was added to the 
mixture while stirring at 500 rpm using overhead stirrer, 115V. Stirring was continued for 
15 min at room temperature to allow CO2 to fully develop. For the PAH modified with 
TMV (TMV-PAH), or PAH modified with mutant TMV-RGD (RGD-PAH), 0.1% w/v of 
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virus was added to the solution 10 min after adding citric acid. The mixture was stirred 
for another 5 min.  Afterward, the foamy alginate solution was cast in 6.35 mm (0.25 
inches) diameter, 2 mm thick aluminum mold and freeze-dried. The resulting solid foam 
disc was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based 
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid 
foam was freeze-dried, resulting in porous alginate hydrogel (PAH) for implantation in 
animal study.  
 
4.4.2 Animals, Lethality Test and Animal Treatments.  
The procedures were performed in accordance with the guidelines for animal 
experimentation and the protocol approved by the Institutional Animal Care and Use 
Committee, University of South Carolina. NIH guidelines (or for non-U.S. residents 
similar national regulations) for the care and use of laboratory animals (NIH Publication 
#85 - 23 Rev. 1985) have been observed. Twelve-week-old male Sprague-Dawley rats 
were housed at 22 ± 2 °C with a 12/12 h light/ dark cycle and fed standard rodent chow 
and water ad libitum. Twenty-one rats were randomly assigned to experimental groups. 
Two groups that were implanted by TMV-PAH, and RGD-PAH consisted of 7 rats each. 
Another group implanted by PAH consisted of 6 rats. Disk-shaped hydrogels were 
implanted to fill the cranial bone defects created in the surgery. Rats were given 2 - 4 
mg/kg of Carprofen 2 - 4 hours before surgery subcutaneously for analgesia. Procaine 
penicillin (60,000IU) was given SQ for infection prophylaxis. Instruments were 
autoclaved prior to use to minimize risk of post-surgical infection and cross 
contamination. The animal was anesthetized with 3% isoflurance in oxygen. After the 
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appropriate plane of anesthesia was obtained, the fur over each animal's cranium was 
shaved and the skin was cleansed with normal saline to remove loose hair. A dry heating 
pad was used to keep the animal warm during surgery. A midline incision was made from 
the middle of the nasofrontal area to the external occipital protuberance, utilizing a sterile 
No. 15 scalpel blade. Full-thickness skin flaps will be reflected laterally with a periosteal 
elevator to expose the calvaria. An 8-mm craniotomy was performed in all animals 
utilizing a dental handpiece system at low speed and with copious sterile saline irrigation 
to remove loose debris and to avoid generation of frictional heat at the surgical site. Bone 
defects were standardized by using an 8-mm diameter trephine bur to outline the 
treatment area. A PTFE barrier membrane (Osteogenics Biomedical, Lubbock, TX) was 
inserted to form a barrier on top of the dura. Next, the hydrogel scaffold was carefully 
placed into the defect and the second PTFE membrane was placed over the defect and 
under the periosteum. The periosteum was repositioned and closed utilizing continuous 
interlocking sutures using Nylon suture material. Postoperative analgesia to relieve pain 
with carprofen (2 - 4 mg/kg) was given orally at least once every 24 hours for 48 hours. 
The animals were weighed immediately before/after surgery and daily afterward for the 
first 2 days. Then they were weighed once a week until the experiment ended. Signs of 
pain or distress were monitored daily after surgery.  
 Blood withdrawal was performed on day 4, weekly at the first 4 weeks, and 
biweekly until the end point at week 10, after the surgery. Blood samples from all 
animals were subjected to total blood count and antigen-antibody ELISA assay specific to 
TMV. Three-hundred microliters of blood was withdrawn from the tail vein while the 
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animals were restrained using a restraint tube. After iodine scrub, a butterfly needle was 
inserted into the vein. The blood was then collected into the collection tube. 
 At 10 week time point, the animals were euthanized. The implants were recovered 
together with their surrounding tissues. The excised implants with the surrounding tissues 
were then preserved in 10% neutral-buffered formalin for subsequent analyses. The 
spleen of every rat was isolated and weighted.  
 
4.4.3 Micro computed tomography 
The samples and the surrounding bone tissues were fixed in a 10% formalin solution for 
micro-computed tomography (Micro-CT, Skyscan 1076, Skyscan, Belgium) analysis and 
histopathology study 1 and 2 months after implantation. MicroCT was used to observe 
the new bone formation in the defected skull site. Each sample was fixed on the object 
stage, and imaging was performed on the sample for 360° of rotation with an exposure 
time of 20 min. MicroCT images were reconstructed over the region of interest (ROI) 
using CTAn (Skyscan) and CTVol (Skyscan) to make 3D images. 
 
4.4.4 Hematological assay.  
Complete Blood Count (CBC) was preceded right after each blood withdrawal. The 
blood sample of 10-50 µL was transferred into 1 mL BD Microtainer Tube with 
Dipotassium EDTA. Each tube was subjected to the automated blood counter machine, 
model VetScan HM5 Hematology System. The numbers of total white blood cell (WBC), 
neutrophil (NEU), monocyte (MON), lymphocyte (LYM), red blood cell (RBC), 
hemoglobin (HGB), platelet (PLT), and mean platelet volume (MPV) were recorded and 
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analyzed according to the calibrated instrumental protocol, which indicated the normal 
range of each parameter. 
 
4.4.5 Paraffin Embedding and Histological Assays.  
The formalin preserved implanted hydrogels/tissues of all rats were decalcified using 10% 
formic acid in formalin for 1 week and then embedded in paraffin blocks individually 
with proper orientations. Tissue sections (5 µm) were prepared and stained with 
Masson’s trichrome. Based on the amount of inflammatory cells (basically lymphocytes, 
neutrophils, macrophages, and so on) observed within areas of implants, the degree of 
tissue inflammation was scored as 0, 1, and 2 (normal: none or rarely seen, slightly 
increased: 5 to 20 per × 40 objective field, and obviously increased: > 20 per × 40 
objective field). Based on the degree of fibrous/connective tissues and capillary blood 
vessels observed within the areas of implants, the tissue fibrosis and vasculization were 
scored as 0, 1, 2 and 3 (none, rarely seen; ≤ 2 vessels/   40 field, slightly increased; 3 - 
10/ × 40, and obviously increased; > 10 vessels/ × 40 field, respectively). Bone 
regeneration was evaluated on the same tissue sections and given the degree of new bone 
formation as follows: none or rarely seen; ≤ 2 per   40 field, few or moderate; 3 - 10 per 
× 40 field, and dense; > 10 per × 40 field. Histological images were taken by using a 
Nikon microscope and an Olympus digital camera. 
 
4.4.6 Enzyme-Linked Immunosorbent Assay (ELISA).  
The serum samples for ELISA were obtained after centrifugation (2,000 g, 15 min, 4 °C) 
of blood samples collected from every animal and stored at -80 °C. ELISA was 
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performed no later than 3 months after the sera were collected. To coat wells with TMV 
antigen, high protein-binding conical bottom 96-well plate was used. Wild-type TMV (10 
µg/mL, 100 mL) in phosphate buffer saline (PBS) was added to the microwells and 
incubated for 1 h at room temperature, followed by three PBS washes. Blocking for non-
specific binding was performed by adding 100 µL of 1% bovine serum albumin (BSA) 
and incubating for 30 min at room temperature, followed by three PBS washes. Binding 
was performed by adding 100 µL of serially diluted antiserum into microwells and 
incubating for 1 h at room temperature, followed by thorough washes. HRP conjugate 
anti-mouse IgG (Cayman Chemical Company) diluted at 1:20000 ratio was added and 
incubated for 30 min at room temperature. Tetramethyl benzidine (TMB Plus, Amresco) 
and 1 M H2SO4 were added in sequence to the wells according to the manufacturer’s 





CHONDROGENIC DIFFERENTIATION OF BONE MARROW STROMAL CELLS IN THREE- 
DIMENSIONAL CULTURES 
5.1 INTRODUCTION 
5.1.1 Hydrogels as scaffolds for chondrogenesis of bone marrow stromal cells 
Cartilage tissue engineering has been of significant interest with incessant efforts in 
research and development because damaged human articular cartilage lacks the ability for 
self-repair.
147-149
 Current clinical methods to repair defective cartilage are limited in their 
ability to regenerate functional cartilage both in terms of composition and mechanics.
149
 
In replicating the native cartilage microenvironment, hydrogels provide cell support and 
display high water retention.
150
 Many studies have evidenced that hydrogel-based 
biomaterials can offer an instructive three-dimensional (3D) microenvironment for 




 Bone marrow stromal cells (BMSCs) have emerged as a clinically relevant cell 
source for regenerative medicine due to their potential to differentiate into several 
mesenchymal lineages including cartilage, bone, and fat.
153, 154
 The multipotent 
differentiation of BMSCs is regulated by both soluble and physical factors present in the 
extracellular microenvironment, including cell-cell and cell-matrix interactions, features 





The scaffolds not only provide structural support for chondrogenesis of BMSCs, but also 





5.1.2 Tobacco mosaic virus as bionanoparticle to functionalize hydrogels 
Here, we utilized the tobacco mosaic virus (TMV) as a functional nano-scaffolding 
material to decorate the hydrogel with multivalent RGD peptide, i.e. a common integrin-
binding motif, through its RGD mutant. RGD has been shown to influence both 
chondrogenesis and osteogenesis in alginate hydrogels in dose-dependent manner.
156, 158, 
159
 The degree of cellular adhesion to the environment (e.g., through changes in ligand 
density) regulates integrin clustering, cytoskeletal organization, overall morphology, and, 
specifically in the case of stem cells, differentiation.
160-163
 In Chapter 1, we explored the 
use of this virus functionalized hydrogels by studying the cell adhesion and osteogenic 
differentiation of BMSCs in 3D environment. The porous alginate hydrogel (PAH) 
scaffold was modified with TMV (TMV-PAH) and TMV-RGD1 mutant (RGD-PAH). 
The virus-functionalized hydrogels were cyto-compatible in vitro (Chapter 1), and 
biocompatible in mice and rats (Chapter 2 - 4). The RGD motif presented in the hydrogel 
was shown accessible to the cells by the increase in cell binding. Moreover, the hydrogels 
allowed the osteogenic differentiation with higher degree of mineralization in virus-
functionalized hydrogels. In this chapter, we laid the concept of easy-to-functionalize 
hydrogel scaffold with controllable RGD dose and multivalency via viral nanoparticle on 
chondrogenesis of BMSC in 3D culture and characterization.   
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5.2 RESULTS AND DISCUSSION 
5.2.1 Chondrogenesis primer optimization 
In this chapter, gene expression for 4 chondrogenesis marker proteins including 
Aggrecan, COMP (Cartilage Oligomeric Matrix Protein), Collagen II, and Sox9 were 
proposed to be used for characterization of the cartilage differentiation of BMSCs in 3D 
porous hydrogel scaffolds. First, Aggrecan is a cartilage-specific proteoglycan core 
protein (CSPCP) or chondroitin sulfate proteoglycan 1 that performs as an integral part of 
the extracellular matrix (ECM) in cartilaginous tissue. This molecule is important in the 
proper functioning of articular cartilage because it provides a hydrated gel structure (via 
its interaction with hyaluronan and link protein) that endows the cartilage with load-
bearing properties. It is expressed by chondrocytes and is also crucial in chondroskeletal 
morphogenesis during development.
164
 Second, cartilage oligomeric matrix protein 
(COMP) is a non-collagenous ECM protein expressed primarily in cartilage, ligament, 
and tendon. The molecular functions of COMP include: binding other ECM proteins, 
catalyzing polymerization of type II collagen fibrils, and regulation of chondrocyte 
proliferation.
165
 Third, the synthesis of type II collagen is initiated as mesenchymal cells 
differentiate into chondrocytes. The level of cytoplasmic type II collagen mRNA 
progressively increases during the course of chondrogenesis, which parallels the 
progressive accumulation of cartilage matrix by cells.
166
 These three protein markers 
mentioned are considered as the essential parts of the cartilage ECM. Another important 
chondrogenic protein marker, Sox9 is a transcription factor with a high-mobility group 
(HMG-box) DNA-binding domain exhibiting a high degree of homology with that of the 
mammalian testis-determining factor, SRY. During chondrogenesis, Sox9 is expressed in 
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all chondroprogenitors and all differentiated chondrocytes. This transcription factor is 
required in several successive steps of the chondrocyte differentiation pathway during 
endochondral bone formation in vivo and for the proper progression of cells through the 
sequential steps of this process. Akiyama et al. emphasized that Sox9 is needed for the 
commitment of undifferentiated mesenchymal cells to a chondroprogenitor.
167
 To study 
these genes, we first verified the primers and optimized the reverse transcription 
polymerase chain reaction (RT-PCR) condition using the commercial cartilage cDNA. 
 The primer sequences for these genes were listed in Table 5.1. Figure 5.1 
represented the corresponding RT-PCR products on agarose gel suggesting the validity of 
the primers and the respective RT-PCR condition for Sox9 (lane B), COMP (lane C), 
Aggrecan (lane D), and GAPDH (lane E). However, the RT-PCR product of Collagen II 
could not be synthesized from the same batch of cDNA (lane A), even with the increased 
dose of primers (up to 0.4 µM) and/or greater cDNA concentration.  
 
5.2.2 Chondrogenesis gene expression 
The genes related to chondrogenesis were studied from the differentiated BMSCs in 
PAH, TMV-PAH, and RGD-PAH cultured with chondrogenic media. Figure 5.2 showed 
the quantitative PCR results from day 18 culture normalized with non-induced BMSCs 
day 0. Overall, there were insignificant upregulations of all chondrogenic marker genes 
for Aggrecan, COMP, and Sox9 with no statistical significance among different types of 
hydrogels. The standard deviation (SD) expression of each gene normalized with 
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Table 5.1. Primers used for RT-PCR and RT-qPCR to measure chondrogenesis gene 
expression. 
 
Gene Sequence (5'-3') Reference 
GAPDH Forward: ACTAAAGGGCATCCTGGGCTACACTGA 17 
 Reverse: TGGGTGGTCCAGGGTTTCTTACTCCTT  
Aggrecan Forward: GGCCTTCCCTCTGGATTTAG 168 
 Reverse: CCGCACTACTGTCCAAC  
C MP Forward: TGACTTCGATGCTGACAAGG 168 
 Reverse: GAACGATCTCCATTCCCTGA  
Sox9 Forward: CTGAAGGGCTACGACTGGAC 168 
 Reverse: TACTGGTCTGCCAGCTTCCT  
Collagen II Forward: AGGGGTACCAGGTTCTCCATC 169 





Figure 5.1. Agarose gel image of RT-PCR products derived from cartilage cDNA used 
for primer and PCR optimization. Gel image showed the PCR products of house-keeping 
gene (lane E), Aggrecan (lane D), COMP (lane C), and Sox9 (lane B). There was no 





Figure 5.2. Gene expression levels of chondrogenesis markers after chondrogenic 
induction of BMSCs cultured in PAH, TMV-PAH, and RGD-PAH for 18 days.  
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housekeeping gene (GAPDH) and among triplicate samples were very high due to the 
poor quality and quantity of messenger RNA extracted from the hydrogels. Aiming for a 
quality RNA extraction from polysaccharide based scaffolds is extremely challenging.
170-
172
 However, the improvement in RNA purification method is required for more 
conclusive data.  
 
5.2.3 Collagen II immunohistochemical staining  
Immnofluorescence imaging in Figure 5.3 showed that the chondrogenic-induced BMSCs 
cultured in TMV-PAH and RGD-PAH stained positive for type II collagen after 18 days 
with higher fluorescence intensity than it appeared in PAH. It is likely that TMV and 
RGD-TMV could enhance the differentiation of BMSCs into chondrocyte. With very 
limited data, thus far, a possible justification at this point could be that TMV particles 
might induce the chondrogenesis through the stimulation of bone morphogenic protein-2 
(BMP-2) as it has been suggested by Sitasuwan et al. in osteogenesis of BMSCs.
17
 
Likewise, the BMPs have been identified by virtue of their ability to promote cartilage 
formation, especially in commitment and condensation during chondrogenesis.
173-175
 






Figure 5.3. Immunofluorescence images of chondrogenic differentiated BMSCs in 3D 




In this chapter, we have verified the primers and the PCR condition used for 
chondrogenic gene study including Aggrecan, COMP, and Sox9. When BMSCs were 
culture with chondrogenic supplemented media in 3D hydrogels with virus nanoparticles 
(TMV-PAH and RGD-PAH), collagen II was accumulated and that could eventually lead 
to the cartilage-like tissue formation with the ECM components secreted during the 
differentiation and the 3D supports provided by the hydrogel scaffolds. However, the 
appropriate solid data should be continued to explore in order to make the argument 
conclusive. In conclusion, this virus functionalized porous alginate hydrogel system is 
considered a prototypical concept for the development of biomaterials to study the 
regulation of multivalent-displayed biofunctionality or specific scaffold chemistry 
towards cartilage differentiation of stem cells in 3D. 
 
5.4 EXPERIMENTAL SECTION 
All chemicals were obtained from commercial suppliers and used as received unless 
otherwise noted. Wild-type TMV (TMV) and its RGD-mutant (TMV-RGD1) were 




5.4.1 Synthesis of virus-incorporated porous alginate hydrogels 
The synthesis of gas template solid foam was based on the methodology reported by 
Barbetta et al.
28
 Briefly, 5% w/v low viscosity sodium-alginate (Protanal
®
 LF 10/60 FT, 
30 - 60 mPas for 1%, kindly provided by FMC Biopolymer UK Ltd.) was dissolved in 
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2% w/v sodium bicarbonate (NaHCO3) and 4% w/v pluronic F108 solution. Molar 
equivalent of citric acid with respect to NaHCO3 was added to the mixture while stirring. 
Stirring was continued for 15 min to allow CO2 to fully develop. Afterward, the foamy 
alginate solution was flash frozen in liquid nitrogen and freeze-dried. The resulting solid 
foam was soaked in 2 M of CaCl2 for 24 h to induce the formation of the calcium-based 
physical gel and then dialyzed against large volume of 0.1 M CaCl2. Finally, the solid 
foam was freeze-dried, resulting in porous alginate hydrogel (PAH). For the TMV 
modified PAH (TMV-PAH), or mutant TMV-RGD1 modified PAH (RGD-PAH), 0.1% 
w/v of virus was added to the solution 10 min after adding citric acid. The mixture was 
stirred for another 5 min.  
 
5.4.2 Bone Marrow Stem Cells (BMSCs) isolation and culture  
Primary BMSCs were isolated from the bone marrow of young adult 160-180 g male 
Sprague Dawley rats (Charles River Laboratories). The procedures were performed in 
accordance with the guidelines for animal experimentation by the Institutional Animal 
Care and Use Committee, School of Medicine, University of South Carolina. Cells were 
maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS)), kept at 37°C in a CO2 incubator with 




5.4.3 Cell seeding and chondrogenic culture 
Lyophilized PAH, TMV-PAH, and RGD-PAH scaffolds were cut to 3 × 3 × 2 mm
3
 
cubes. For quantitative real-time RT-PCR, each set of experiment (N) contained six 
hydrogels per type of scaffold. For immunostaining experiment, one hydrogel per sample 
was used. Hydrogels were sterilized in 70% ethanol for 15 min, ethanol was drained on 
sterile filter paper and the hydrogels were further sterilized under UV-light for 60 min in 
laminar airflow hood. Hydrogels were then saturated in chondrogenic supplemented 
media at 37°C for 60 min, blotted excess media with sterile filter paper, and placed in 12-
well non-adhesive plate. BMSCs were harvested from 80% confluent culture flask using 
0.25% trypsin/EDTA (Cellgro) for 5 min and counted and re-suspended in complete 
primary media. 4 × 10
3
 BMSCs were seeded per one volume (mm
3
) of hydrogel. Rat 
BMSCs loaded hydrogels were initially incubated with 200 μL of chondrogenic media in 
each well to prevent hydrogels from drying out. After 6 h of an initial incubation, 
hydrogels were completely submersed in 1 mL of chondrogenic media in each well. The 
hydrogels seeded with BMSCs were cultured at 37°C and 5% CO2.  
 Chondrogenic supplemented media comprised of DMEM (Hyclone, Thermo 
scientific), 1% fetal bovine serum (Atlanta biologicals), 1 × Penicillin-Streptomycin-
Amphotericin B (from MP Biomedicals,100 U/mL penicillin and 1000 U/mL 
streptomycin solution, 0.25 μg/mL amphotericin B antimycotic), 100 nM dexamethasone 
(Enzo Life Sciences), 10 ng/mL TGF β1 (R&D System), 50 μg/mL ascorbic acid (Sigma-
Aldrich), 1 mM sodium pyruvate (Hyclone, Thermo scientific), 1 × ITS
+3
(from Sigma-
Aldrich, contains 1.0 mg/ml insulin from bovine pancreas, 0.55 mg/mL human transferrin 
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(substantially iron-free), 0.5 μg/mL sodium selenite, 470 μg/mL linoleic acid, 470 μg/mL 
oleic acid and 50 mg/mL bovine serum albumin), 2 mM l-glutamine (Hyclone, Thermo 
scientific) and 40 μg/mL l-proline (Sigma-Aldrich).
176, 177
 Medium was replaced thrice in 
a week and cultures were harvested at day 18. 
 
5.4.4 RT-PCR 
Rat cartilage cDNA (Zyagen) was used to verify the primers for cartilage related genes 
including Aggrecan, COMP, Sox9, and Collagen II and to optimize the quantitative real-
time RT-PCR condition. RT-PCR was then achieved by the method described as: 45 
cycles of PCR ( 95°C for 20s, 60°C for 15 s, and 72°C for 15 s), after initial denaturation 
step of 5 minutes at 95°C, by using 0.1 μL of Taq DNA polymerase, 0.5 μL of 10 mM 
dNTP Mix, 2.5 μL of 10X PCR Buffer, without Mg, 2 pmol/μL of each forward and 
reverse primers and 30 ng cDNA templates in a final reaction volume of 25 μL. The 
primer sequence used was listed in Table 5.1. The PCR product was then subjected to 
standard agarose DNA gel electrophoresis. 
 
5.4.5 Quantitative real-time RT-PCR analysis (RT-qPCR) 
The chondrogenic cell cultures were terminated after 18 days. At the termination time 
point, the hydrogels were flash frozen then immediately disrupted by high speed 
homogenization in the prechilled RNAzol
®
 RT reagent (MRC). The tissue homogenizer 
probe was rinsed with RNase-free water and 10% sodium lauryl sulfate between each 
sample processing to prevent cross-contamination. Total RNA was subsequently 
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extracted following manufacturers’ protocols of RNAzol
®
 RT (MRC). The resulting 
RNA was reverse transcribed by using qScript™ cDNA Supermix (Quanta Biosciences). 
The number of samples for each experiment (n) was six and each experiment was 
repeated (N) three times. The quality and quantity of the extracted RNA was analyzed 
using Bio-Rad Experion (Bio-Rad Laboratories) and was reverse transcribed by using 
qScript™ cDNA Supermix (Quanta Biosciences). RT-qPCR (iQ5 real-time PCR 
detection system Bio-Rad Laboratories) was done by the method described as: 45 cycles 
of PCR (95°C for 20s, 60°C for 15 s, and 72°C for 15s), after initial denaturation step of 
5 minutes at 95°C, by using 12.5 μL of iQ5 SYBR Green I Supermix, 2 pmol/μL of each 
forward and reverse primers and 2 - 5 μL cDNA templates in a final reaction volume of 
25 μL. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the 
housekeeping gene. Data collection was enabled at 72°C in each cycle and CT (threshold 
cycle) values were calculated using the iQ5 optical system software version 2.1. 
Quantification of gene expression was based on the CT value for each sample which was 
calculated as the average of three replicate measurements for each sample analyzed using 
the same software. The primers used for RT-qPCR are shown in Table 5.1. The primers 
were synthesized commercially (Integrated DNA Technologies, Inc.), and evaluated for 
an annealing temperature of 60°C. 
 
5.4.6 Immunohistochemistry staining for type II collagen 
Immunostaining was performed to observe the presence of collagen II. rBMSCs culture 
in PAH, TMV-PAH, and RGD-PAH were terminated after culturing 18 days in 
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chondrogenic media. Hydrogels were washed three times with 100 mM cacodylated 
buffer and then fixed in 2.5% glutaraldehyde in cacodylated buffer overnight. The fixed 
samples were then permeablized for 15 min in TBST (0.05% Tween20) and blocked in 
2% w/v bovine serum albumin (BSA, Sigma–Aldrich) in TBS for 20 min with gentle 
agitation at room temperature. After blocking, the hydrogels were incubated for 2 h with 
primary antibody targeting the type II collagen (Sigma-Aldrich) at 1:100 dilution. 
Secondary antibody detection Alexa Fluor
®
 546 (Molecular Probes, Invitrogen) was used 
at 1:200 dilutions in blocking buffer for 1 h at room temperature. In the end, the 
hydrogels were washed with TBS and counter-stained with DAPI (nuclear staining). 
Images of the stained samples were obtained using Olympus IX81 with epi-flour mode 
under 20x objective lens (for PAH and TMV-PAH) and 10x objective lens (for RGD-
PAH). Exposure times were kept constant for all samples (50 ms for DAPI and 1000 ms 





IN SITU CROSSLINKING HYDROGELS WITH CYSTEIN-ADDED MUTANT OF TOBACCO  
MOSAIC VIRUS FOR STEM CELL ENCAPSULATION AND CULTURE 
6.1 INTRODUCTION 
6.1.1 Viral nanoparticle as a versatile nano-sized biomaterial in biomedicine 
Plant viruses or virus like particles (VLPs) are becoming attractive platforms in variety of 
biomedical applications. Due to the simplicity of their genome, viruses use repetitive 
protein units to construct their capsids, which lead to highly organized structures on the 
surface.
178
 This can provide a highly ordered platform to display various functionalities in 
high density. By designing the plant virus with simple functional groups, previous reports 
have shown that the tobacco mosaic virus (TMV), as nanometer sized building block, can 
support mammalian cells and dramatically improve the transformation of bone marrow 
derived mesenchymal stem cells (BMSCs) into bone-like cells in the laboratory. 
36, 37
 
Moreover, Sitasuwan et al. reported the acceleration of bone differentiation with 
overexpressed BMP-2 gene in osteogenic induced BMSCs when grown on wild-type 
TMV based substrate.
17
 Our aim was to implement these tissue responses in 3D hydrogel 
system in an injectable format for cartilage tissue engineering. The design of this study 
based on the covalent crosslinking of TMV particles onto the polymer backbone of 
injectable hydrogel. The polymer backbone functionalized with (meth)acrylate groups 
that can undergo Michael addition reaction with thiol molecules. Native TMV particles 





Therefore, in this chapter, we utilized a cysteine added mutant of TMV (TMV-1Cys) to 
serve the crosslinking purpose. Cys mutant of TMV has been successfully expressed in 
tobacco plants and purified in large quantities to utilize the virus platform in various 








6.1.2 Hyaluronic acid as a hydrogel-forming biopolymer 
Hyaluronic acid (HA) is a mucopolysaccharide that binds to water giving it a stiff viscous 
quality similar to “Jello”. It is natively found in most connective tissues and is 
particularly concentrated in human synovial fluid, the vitreous fluid of the eye, umbilical 
cords, nasal cartilage and rooster combs.
182
 It is naturally synthesized by a class of 
integral membrane proteins called hyaluronan synthases, and degraded by a family of 
enzymes called hyaluronidases that are found throughout the body or through oxidative 
mechanisms to yield oligosaccharides and glucuronic acid.
183, 184
 The biological functions 
of HA include maintenance of the elastoviscosity of liquid connective tissues such as 
joint synovial and eye vitreous fluid, control of tissue hydration and water transport, 
supramolecular assembly of proteoglycans in the extracellular matrix (ECM), and 
numerous receptor-mediated roles in cell detachment, mitosis, migration, tumor 
development and metastasis, and inflammation.
185-189
 HA is a linear chain polymer of 
repeating units of disaccharide, β-1,4-D-glucuronic acid–β-1,3-N-acetyl-D-
glucosamine.
182, 190
 The polymer possesses properties desirable for tunable scaffolds for 
tissue engineering as a wide range of molecular weights can be obtained, as well as the 
presence of chemically modifiable groups (hydroxyl and carboxyl groups) on the 
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backbone. Functionalized HA with reactive groups such as methacrylates and acrylates 
has been utilized to form HA-based hydrogels for controlling stem cell differentiation.
191-
194
 HA hydrogel can also be further engineered to obtain different physical and chemical 
properties. For example, gelation time and mechanical property of the hydrogel could be 





6.1.3 Injectable hydrogel for cell encapsulation and tissue engineering 
In situ gelling hydrogel system is currently of significant interest for tissue engineering 
applications due to its advantages over the pre-formed hydrogel scaffold. The key 
benefits include 1) cell encapsulation occurred as the gelation progress eliminating a 
concern over limited cell penetration into scaffold; 2) better cell-material contact closely 
resembling the natural tissue environment; 3) in situ molding feature capable of filling 
irregular shape defect and providing better tissue integration; and 4) minimally invasive 
route of administration improving patient compliance.
84, 196-198
 Injectable hydrogel 
requires that the gel precursors can be gelled under mild conditions driven by physical 
changes like pH value, temperature, ionic concentration, and/or chemical crosslink 
reactions.
17
 Here, we used hyaluronic acid (HA) as the hydrogel forming polymer to 
design the virus-incorporated injectable hydrogel. HA backbone was modified to have the 
reactive methacrylic group and the gel could be formed the physiological condition in 
situ upon addition of dithiothreitol (DTT) crosslinker via thiol-ene Michael addition 
reaction.
190, 195
 The incorporation of TMV could be proceeded through the same thiol-ene 
reaction between thiol group of TMV-1Cys mutant and the methacrylated HA polymer. 
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Together with the previous observation that 2D TMV coated substrate could regulate 
early stem cell differentiation, we hypothesized that TMV displayed in a 3D hydrogel 
system could affect the hydrogel material properties and direct cell responses. In this 
study, we characterized the physical properties of hydrogels including viscoelasticity and 
gelation behaviors, the cross-linked TMV particles within the hydrogel, and the stem cell 
response after encapsulation in the TMV-based hydrogel.  
 
6.2 RESULTS AND DISCUSSION 
6.2.1 HA-methacrylate synthesis and chemical characterization 
Firstly, to fabricate the hydrogels, HA was functionalized with methacrylate groups using 
a simple, one-step reaction with methacrylic anhydride. Methacrylate groups were then 
crosslinked via a rapid Michael addition reaction with thiol-containing molecules. In our 
experiment, the cysteine-containing coat protein subunits of TMV-1Cys and dithiothreitol 
(DTT; a small molecule crosslinker) were used as the crosslinkers (Figure 6.1). Thiol-
(meth)acrylate Michael addition is an efficient reaction that may be completed in aqueous 
medium at physiological temperature and pH in the presence of proteins or cells.
199-202
  
 We synthesized many variants of methacrylated HA as listed in Table 6.1. An 
excess of methacrylic anhydride with respect to HA was often used because of the limited 
solubility and potential hydrolysis reaction of methacrylic anhydride in aqueous medium. 
By varying HA monomer : methacrylic anhydride molar ratio, we consistently obtained 
low (~ 10%), medium (~ 40 - 50%), and high (100%) degree of modification of HA 
backbones (~ 47 kDa MW) as determined by 
1









Figure 6.1. Injectable hydrogel from virus-linked biopolymer. The hydrogel synthetic scheme illustrated the incorporation of TMV in 
the in situ crosslinked hydrogel (A). Hyaluronic acid (HA) was reacted with different molar excesses of methacrylic anhydride to yield  
methacrylated HA in various degrees of modification (A1). TMV-Cys mutant was linked to methcrylated HA backbone via thiol-ene 




Table 6.1. Percent degree of methacrylation of different macromer size HA when 
reacting with various molar ratio of methacrylic anhydride.   
 
MW of HA HA monomer : Methacrylic anhydride molar ratio 
1:3 1:6 1:10 1:12 
47 kDa ~ 10% ~ 40-50% 100% 100% 
310 kDa N/A ~ 30% N/A ~ 75% 
1 MDa  N/A Not detectable N/A N/A 
N/A data not available
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Slightly lower percentage of modification could be obtained from the higher molecular 
weight HA (310 kDa) using the same reaction condition with 1:6 and 1:12 HA monomer 
: methacrylic anhydride molar ratio. Nonetheless, the degree of modification could not be 
detected by 
1
H NMR when the same reaction condition applied to 1M Da HA, likely due 
to the high viscosity of the HA solution which reduces the reaction rate. Thus, the 
modification reaction of high molecular weight HA could be optimized by reducing the 
concentration of HA polymer. By far, giving optimum viscosity and modularity in a wide 
range of % methacrylation, 47 kDa HA macromere seemed feasible for our experiment. 
 The rational supporting the use of relatively small HA macromer (around 50 kDa) 
was also based on the report by Chung et al. They suggested that the hydrogels fabricated 
from 2 wt% of the 50 kDa HA macromer most resembled the properties of native 
cartilage and showed the greatest promise for continued development for cartilage 
regeneration when compared to the hydrogels from the larger HA (tested up to 1100 
kDa).
190, 203
 For the purpose of future chondrogenic (cartilage) differentiation study of 
BMSCs, 47 kDa HA was used for the rest of this report. For consistency of the 
nomenclature for each hydrogel formulation in this report, the terms, “TMV-SH, 0.1% + 
xx-DMHA, 5%” and “xx-DMHA, 5%,” represent for TMV-1Cys modified methacrylated 
HA hydrogel and non-modified methacrylated HA hydrogel, respectively; with xx-DM 




6.2.2 Gelling behavior and mechanical characterization of HA hydrogels 
TMV-1Cys (TMV-SH) mutant contained cysteine in addition to the wild-type TMV at N-
terminus of its hierarchically assembled coat proteins (see Appendix F for TEM image of 
TMV-1Cys). We covalently conjugated TMV-1Cys to methacrylated HA backbone via 
Michael addition reaction. The methacrylated HA functionalized with TMV-SH pre-
hydrogel solution was then crosslinked to create hydrogel with DDT via the same thiol-
ene reaction. Oscillatory rheology was used to study sol-to-gel transition. The DTT 
molecular crosslinker was added to the pre-hydrogel solution (with and without TMV-
SH) right before loading sample onto the rheometer. The gelation time of each hydrogel 
was determined from crossing-over between storage modulus and loss modulus. Storage 
modulus G' and loss modulus G" are parameters describing the rheological properties of 
viscoelastic polymeric materials. Storage modulus G' defined by the ratio of elastic stress 
to strain, describes the amount of stored (saved) energy during shear, and refers to the 
elastic properties of the material. Loss modulus G" expressed by the ratio of viscoelastic 
stress to strain, shows how much energy was dissipated in a cycle of deformation in the 
form of heat and defines the viscous properties of the material.
204, 205
Here, we observed 
substantially faster gelation time when TMV-SH was attached and incorporated into the 
hydrogel (Figure 6.2). Figure 6.2A showed that the modulus cross-over appeared much 
earlier in the hydrogel formulation with 0.1 wt% TMV-SH. The same study was repeated 
for 3 times, and the significant difference of average gelation times of the hydrogel with 
and without TMV-SH was displayed in Figure 6.2B. The gels could be formed in situ 









Figure 6.2. Gelation behavior of injectable hydrogels was observed via oscillation time sweep at 25 °C, 2% strain and 10 rad/s 
frequency. (A) The gel with the crosslinked virus gelled faster and yielded stable solid-like structure hydrogel with higher storage 
modulus. (B) The average gelation time of TMV-gel was significantly faster than that of the control HA gel. (B inset) The structured 
hydrogel with virus particles formed when the control hydrogel mixture was still in viscous liquid after fabricated at the same time. 
The horizontal bars are means ± SD with each data expressed in dot plots (n = 3); *p < 0.05. 
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 The mechanical properties of TMV-SH+HA and control HA hydrogels were 
assessed through oscillatory rheology. Usually the rheological properties of a viscoelastic 
material are independent of strain up to a critical strain level γc. Beyond this critical strain 
level, the material’s behavior is non-linear and the storage modulus declines. A strain 
sweep will establish the extent of the material’s linearity. Figure 6.3A showed a strain 
sweep for both types of hydrogel giving higher average G′ of TMV-SH, 0.1% + 30-
DMHA (435.60 Pa) than that of 30-DMHA, 5% (304.79 Pa). The critical strain γc of 
TMV-SH, 0.1% + 30-DMHA, 5% was approximately 400%, while 30-DMHA, 5% alone 
showed γc at ~ 200%. Below γc, the structure is intact, the material behaves solid-like, 
and G′ > G″, indicating that the material is highly structured. Increasing the strain above 
the critical strain disrupts the network structure. This result suggested that the gel with 
TMV-SH was stiffer than the control HA gel. 
In oscillation analysis, frequency sweep is used to characterize materials’ 
structures. It can be used to determine if a material is a three-dimensional network (gel), 
an entangled solution (paste), or a particle solution (liquid).
206
 From Figure 6.3B, the 
elastic and loss moduli of both gels was essentially frequency-independent (G′ ∝ ω0.01 Hz) 
and very slightly frequency-dependent, respectively; with elastic moduli higher than loss 
moduli. This viscoelastic behavior defined material’s structure as 3D network of a 
hydrogel consisting of permanent crosslinks. As the test continued within a wide 
frequency range of 0.01 - 9, the gel maintained its solid-like viscoelasticity (G′ > G″) 
confirming its high resistance to deformation and subsequent high yield value.
206, 207
 
Further analysis on this frequency sweep experiment revealed that TMV-SH modified 









Figure 6.3. Viscoelastic properties of HA hydrogels with and without TMV particle. (A) Amplitude sweeps at 1 Hz frequency showed 
that TMV-SH modified HA gel increase the critical strain and elastic modulus of the hydrogel. (B) Frequency sweeps at 2% strain 
amplitude confirmed the increase in gel modulus with TMV-SH modified hydrogel (n = 3). Each plot expressed mean ± SD.    
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from 0.033 to 0.015. From this test, the average G′ ± SD (taken from the frequency-
independent range, n = 3) of TMV-SH, 0.1% + 30-DMHA, 5% and 30-DMHA, 5% gel 
were calculated 422.89 ± 26.60 Pa and 273.25 ± 23.29 Pa, respectively. This analysis 
confirmed the result from amplitude sweep that the crosslinked TMV-SH increased the 
storage modulus of 30-DMHA, 5% gel. 
 
6.2.3 Presentation of TMV-1Cys in HA hydrogels 
MALDI-TOF analysis was used to determine the crosslinking between TMV-1Cys and 
HA backbone after fabrication of hydrogel. The TMV-SH, 0.1% + 50-DMHA, 5% 
hydrogel was first digested using 1800 units HAase (Hyaluronidase enzyme) for 48 h. 
The digested-hydrogel solution was then mixed with matrix, dropped on target plate, and 
subjected to MALDI-TOF analysis. The 2 controls included 1) purified TMV-1Cys in 10 
mM potassium phosphate buffer, pH 7; and 2) 50-DMHA, 5% hydrogel digested with 
900 units HAase as shown in the last 2 bottom panel of Figure 6.4A. HAase randomly 
cleaves β-N-acetylhexosamine-[1→4] glycosidic bonds in hyaluronic acid. Figure 6.4A 
demonstrated that TMV-SH gel obtained pronounced peaks in addition to the peak of 
original TMV-SH coat protein (around 17630 m/z). One of the additional peaks appeared 
at 19652 m/z. From this representative peak, the mass difference subtracted from the 
TMV-1Cys peak was calculated and matched with the molar mass of the possible 
backbone structure proposed in Figure 6.4B.  
 To confirm the existence of TMV-1Cys particles in the methacrylated HA 





Figure 6.4. Interaction of TMV-1Cys and its structural integrity in modified-HA 
hydrogel. (A) MALDI-TOF spectra compared the m/z profiles of TMV cys-mutant 
functionalized hydrogel after enzyme digestion of HA backbone (top panel) with the 
virus alone (middle panel) and with the control HA hydrogel (last panel). The extra peak 
marked in the top panel was analyzed to match the structure proposed in (B). (B) From 
MALDI-TOF analysis, the TMV-1Cys was shown to have a covalent interaction with the 
polymer backbone. (C) AFM height image (spin coated) showed the presence of TMV-
1Cys intact particles in the hydrogel. 
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The TMV-SH, 0.1% + 50-DMHA, 5% hydrogel, after adding DTT and allowing 10 min 
gelation, was spin-coated on the silicon wafer. The hydrogel coated wafer was then dried 
and subjected to AFM imaging. Figure 6.4C showed the height profile of TMV-1Cys 
particles on the silicon wafer substrate coated with TMV-incorporated hydrogel, which 
confirmed the existence TMV particles in the hydrogel. TMV-1Cys has the same 
appearance with wild-type TMV observed by AFM (See appendix G).  
 
6.2.4 Microstructural characterization of hydrogels 
As described earlier in chapter 1, the high porosity and interconnectivity of hydrogel are 
critical for cell survival in vitro, when the capillaries are not present, since these 
properties influence cell migration and diffusion of oxygen, nutrients, waste products and 
signaling molecules.
148, 208, 209
 The extent of ECM secretion also increases by increasing 
the pore size. It was found that in genipin crosslinked gelatin hydrogels with smaller 
pores, the tendency was tilted toward cell growth rather than of ECM secretion, resulting 
in over-confluence during the middle and late stages of differentiation; consequently, the 
extent of ECM secretion decreased compared to that within gelatin hydrogels with larger 
pores.
210
 The effect of implant pore size on tissue regeneration is emphasized by 
experiments demonstrating the optimum pore size of 5 µm for neovascularization, 5–15 
µm for fibroblast ingrowth, 20 – 125 µm for regeneration of adult mammalian skin, 100 – 
350 µm for regeneration of bone, 40 – 100 µm for osteoid ingrowth, and 20 µm for the 
ingrowth of hepatocytes.
211
 In addition, mean pore size has been shown to impact the 
amount of contraction a graft will undergo after implantation. An average pore diameter 
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of 20 – 125 µm was required for contraction-inhibiting activity to be observed in 
collagen–glycosaminoglycan graft copolymers used for dermal repair.
212
 To characterize 
the microstructure of our HA gels, we used scanning electron microscopy (SEM) for 
imaging hydrogels after freeze-drying (Figure 6.5). The cross-section electron 
micrograph of TMV-SH, 0.1%+100-DMHA, 3% revealed 20 - 100 µm range of interior 
pore size with high porosity and interconnectivity. Furthermore, the thin, dense, sheet-
like layers of polymer extending along the outer edge of the hydrogel cross-section were 
observed (Figure 6.5). 100-DMHA, 3% obtained the similar pore architecture except the 
lesser inter-connectivity with more well-defined pore structure and the thicker layer of 
dense outer edge (Figure 6.5). Besides, the exterior surfaces of both gels were dense, 
rough, folded architecture with sub-micron sized pores (< 2 µm). This surface layers were 
uniform and continuous, which made the surface essentially less porous. This result was 
consistent with previous studies of HA hydrogels. 
213-215
 
 Apart from the porosity, permeability also has a remarkable effect on proliferation 
and phenotype of cells.
148, 216
 Here, we investigated the permeability of the hydrogels by 
observing the fluorescent dye diffusion. First, the standard curve of Fluoresceinamine 
isomer I in PBS was generated from 1 - 10 µg/mL concentration range (See Appendix 
H). The amount of dye diffused into the pre-saturated hydrogel was calculated from the 
reduction of fluorescence intensity measured from the medium over time. Figure 6.6 
showed that both hydrogels, TMV-SH, 0.1%+50-DMHA, 5% and 50-DMHA, 5%, could 
absorb the dye in a similar manner. The dye diffusion reached equilibrium within one 
hour in both hydrogels. The value of dye diffusion presented in Figure 6.6 depicted the 





Figure 6.5. Cross-section and surface SEM micrographs of virus-modified injectable 
hydrogel. The cross-section ESEM images showed the porous interior architecture of 
both hydrogel after freeze-dried. The virus incorporated hydrogel obtained larger extent 
of interconnecting channels with thinner dense layers along the outer edge. The exterior 






Figure 6.6. Permeability of the hydrogels in term of molecular diffusion was tested using 
dye diffusion study. The hydrogel functionalized with virus particles allowed faster rate 
and better diffusion of the fluorescent dye when incubated at 37°C. Each plot represented 
means ± SD (ANOVA, p = 0.05).
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with the hydrogel altogether (theoretical). TMV-SH, 0.1%+50-DMHA, 5% gel absorbed 
slightly more dye at equilibrium around 100% on average comparing to the value 
calculated for the 50-DMHA, 5% gel, which was around 75% (p = 0.05). This might be a 
consequence from the pore and interconnect structural differences discussed earlier.  
 
6.2.5 Swelling property and stability of hydrogels 
To exploit swelling property of each hydrogel, 250 µL of TMV-SH, 0.1%+50-DMHA, 
5% and 50-DMHA, 5% hydrogels were fabricated and immersed in 1 mL PBS. The 
representative of fully structured hydrogel before incubation with PBS was shown in 
Figure 6.7A inset. Swelling ratio of HA hydrogel with TMV-1Cys was shown to be 
slightly higher than the control HA gel without the virus nanoparticle in early time points 
(Figure 6.7A). However, the swelling ratios of both hydrogels became insignificantly 
different at later time points. This, as well, could be a result of the higher 
interconnectivity and the thinner wall of TMV-SH, 0.1%+50-DMHA, 5% gel observed 
from the cross-section scanning electron micrograph. This microstructure of TMV-SH, 
0.1%+50-DMHA, 5% gel allowed better water absorption and could entrapped higher 
volume of aqueous media at faster rate in comparison to 50-DMHA, 5% gel. Slight 
increases in swelling ratios were observed during the 120 h incubation, which could 
indicate a possible onset of the degradation of the hydrogel. Stability of both hydrogels 









Figure 6.7. Swelling properties and stability of the hydrogels. The hydrogel after gelation (A inset) was immersed into PBS (A) The 
weight change due to water absorption was monitored over time. Swelling rate appeared faster with the TMV-SH modified hydrogel. 
(B) No weight decreases were observed from both hydrogels measured after freeze-drying at each time point for up to 3 weeks 
incubation. The values expressed are means ± SD, n = 3. 
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6.2.6 In situ encapsulation and culture of bone marrow stromal cells in 3D hydrogel 
We next explored the compatibility of TMV-1Cys HA hydrogel for culturing BMSCs. 
BMSCs were encapsulated in situ by mixing the cells (1 million /mL) thoroughly with 
TMV-SH, 0.1%+50-DMHA, 5% and 50-DMHA, 5% pre-hydrogel solutions in complete 
DMEM cell culture media before loading into Transwell
®
 inserts. Metabolic rate of 
BMSCs encapsulated in the hydrogels TMV-SH, 0.1%+50-DMHA, 5% and control 
hydrogel 50-DMHA, 5% was carried out at different time points using CellTiter-Blue
®
 
(CTB) reagent. Metabolite of CTB reagent generated by viable cells is fluorescent. Figure 
6.8 showed the preliminary result from each hydrogel, n = 1. The cell metabolic rates in 
both hydrogels were similar. On day 4, the metabolic rates decreased from the first day of 
culture, and then increased continuously until the end point on day 15. Cell viability was 
then confirmed by live-cell staining, Calcein AM (CAM), at different time points. Figure 
6.9 illustrated the viable cells in both hydrogels stained green from day 9 and 17.  
 
6.2.7 RNA extraction for future gene study 
For application in BMSC differentiations, this cell-encapsulated hydrogel culture was 
validated for RNA extraction. We were able to purify RNA in the sufficient amount and 
quality for the future gene expression studies. Figure 6.10 showed an agarose gel with 
polymerase chain reaction (PCR) products of GAPDH, a house keeping gene, which was 
synthesized from cDNA of mRNA purified from cells cultured in TMV-SH, 0.1%+50-





Figure 6.8. Celltiter Blue assay of viable cells encapsulated at a concentration of 1 M/mL 






Figure 6.9. Live cell staining of BMSCs cultured in hydrogels. BMSCs were embedded 
into the 3D hydrogel, in situ, at 1 million cells/mL concentration in complete primary 





Figure 6.10. Agarose gel image of PCR product derived from mRNA of BMSCs cultured 
in hydrogels. Sufficient amount of RNA could be isolated from the culture. Gel image 
shows the PCR product of house-keeping gene from RNA isolated on day 6 (lane  2), 10 




HA hydrogel can be engineered to obtain different properties. HA backbone could be 
modified to have the reactive methacrylic group and the gel can be formed in situ after 
addition of DTT crosslinker via Michael addition reaction under physiological condition. 
The incorporation of TMV particles could be preceded through the same thiol-ene click 
reaction between thiol group of TMV-1Cys mutant and the methacrylated HA polymer. 
The gelation time was improved after addition of TMV-1Cys to 12 minute allowing 
adequate operation time, yet providing sufficiently rapid rate for clinical efficacy. The 
resulting gel obtained the micro-and macro-pore structures enabling an exchange of 
nutrients. The mechanical property of hydrogel could be enhanced by incorporation of 
TMV-1Cys nanoparticles. The hydrogel was compatible for stem cell culture, and genetic 
material could be extracted for further gene analysis. This study is considered a 
foundation of the development of injectable hydrogel with TMV covalently linked to the 
back-bone polymer that can be further functionalized to direct the encapsulated cell 
responses in 3D.  
 
6.4 EXPERIMENTAL SECTION 
All chemicals were obtained from commercial suppliers and used as received unless 
otherwise noted. Wild-type TMV (TMV) and its Cys-mutant (TMV-1Cys) were isolated 






6.4.1 HA-methacrylate synthesis 
Synthesis of HA-methacrylate was modified from the method originally described by 
Smeds et al.
217
 according to the protocol detailed by Marklein et al.
218
 Briefly, HA of 
molecular weight 47, 310,or 1000 kDa (Dali) was dissolved at 1 wt% in potassium 
phosphate buffer, pH 8 and methacrylic anhydride (Alfa Aesar) of different folds molar 
excess (relative to the HA disaccharide repeat unit) as listed in Table 1 was added 
dropwise to the solution on ice. The pH of the two-phase reaction mixture was adjusted to 
8.0 with 5 M NaOH, and the reaction was allowed to continue for 24 h. at 4 °C with 
frequent re-adjustment of the pH. The product was dialyzed against milli-Q water for at 
least 48 h, followed by centrifugation to recover the precipitate, which was then flash 





6.4.2 HA gelation and rheology 
In general, to form crosslinked HA gels, HA-methacrylate polymers with 30-50% 
degrees of functionalization (hereafter denoted as xx-DMHA; with xx represented % 
degree of modification) was dissolved in phosphate buffer saline (PBS) at the desired 
concentration. The crosslinker dl-dithiothreitol (DTT) was added at the ratio of thiol:ene 
  1:4. For “TMV-SH, 0.1% + xx-DMHA, 5%”, xx-DMHA was dissolved in PBS at 5 wt 
% concentration, and 10 mg/mL TMV-1Cys was then added before adding DTT to make 
final concentration of 0.1 wt %. Oscillatory shear rheology was performed using a DHR-
3 rheometer (TA instrument) with 12 mm diameter parallel-plate geometry and 
temperature controlled peltier plate. For the gelation study, the gels were crosslinked in 
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situ between the rheometer plates in a close chamber protecting hydrogel from 
dehydration. The measurement in oscillatory time sweep mode (2% strain amplitude, 10 
rad/s) immediately started after the freshly prepared pre-hydrogel mixture was loaded on 
the peltier plate. Typically, 200 µL of the gel solution was used with a gap width of 1 mm 
between the plates. Amplitude sweeps at constant frequency (1 Hz) were performed to 
determine the linear viscoelastic range of deformation for each sample, after which 
frequency sweeps (0.01-100 Hz) were performed at a strain amplitude within the linear 
range (2%). In amplitude and frequency sweeps measurement, the geometry gaps were 
conditioned by axial force at 0.5 N for every run. 
 
6.4.3 MALDI-TOF analysis 
The 100 μL of pre-formed TMV-SH hydrogel was digested using 1800 U HAase in 1 mL 
PBS (Type IV-S from bovine testes, Sigma) for 2 days. The control hydrogel without the 
virus was digested with the 900 U HAase in 200 μL PBS. Each sample was prepared by 
mixing the virus (0.5 mg/mL, 1 μL) or digested hydrogels solution (1 μL) with 9 μL of 
matrix solution (saturated sinapic acid in 70% acetonitrile, 0.1% trifluoroacetic acid). 
 ne μL of the mixture was spotted on a MALDI plate, air-dried and analyzed by 
MALDI-TOF mass spectrometry (Bruker Ultraflex MALDI-TOF/TOF). 
 
6.4.4 Atomic force microscopy of TMV-SH hydrogel 
Atomic force microscopy (AFM) was performed on the TMV-SH, 0.1% + 50-DMHA, 
5% hydrogel. First, 5% methacrylated HA polymer solution in PBA, after adjusting pH to 
pH 8, was mixed with TMV-1Cys to make 0.1 wt % final concentration. DTT was added 
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to the mixture. After 10 min gelation, the hydrogel was spin-coated on the silicon wafer. 
The hydrogel coated wafer was then dried and subjected to AFM imaging. The TMV-
1Cys in the hydrogel on the wafers was characterized using tapping-mode AFM images 
using a NanoScope IIIA MultiMode AFM (Veeco). Si tips with a resonance frequency of 
approximately 300 kHz, a spring constant of about 40 Nm
-1 
and a scan rate of 1.0 Hz 
were used. 
 
6.4.5 Environmental scanning electron microscopy 
Environmental scanning electron microscopy (ESEM) images were obtained by VEGA3 
TESCAN electron microscope. Freeze dried samples were cross-sectioned and mounted 
on aluminum stubs with carbon tape. Samples were observed under a low vacuum with 
20 kV of electron acceleration and a 9.95 -13.16 mm working distance.  
 
6.4.6 Dye diffusion study 
After the 150 µL hydrogels were fabricated as mentioned earlier, each gel was soaked 
into 400 µL of 5 µg/mL fluoresceinamine isomer I (sigma) in PBS. The amount of dye 
diffused into the hydrogel was calculated from the left-over dye detected from the 
medium. Dye amounts were transformed from fluorescence intensity measured at 
490/520 nm (Ex/Em) by SpectraMax M2 Multi-Mode microplate reader (Molecular 
Devices). The standard curve was generated from different dye concentrations in the 
range of 1-10 µg/mL plotted over fluorescence intensities. The amounts of dye diffusion 
were then calculated into concentrations of dye in the hydrogels and normalized against 
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the concentrations of dye in total volume (hydrogel volume + medium volume) as shown 
in the following equation. 
Dye concentration diffusion percentage    
amount of dye in hydrogel/hydrogel volume
amount of dye in total/(hydrogel volume   dye solution volume)
 
 
6.4.7 Swelling property and stability 
Swelling property of each hydrogel was determined by the final weight divided by the 
initial weight of the hydrogel. The initial weights (~ 250 mg) of hydrogels were recorded 
(µ0). Hydrogels were immersed in 1 mL PBS at room temperature, and then the weights 
after immersion over time were recorded (µt). Surrounding water was drained and blotted 
out with Whatman filter paper from hydrogels before weighing. The swelling ratios were 
calculated from μt/μ0. For stability test, pre-formed hydrogels (250 µL) were incubated 
with 1 mL of PBS at room temperature. The hydrogel mass reduction at each time point 
was monitored. The hydrogel was collected and lyophilized for at least 24 h. before the 
dry weight was measured. The dry weight at the starting point was measured as γ
0
 (~ 16 
mg). The dry weight measured at different time point was symbolized γ
t
. Normalized 






6.4.8 Bone Marrow Stem Cells (BMSCs) isolation and culture  
Primary BMSCs were isolated from the bone marrow of young adult 160 - 180 g male 
Sprague Dawley rats (Charles River Laboratories). The procedures were performed in 
accordance with the guidelines for animal experimentation by the Institutional Animal 
Care and Use Committee, School of Medicine, University of South Carolina. Cells were 
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maintained in complete primary media (Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS)), kept at 37 ⁰C in a CO2 incubator with 
5% CO2 : 95% air and passaged no more than seven times after isolation. 
 
6.4.9 In situ cell encapsulation with hydrogel matrix 
The hydrogels were prepared s previously described, except that the preparation occurred 
under sterile condition and pre-warmed complete DMEM media was used to dissolve the 
polymer. TMV-1Cys was filtered to remove all pathogen before mixing. All other 
components including 5 M NaOH and 0.2 M DTT in PBS were also sterile filtered with 
0.2 µm PES membranes. BMSCs were harvested from the tissue culture plate after 
reaching 80% confluency. The cells were then mixed with the mixture of pre-warmed 
hydrogel in DMEM media at 1 M/mL concentration right after addition of DTT. One 
hundred and fifty microliters of the cells-hydrogel mixture was then injected into each 
Transwell (Corning) that was inserted and anchored in 24 well tissue culture plate, and 
incubated at 37 ⁰C in a CO2 incubator with 5% CO2 : 95% air. Approximately 6 h after 
casting the gel into Transwell, 400 µL additional DMEM media was added into each 
well. The fresh media was exchanged every day for the entire experimental period. 
 
6.4.10 Cell metabolic rate 
CellTiter-Blue
®
 (CTB) cell viability assay (Promega) after day 1, 4, 8 and day 15 of 
culture was performed in a separate sample for each type of hydrogel. The culture media 
in each well was replaced by 300 mL of pre-warmed media containing 15% CTB and 
incubated for 20 h at 37 °C and 5% CO2. The media containing CTB was used without 
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cells as negative controls. The media containing metabolite of CTB was measured for 
fluorescence intensity at 560/590 nm (Ex/Em) using SpectraMax M2 Multi-Mode 
microplate reader (Molecular Devices).  
 
6.4.11 Live cell staining 
On day 9 and 17 of cell culture, 10 μg/mL of calcein AM in media was added in each 
cell-hydrogel culture well and incubated for 30 minutes in 37°C. Then, hydrogels in each 
well were washed by PBS. After washing, PBS was replaced with fixative solution (4% 
paraformaldehyde in 1× Dulbecco's Phosphate Buffered Saline; DPBS). Hydrogels were 
fixed overnight at 4 °C. Fixed hydrogels were then washed with PBS 3 times and stored 
in PBS. Images of the stained samples were obtained using Olympus IX81 with DSU 
confocal mode. 
 
6.4.12 RNA isolation 
At the cell culture end point, total RNA could be purified from the hydrogel. First, each 
hydrogel was preserved in RNA later (Qiagen) overnight at 4°C. This step was critical to 
help protecting RNA from degradation during complex isolation procedures. The 
preserved hydrogel was then disrupted by high speed homogenization. The tissue 
homogenizer probe was rinsed with RNase-free water and 10% sodium lauryl sulfate 
between each sample processing to prevent cross-contamination. Total RNA was 
subsequently extracted following manufacturers’ protocols of either QIAShredder 
(Qiagen) with E.Z.N.A. Total RNA Kit (Omega) or RNAzol
®
 RT (MRC). The resulting 
RNA was reverse transcribed by using qScript™ cDNA Supermix (Quanta Biosciences). 
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RT-PCR was then achieved by the method described as: 45 cycles of PCR ( 95°C for 20s, 
58°C for 15 s, and 72°C for 15 s), after initial denaturation step of 5 minutes at 95°C, by 
using 0.1 μL of Taq DNA polymerase, 0.5 μL of 10 mM dNTP Mix, 2.5 μL of 10× PCR 
Buffer, without Mg, 2 pmol/μL of each forward and reverse primers and 30 ng cDNA 
templates in a final reaction volume of 25 μL. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was used as an example gene. Here, we used GAPDH primer 
sequence from the report by Sitasuwan et al.
17
 The PCR product was then subjected to 





1. Khademhosseini A, Vacanti JP, Langer R. Progress in tissue engineering. Sci Am 
2009;300:64-71. 
2. Khademhosseini A, Langer R, Borenstein J, Vacanti JP. Microscale technologies 
for tissue engineering and biology. Proc Natl Acad Sci U S A 2006;103:2480-7. 
3. Griffith LG, Naughton G. Tissue Engineering--Current Challenges and Expanding 
Opportunities. Science 2002;295:1009-14. 
4. Khademhosseini A, Langer R. Microengineered hydrogels for tissue engineering. 
Biomaterials 2007;28:5087-92. 
5. Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue 
engineering. Biomaterials 2010;31:4639-56. 
6. Elisseeff J. Injectable cartilage tissue engineering. Expert Opin Biol Ther 
2004;4:1849-59. 
7. Bichara DA, Zhao X, Bodugoz-Senturk H, Ballyns FP, Oral E, Randolph MA, 
Bonassar LJ, Gill TJ, Muratoglu OK. Porous poly(vinyl alcohol)-hydrogel matrix-
engineered biosynthetic cartilage. Tissue Eng Part A 2011;17:301-9. 
8. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for 
dynamic tuning of physical and chemical properties. Science 2009;324:59-63.
 
150 
9. Halberstadt C, Austin C, Rowley J, Culberson C, Loebsack A, Wyatt S, Coleman 
S, Blacksten L, Burg K, Mooney D, Holder W, Jr. A hydrogel material for plastic and 
reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng 
2002;8:309-19. 
10. Aldaye FA, Senapedis WT, Silver PA, Way JC. A Structurally Tunable DNA-
Based Extracellular Matrix. Journal of the American Chemical Society 2010;132:14727-
9. 
11. Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC. Crystal structure 
of the anthrax toxin protective antigen. Nature 1997;385:833-8. 
12. Mammen M, Choi S-K, Whitesides GM. Polyvalent Interactions in Biological 
Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. 
Angewandte Chemie International Edition 1998;37:2754-94. 
13. Kiessling LL, Gestwicki JE, Strong LE. Synthetic Multivalent Ligands as Probes 
of Signal Transduction. Angewandte Chemie International Edition 2006;45:2348-68. 
14. Petrie TA, Raynor JE, Dumbauld DW, Lee TT, Jagtap S, Templeman KL, Collard 
DM, Garcia AJ. Multivalent integrin-specific ligands enhance tissue healing and 
biomaterial integration. Sci Transl Med 2010;2:45ra60. 
15. Lee LA, Wang Q. Dynamic 3D Patterning of Biochemical Cues by using 
Photoinduced Bioorthogonal Reactions. Angewandte Chemie International Edition 
2012;51:4004-5. 
16. Kaur G, Valarmathi MT, Potts JD, Jabbari E, Sabo-Attwood T, Wang Q. 
Regulation of osteogenic differentiation of rat bone marrow stromal cells on 2D nanorod 
substrates. Biomaterials 2010;31:1732-41. 
 
151 
17. Sitasuwan P, Lee LA, Bo P, Davis EN, Lin Y, Wang Q. A plant virus substrate 
induces early upregulation of BMP2 for rapid bone formation. Integr Biol (Camb) 
2012;4:651-60. 
18. Stubbs G. Tobacco mosaic virus particle structure and the initiation of 
disassembly. Philos Trans R Soc Lond B Biol Sci 1999;354:551-7. 
19. Butler PJ. Self-assembly of tobacco mosaic virus: the role of an intermediate 
aggregate in generating both specificity and speed. Philos Trans R Soc Lond B Biol Sci 
1999;354:537-50. 
20. Schlick TL, Ding Z, Kovacs EW, Francis MB. Dual-Surface Modification of the 
Tobacco Mosaic Virus. Journal of the American Chemical Society 2005;127:3718-3723. 
21. Lee LA, Wang Q. Adaptations of nanoscale viruses and other protein cages for 
medical applications. Nanomedicine: Nanotechnology, Biology and Medicine 
2006;2:137-49. 
22. Gerasopoulos K, McCarthy M, Banerjee P, Fan X, Culver JN, Ghodssi R. 
Biofabrication methods for the patterned assembly and synthesis of viral nanotemplates. 
Nanotechnology 2010;21:055304. 
23. Bruckman MA, Kaur G, Lee LA, Xie F, Sepulveda J, Breitenkamp R, Zhang X, 
Joralemon M, Russell TP, Emrick T, Wang Q. Surface modification of tobacco mosaic 
virus with "click" chemistry. ChemBioChem 2008;9:519-23. 
24. Lee LA, Nguyen QL, Wu L, Horvath G, Nelson RS, Wang Q. Mutant plant 
viruses with cell binding motifs provide differential adhesion strengths and 
morphologies. Biomacromolecules 2012;13:422-31. 
 
152 
25. Kaur G, Wang C, Sun J, Wang Q. The synergistic effects of multivalent ligand 
display and nanotopography on osteogenic differentiation of rat bone marrow stem cells. 
Biomaterials 2010;31:5813-24. 
26. Hsiong SX, Boontheekul T, Huebsch N, Mooney DJ. Cyclic arginine-glycine-
aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue 
Eng Part A 2009;15:263-72. 
27. Eiselt P, Yeh J, Latvala RK, Shea LD, Mooney DJ. Porous carriers for biomedical 
applications based on alginate hydrogels. Biomaterials 2000;21:1921-7. 
28. Barbetta A, Barigelli E, Dentini M. Porous Alginate Hydrogels: Synthetic 
Methods for Tailoring the Porous Texture. Biomacromolecules 2009;10:2328-37. 
29. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables 
and applications. Biomaterials 2003;24:4337-51. 
30. Rokstad AM, Donati I, Borgogna M, Oberholzer J, Strand BL, Espevik T, Skjak-
Braek G. Cell-compatible covalently reinforced beads obtained from a 
chemoenzymatically engineered alginate. Biomaterials 2006;27:4726-37. 
31. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, 
Kennedy MB, Pockwinse S, Lian JB, Stein GS. Progressive development of the rat 
osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated 
with osteoblast proliferation and differentiation during formation of the bone extracellular 
matrix. J Cell Physiol 1990;143:420-30. 
32. Kaur G, Valarmathi MT, Potts JD, Wang Q. The promotion of osteoblastic 




33. Langer R. Perspectives and Challenges in Tissue Engineering and Regenerative 
Medicine. Advanced Materials 2009;21:3235-6. 
34. He L, Liu B, Xipeng G, Xie G, Liao S, Quan D, Cai D, Lu J, Ramakrishna S. 
Microstructure and properties of nano-fibrous PCL-b-PLLA scaffolds for cartilage tissue 
engineering. Eur Cell Mater 2009;18:63-74. 
35. Klompmaker J, Jansen HW, Veth RP, Nielsen HK, de Groot JH, Pennings AJ. 
Porous polymer implants for repair of full-thickness defects of articular cartilage: an 
experimental study in rabbit and dog. Biomaterials 1992;13:625-34. 
36. Lee LA, Muhammad SM, Nguyen QL, Sitasuwan P, Horvath G, Wang Q. 
Multivalent ligand displayed on plant virus induces rapid onset of bone differentiation. 
Mol Pharm 2012;9:2121-5. 
37. Luckanagul J, Lee LA, Nguyen QL, Sitasuwan P, Yang X, Shazly T, Wang Q. 
Porous alginate hydrogel functionalized with virus as three-dimensional scaffolds for 
bone differentiation. Biomacromolecules 2012;13:3949-58. 
38. Lee LA, Nguyen HG, Wang Q. Altering the landscape of viruses and 
bionanoparticles. Org Biomol Chem 2011;9:6189-95. 
39. Simons K, Helenius A, Leonard K, Sarvas M, Gething MJ. Formation of protein 
micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A 1978;75:5306-
10. 
40. Reilly GC, Engler AJ. Intrinsic extracellular matrix properties regulate stem cell 
differentiation. Journal of biomechanics 2010;43:55-62. 
 
154 
41. Xiao C, Weng L, Zhang L. Improvement of physical properties of crosslinked 
alginate and carboxymethyl konjac glucomannan blend films. Journal of Applied 
Polymer Science 2002;84:2554-60. 
42. Destito G, Yeh R, Rae CS, Finn MG, Manchester M. Folic acid-mediated 
targeting of cowpea mosaic virus particles to tumor cells. Chem Biol 2007;14:1152-62. 
43. Moioli EK, Hong L, Mao JJ. Inhibition of osteogenic differentiation of human 
mesenchymal stem cells. Wound Repair Regen 2007;15:413-21. 
44. Healy KE, Guldberg RE. Bone tissue engineering. J Musculoskelet Neuronal 
Interact 2007;7:328-30. 
45. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of 
tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-
23. 
46. Pockwinse SM, Wilming LG, Conlon DM, Stein GS, Lian JB. Expression of cell 
growth and bone specific genes at single cell resolution during development of bone 
tissue-like organization in primary osteoblast cultures. J Cell Biochem 1992;49:310-23. 
47. Gallagher WH, Lauffer MA. Calcium ion binding by tobacco mosaic virus. J Mol 
Biol 1983;170:905-19. 
48. Gallagher WH, Lauffer MA. Calcium ion binding by isolated tobacco mosaic 
virus coat protein. J Mol Biol 1983;170:921-9. 
49. Venugopal J, Prabhakaran MP, Zhang Y, Low S, Choon AT, Ramakrishna S. 
Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue 
engineering. Philos Transact A Math Phys Eng Sci 2010;368:2065-81. 
 
155 
50. Evangelista MB, Hsiong SX, Fernandes R, Sampaio P, Kong HJ, Barrias CC, 
Salema R, Barbosa MA, Mooney DJ, Granja PL. Upregulation of bone cell 
differentiation through immobilization within a synthetic extracellular matrix. 
Biomaterials 2007;28:3644-55. 
51. Yang F, Williams CG, Wang DA, Lee H, Manson PN, Elisseeff J. The effect of 
incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on 
osteogenesis of bone marrow stromal cells. Biomaterials 2005;26:5991-8. 
52. Huang C, Das A, Barker D, Tholpady S, Wang T, Cui Q, Ogle R, Botchwey E. 
Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation. 
Cell Tissue Res 2012;347:553-66. 
53. Zhang H, Migneco F, Lin CY, Hollister SJ. Chemically-conjugated bone 
morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates 
osteogenic activity in bone marrow stromal cells. Tissue Eng Part A 2010;16:3441-8. 
54. Liu Z, Qiao J, Niu Z, Wang Q. Natural supramolecular building blocks: from 
virus coat proteins to viral nanoparticles. Chem Soc Rev 2012;41:6178-94. 
55. Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol 
Pharm 2011;8:29-43. 
56. Chung WJ, Merzlyak A, Yoo SY, Lee SW. Genetically engineered liquid-
crystalline viral films for directing neural cell growth. Langmuir 2010;26:9885-90. 
57. Merzlyak A, Indrakanti S, Lee SW. Genetically engineered nanofiber-like viruses 
for tissue regenerating materials. Nano Lett 2009;9:846-52. 
 
156 
58. Mills CA, Martinez E, Errachid A, Engel E, Funes M, Moormann C, Wahlbrink 
T, Gomila G, Planell J, Samitier J. Nanoembossed polymer substrates for biomedical 
surface interaction studies. J Nanosci Nanotechnol 2007;7:4588-94. 
59. Steinmetz NF. Viral nanoparticles as platforms for next-generation therapeutics 
and imaging devices. Nanomedicine 2010;6:634-41. 
60. Steinmetz NF. Viral nanoparticles in drug delivery and imaging. Mol Pharm 
2013;10:1-2. 
61. Wen AM, Rambhia PH, French RH, Steinmetz NF. Design rules for nanomedical 
engineering: from physical virology to the applications of virus-based materials in 
medicine. J Biol Phys 2013;39:301-25. 
62. Bruckman MA, Randolph LN, VanMeter A, Hern S, Shoffstall AJ, Taurog RE, 
Steinmetz NF. Biodistribution, pharmacokinetics, and blood compatibility of native and 
PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology 
2014;449:163-73. 
63. Kaiser CR, Flenniken ML, Gillitzer E, Harmsen AL, Harmsen AG, Jutila MA, 
Douglas T, Young MJ. Biodistribution studies of protein cage nanoparticles demonstrate 
broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine 2007;2:715-33. 
64. Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, 
Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nat Med 
2006;12:354-60. 
65. Molenaar TJ, Michon I, de Haas SA, van Berkel TJ, Kuiper J, Biessen EA. 
Uptake and processing of modified bacteriophage M13 in mice: implications for phage 
display. Virology 2002;293:182-91. 
 
157 
66. Singh P, Prasuhn D, Yeh RM, Destito G, Rae CS, Osborn K, Finn MG, 
Manchester M. Bio-distribution, toxicity and pathology of cowpea mosaic virus 
nanoparticles in vivo. J Control Release 2007;120:41-50. 
67. Wu M, Shi J, Fan D, Zhou Q, Wang F, Niu Z, Huang Y. Biobehavior in normal 
and tumor-bearing mice of tobacco mosaic virus. Biomacromolecules 2013;14:4032-7. 
68. Manchester M, Singh P. Virus-based nanoparticles (VNPs): platform technologies 
for diagnostic imaging. Adv Drug Deliv Rev 2006;58:1505-22. 
69. Wen AM, Lee KL, Yildiz I, Bruckman MA, Shukla S, Steinmetz NF. Viral 
nanoparticles for in vivo tumor imaging. J Vis Exp 2012:e4352. 
70. Rappaport I. The antigenic structure of tobacco mosaic virus. Adv Virus Res 
1965;11:223-75. 
71. Van Regenmortel MH, Altschuh D, Zeder-Lutz G. Tobacco mosaic virus: a model 
antigen to study virus-antibody interactions. Biochimie 1993;75:731-9. 
72. Hinrichs J, Berger S, Shaw JG. Induction of antibodies to plant viral proteins by 
DNA-based immunization. J Virol Methods 1997;66:195-202. 
73. Smith ML, Corbo T, Bernales J, Lindbo JA, Pogue GP, Palmer KE, McCormick 
AA. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco 
mosaic virus and Semliki Forest virus and their evaluation as immunogens. Virology 
2007;358:321-33. 
74. Van Regenmortel MH. The antigenicity of tobacco mosaic virus. Philos Trans R 
Soc Lond B Biol Sci 1999;354:559-68. 
 
158 
75. Heinz FX, Allison SL, Stiasny K, Schalich J, Holzmann H, Mandl CW, Kunz C. 
Recombinant and virion-derived soluble and particulate immunogens for vaccination 
against tick-borne encephalitis. Vaccine 1995;13:1636-42. 
76. Smith ML, Lindbo JA, Dillard-Telm S, Brosio PM, Lasnik AB, McCormick AA, 
Nguyen LV, Palmer KE. Modified tobacco mosaic virus particles as scaffolds for display 
of protein antigens for vaccine applications. Virology 2006;348:475-88. 
77. Staczek J, Bendahmane M, Gilleland LB, Beachy RN, Gilleland HE, Jr. 
Immunization with a chimeric tobacco mosaic virus containing an epitope of outer 
membrane protein F of Pseudomonas aeruginosa provides protection against challenge 
with P. aeruginosa. Vaccine 2000;18:2266-74. 
78. Zan X, Sitasuwan P, Powell J, Dreher TW, Wang Q. Polyvalent display of RGD 
motifs on turnip yellow mosaic virus for enhanced stem cell adhesion and spreading. 
Acta Biomater 2012;8:2978-85. 
79. McCormick AA, Palmer KE. Genetically engineered Tobacco mosaic virus as 
nanoparticle vaccines. Expert Rev Vaccines 2008;7:33-41. 
80. Modelska A, Dietzschold B, Sleysh N, Fu ZF, Steplewski K, Hooper DC, 
Koprowski H, Yusibov V. Immunization against rabies with plant-derived antigen. Proc 
Natl Acad Sci U S A 1998;95:2481-5. 
81. Pinchuk LM, Filipov NM. Differential effects of age on circulating and splenic 
leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing 2008;5:1. 
82. Veriter S, Mergen J, Goebbels RM, Aouassar N, Gregoire C, Jordan B, Leveque 
P, Gallez B, Gianello P, Dufrane D. In vivo selection of biocompatible alginates for islet 
encapsulation and subcutaneous transplantation. Tissue Eng Part A 2010;16:1503-13. 
 
159 
83. Nunamaker EA, Purcell EK, Kipke DR. In vivo stability and biocompatibility of 
implanted calcium alginate disks. J Biomed Mater Res A 2007;83:1128-37. 
84. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 
2001;101:1869-79. 
85. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for 
tissue engineering applications. Tissue Eng Part B Rev 2008;14:149-65. 
86. Andersen T, Melvik JE, Gaserod O, Alsberg E, Christensen BE. Ionically gelled 
alginate foams: physical properties controlled by operational and macromolecular 
parameters. Biomacromolecules 2012;13:3703-10. 
87. Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol 
Biosci 2006;6:623-33. 
88. Holme HK, Lindmo K, Kristiansen A, Smidsrod O. Thermal depolymerization of 
alginate in the solid state. Carbohydrate Polymers 2003;54:431-8. 
89. Nsereko S, Amiji M. Localized delivery of paclitaxel in solid tumors from 
biodegradable chitin microparticle formulations. Biomaterials 2002;23:2723-31. 
90. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, 
Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult 
human mesenchymal stem cells. Science 1999;284:143-7. 
91. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. 
Science 1997;276:71-4. 
92. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus 
regenerative medicine. J Cell Physiol 2007;213:341-7. 
 
160 
93. Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, Sharma M, 
Sharma P, Tripathi RP, Gurudutta GU. Mesenchymal stem cell-based therapy: a new 
paradigm in regenerative medicine. J Cell Mol Med 2009;13:4385-402. 
94. Eliopoulos N, Lejeune L, Martineau D, Galipeau J. Human-compatible collagen 
matrix for prolonged and reversible systemic delivery of erythropoietin in mice from 
gene-modified marrow stromal cells. Mol Ther 2004;10:741-8. 
95. Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O'Brien T, 
Ritter T. Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 
2012;16:2094-103. 
96. Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S. Mesenchymal 
stromal cells lose their immunosuppressive potential after allotransplantation. Exp 
Hematol 2008;36:1370-6. 
97. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. 
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and 
stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114-20. 
98. Mukonoweshuro B, Brown CJ, Fisher J, Ingham E. Immunogenicity of 
undifferentiated and differentiated allogeneic mouse mesenchymal stem cells. Journal of 
Tissue Engineering 2014;5. 
99. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of 
allogeneic T-cell proliferation by human marrow stromal cells: implications in 
transplantation. Transplantation 2003;75:389-97. 
 
161 
100. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal 
stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses 
independently of the major histocompatibility complex. Scand J Immunol 2003;57:11-20. 
101. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic 
immune cell responses. Blood 2005;105:1815-22. 
102. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells 
inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. 
Exp Cell Res 2005;305:33-41. 
103. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid 
allogeneic rejection. J Inflamm (Lond) 2005;2:8. 
104. Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G. 
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by 
activation of the programmed death 1 pathway. Eur J Immunol 2005;35:1482-90. 
105. Rafei M, Hsieh J, Fortier S, Li M, Yuan S, Birman E, Forner K, Boivin MN, 
Doody K, Tremblay M, Annabi B, Galipeau J. Mesenchymal stromal cell-derived CCL2 
suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 
induction. Blood 2008;112:4991-8. 
106. Comoli P, Ginevri F, Maccario R, Avanzini MA, Marconi M, Groff A, Cometa A, 
Cioni M, Porretti L, Barberi W, Frassoni F, Locatelli F. Human mesenchymal stem cells 




107. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, 
Gualandi F, Mancardi GL, Pistoia V, Uccelli A. Human mesenchymal stem cells 
modulate B-cell functions. Blood 2006;107:367-72. 
108. Martin PK, Stilhano RS, Samoto VY, Takiya CM, Peres GB, da Silva Michelacci 
YM, da Silva FH, Pereira VG, D'Almeida V, Marques FL, Otake AH, Chammas R, Han 
SW. Mesenchymal stem cells do not prevent antibody responses against human alpha-L-
iduronidase when used to treat mucopolysaccharidosis type I. PLoS One 2014;9:e92420. 
109. Fumimoto Y, Matsuyama A, Komoda H, Okura H, Lee CM, Nagao A, Nishida T, 
Ito T, Sawa Y. Creation of a rich subcutaneous vascular network with implanted adipose 
tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in 
diabetic mice. Tissue Eng Part C Methods 2009;15:437-44. 
110. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, 
Boyd R, Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of 
bleomycin-induced lung injury. Am J Pathol 2009;175:303-13. 
111. Leung VY, Aladin DM, Lv F, Tam V, Sun Y, Lau RY, Hung SC, Ngan AH, Tang 
B, Lim CT, Wu EX, Luk KD, Lu WW, Masuda K, Chan D, Cheung KM. Mesenchymal 
stem cells reduce intervertebral disc fibrosis and facilitate repair. Stem Cells 2014. 
112. Chong PP, Selvaratnam L, Abbas AA, Kamarul T. Human peripheral blood 
derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic 
differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res 
2012;30:634-42. 
113. Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin 
Orthop Relat Res 1999:71-86. 
 
163 
114. Rimondini L, Nicoli-Aldini N, Fini M, Guzzardella G, Tschon M, Giardino R. In 
vivo experimental study on bone regeneration in critical bone defects using an injectable 
biodegradable PLA/PGA copolymer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2005;99:148-54. 
115. Fini M, Nicoli Aldini N, Gandolfi MG, Mattioli Belmonte M, Giavaresi G, 
Zucchini C, De Benedittis A, Amati S, Ravaglioli A, Krayewski A, Rocca M, 
Guzzardella GA, Biagini G, Giardino R. Biomaterials for orthopedic surgery in 
osteoporotic bone: a comparative study in osteopenic rats. Int J Artif Organs 
1997;20:291-7. 
116. Goldberg VM, Stevenson S. Natural history of autografts and allografts. Clin 
Orthop Relat Res 1987:7-16. 
117. Fini M, Motta A, Torricelli P, Giavaresi G, Nicoli Aldini N, Tschon M, Giardino 
R, Migliaresi C. The healing of confined critical size cancellous defects in the presence of 
silk fibroin hydrogel. Biomaterials 2005;26:3527-36. 
118. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for 
craniomandibulofacial nonunions. Clin Orthop Relat Res 1986:299-308. 
119. Cancedda R, Giannoni P, Mastrogiacomo M. A tissue engineering approach to 
bone repair in large animal models and in clinical practice. Biomaterials 2007;28:4240-
50. 
120. Bodde EW, Spauwen PH, Mikos AG, Jansen JA. Closing capacity of segmental 
radius defects in rabbits. J Biomed Mater Res A 2008;85:206-17. 
121. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal models for 
implant biomaterial research in bone: a review. Eur Cell Mater 2007;13:1-10. 
 
164 
122. Freeman E, Turnbull RS. The value of osseous coagulum as a graft material. J 
Periodontal Res 1973;8:229-36. 
123. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein 
(BMP) in repair of skull defects. Ann Surg 1982;196:100-9. 
124. Ferland CE, Laverty S, Beaudry F, Vachon P. Gait analysis and pain response of 
two rodent models of osteoarthritis. Pharmacol Biochem Behav 2011;97:603-10. 
125. Spicer PP, Kretlow JD, Young S, Jansen JA, Kasper FK, Mikos AG. Evaluation 
of bone regeneration using the rat critical size calvarial defect. Nat Protoc 2012;7:1918-
29. 
126. Yin Z, Nguyen HG, Chowdhury S, Bentley P, Bruckman MA, Miermont A, 
Gildersleeve JC, Wang Q, Huang X. Tobacco mosaic virus as a new carrier for tumor 
associated carbohydrate antigens. Bioconjug Chem 2012;23:1694-703. 
127. Karpova OV, Ivanov KI, Rodionova NP, Dorokhov Yu L, Atabekov JG. 
Nontranslatability and dissimilar behavior in plants and protoplasts of viral RNA and 
movement protein complexes formed in vitro. Virology 1997;230:11-21. 
128. Mallajosyula JK, Hiatt E, Hume S, Johnson A, Jeevan T, Chikwamba R, Pogue 
GP, Bratcher B, Haydon H, Webby RJ, McCormick AA. Single-dose monomeric HA 
subunit vaccine generates full protection from influenza challenge. Hum Vaccin 
Immunother 2013;10. 
129. Sengupta P. The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med 
2013;4:624-30. 
130. Piao Y, Liu Y, Xie X. Change trends of organ weight background data in sprague 
dawley rats at different ages. J Toxicol Pathol 2013;26:29-34. 
 
165 
131. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle 
size-dependent organ distribution of gold nanoparticles after intravenous administration. 
Biomaterials 2008;29:1912-9. 
132. De Jong WH, Van Der Ven LT, Sleijffers A, Park MV, Jansen EH, Van Loveren 
H, Vandebriel RJ. Systemic and immunotoxicity of silver nanoparticles in an intravenous 
28 days repeated dose toxicity study in rats. Biomaterials 2013;34:8333-43. 
133. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander 
CW, Van Eijkeren JC, Geertsma RE, De Jong WH. The kinetics of the tissue distribution 
of silver nanoparticles of different sizes. Biomaterials 2010;31:8350-61. 
134. Schoeffner DJ, Warren DA, Muralidara S, Bruckner JV, Simmons JE. Organ 
weights and fat volume in rats as a function of strain and age. J Toxicol Environ Health A 
1999;56:449-62. 
135. Mirfazaelian A, Fisher JW. Organ growth functions in maturing male Sprague-
Dawley rats based on a collective database. J Toxicol Environ Health A 2007;70:1052-
63. 
136. Mirfazaelian A, Kim KB, Lee S, Kim HJ, Bruckner JV, Fisher JW. Organ growth 
functions in maturing male Sprague-Dawley rats. J Toxicol Environ Health A 
2007;70:429-38. 
137. Kim YS, Min KS, Jeong DH, Jang JH, Kim HW, Kim EC. Effects of fibroblast 
growth factor-2 on the expression and regulation of chemokines in human dental pulp 
cells. J Endod 2010;36:1824-30. 




139. Schutte RJ, Xie L, Klitzman B, Reichert WM. In vivo cytokine-associated 
responses to biomaterials. Biomaterials 2009;30:160-8. 
140. Bellis SL. Advantages of RGD peptides for directing cell association with 
biomaterials. Biomaterials 2011;32:4205-10. 
141. Shu XZ, Ghosh K, Liu Y, Palumbo FS, Luo Y, Clark RA, Prestwich GD. 
Attachment and spreading of fibroblasts on an RGD peptide-modified injectable 
hyaluronan hydrogel. J Biomed Mater Res A 2004;68:365-75. 
142. Kallai I, Mizrahi O, Tawackoli W, Gazit Z, Pelled G, Gazit D. Microcomputed 
tomography-based structural analysis of various bone tissue regeneration models. Nat 
Protoc 2011;6:105-10. 
143. Holdsworth DW, Thornton MM. Micro-CT in small animal and specimen 
imaging. Trends in Biotechnology 2002;20:S34-S39. 
144. Chen J, Bly RA, Saad MM, AlKhodary MA, El-Backly RM, Cohen DJ, Kattamis 
N, Fatta MM, Moore WA, Arnold CB, Marei MK, Soboyejo WO. In-vivo study of 
adhesion and bone growth around implanted laser groove/RGD-functionalized Ti-6Al-4V 
pins in rabbit femurs. Materials Science and Engineering: C 2011;31:826-832. 
145. Ferris DM, Moodie GD, Dimond PM, Gioranni CW, Ehrlich MG, Valentini RF. 
RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 
1999;20:2323-31. 
146. Kroese-Deutman HC, van den Dolder J, Spauwen PH, Jansen JA. Influence of 
RGD-loaded titanium implants on bone formation in vivo. Tissue Eng 2005;11:1867-75. 
 
167 
147. Liu SQ, Tian Q, Hedrick JL, Po Hui JH, Ee PL, Yang YY. Biomimetic hydrogels 
for chondrogenic differentiation of human mesenchymal stem cells to neocartilage. 
Biomaterials 2010;31:7298-307. 
148. Kock L, van Donkelaar CC, Ito K. Tissue engineering of functional articular 
cartilage: the current status. Cell Tissue Res 2012;347:613-27. 
149. Ahmed TA, Hincke MT. Strategies for articular cartilage lesion repair and 
functional restoration. Tissue Eng Part B Rev 2010;16:305-29. 
150. Toh WS, Spector M, Lee EH, Cao T. Biomaterial-mediated delivery of 
microenvironmental cues for repair and regeneration of articular cartilage. Mol Pharm 
2011;8:994-1001. 
151. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 
2002;54:3-12. 
152. Toh WS, Lee EH, Guo XM, Chan JK, Yeow CH, Choo AB, Cao T. Cartilage 
repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived 
chondrogenic cells. Biomaterials 2010;31:6968-80. 
153. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-50. 
154. Rogers JJ, Young HE, Adkison LR, Lucas PA, Black AC, Jr. Differentiation 
factors induce expression of muscle, fat, cartilage, and bone in a clone of mouse 
pluripotent mesenchymal stem cells. Am Surg 1995;61:231-6. 
155. Huang AH, Farrell MJ, Mauck RL. Mechanics and mechanobiology of 
mesenchymal stem cell-based engineered cartilage. J Biomech 2010;43:128-36. 
156. Connelly JT, Garcia AJ, Levenston ME. Inhibition of in vitro chondrogenesis in 
RGD-modified three-dimensional alginate gels. Biomaterials 2007;28:1071-83. 
 
168 
157. Lee HJ, Yu C, Chansakul T, Hwang NS, Varghese S, Yu SM, Elisseeff JH. 
Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-
mediated microenvironment. Tissue Eng Part A 2008;14:1843-51. 
158. Kim IL, Khetan S, Baker BM, Chen CS, Burdick JA. Fibrous hyaluronic acid 
hydrogels that direct MSC chondrogenesis through mechanical and adhesive cues. 
Biomaterials 2013;34:5571-80. 
159. Comisar WA, Kazmers NH, Mooney DJ, Linderman JJ. Engineering RGD 
nanopatterned hydrogels to control preosteoblast behavior: a combined computational 
and experimental approach. Biomaterials 2007;28:4409-17. 
160. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions 
to the third dimension. Science 2001;294:1708-12. 
161. Huebsch N, Arany PR, Mao AS, Shvartsman D, Ali OA, Bencherif SA, Rivera-
Feliciano J, Mooney DJ. Harnessing traction-mediated manipulation of the cell/matrix 
interface to control stem-cell fate. Nat Mater 2010;9:518-26. 
162. Wang X, Yan C, Ye K, He Y, Li Z, Ding J. Effect of RGD nanospacing on 
differentiation of stem cells. Biomaterials 2013;34:2865-74. 
163. Wang X, Ye K, Li Z, Yan C, Ding J. Adhesion, proliferation, and differentiation 
of mesenchymal stem cells on RGD nanopatterns of varied nanospacings. Organogenesis 
2013;9:280-6. 
164. Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB. Structure and function of aggrecan. 
Cell Res 2002;12:19-32. 
165. Posey KL, Hecht JT. The role of cartilage oligomeric matrix protein (COMP) in 
skeletal disease. Curr Drug Targets 2008;9:869-77. 
 
169 
166. Kosher RA, Kulyk WM, Gay SW. Collagen gene expression during limb cartilage 
differentiation. J Cell Biol 1986;102:1151-6. 
167. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The 
transcription factor Sox9 has essential roles in successive steps of the chondrocyte 
differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 
2002;16:2813-28. 
168. Grassel S, Ahmed N, Gottl C, Grifka J. Gene and protein expression profile of 
naive and osteo-chondrogenically differentiated rat bone marrow-derived mesenchymal 
progenitor cells. Int J Mol Med 2009;23:745-55. 
169. Hwang NS, Varghese S, Theprungsirikul P, Canver A, Elisseeff J. Enhanced 
chondrogenic differentiation of murine embryonic stem cells in hydrogels with 
glucosamine. Biomaterials 2006;27:6015-23. 
170. Wang C, Hao J, Zhang F, Su K, Wang DA. RNA extraction from polysaccharide-
based cell-laden hydrogel scaffolds. Anal Biochem 2008;380:333-4. 
171. Wang C, Li X, Yao Y, Wang DA. Concurrent extraction of proteins and RNA 
from cell-laden hydrogel scaffold free of polysaccharide interference. J Chromatogr B 
Analyt Technol Biomed Life Sci 2009;877:3762-6. 
172. Wang L, Stegemann JP. Extraction of high quality RNA from polysaccharide 
matrices using cetyltrimethylammonium bromide. Biomaterials 2010;31:1612-8. 
173. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage 
development. Osteoarthritis Cartilage 2000;8:309-34. 
174. Fischer L, Boland G, Tuan RS. Wnt signaling during BMP-2 stimulation of 
mesenchymal chondrogenesis. J Cell Biochem 2002;84:816-31. 
 
170 
175. Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. J Cell 
Biochem 2004;93:93-103. 
176. Bhardwaj N, Kundu SC. Chondrogenic differentiation of rat MSCs on porous 
scaffolds of silk fibroin/chitosan blends. Biomaterials 2012;33:2848-57. 
177. Salinas CN, Anseth KS. The enhancement of chondrogenic differentiation of 
human mesenchymal stem cells by enzymatically regulated RGD functionalities. 
Biomaterials 2008;29:2370-7. 
178. Lee KL, Uhde-Holzem K, Fischer R, Commandeur U, Steinmetz NF. Genetic 
engineering and chemical conjugation of potato virus X. Methods Mol Biol 2014;1108:3-
21. 
179. Yi H, Rubloff GW, Culver JN. TMV microarrays: hybridization-based assembly 
of DNA-programmed viral nanotemplates. Langmuir 2007;23:2663-7. 
180. Yi H, Nisar S, Lee SY, Powers MA, Bentley WE, Payne GF, Ghodssi R, Rubloff 
GW, Harris MT, Culver JN. Patterned assembly of genetically modified viral 
nanotemplates via nucleic acid hybridization. Nano Lett 2005;5:1931-6. 
181. Royston E, Ghosh A, Kofinas P, Harris MT, Culver JN. Self-assembly of virus-
structured high surface area nanomaterials and their application as battery electrodes. 
Langmuir 2008;24:906-12. 
182. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6:2397-404. 
183. Sahoo S, Chung C, Khetan S, Burdick JA. Hydrolytically degradable hyaluronic 
acid hydrogels with controlled temporal structures. Biomacromolecules 2008;9:1088-92. 
184. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound 
Repair Regen 1999;7:79-89. 
 
171 
185. Balazs EA, Laurent TC, Jeanloz RW. Nomenclature of hyaluronic acid. Biochem 
J 1986;235:903. 
186. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan 
receptors. J Biol Chem 2002;277:4589-92. 
187. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA, 
Strong SA, Wight TN. Intracellular hyaluronan: a new frontier for inflammation? 
Biochim Biophys Acta 2004;1673:3-12. 
188. Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-
independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell 
survival pathway. J Biol Chem 2002;277:38013-20. 
189. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and 
vascular disease. J Biol Chem 2002;277:4593-6. 
190. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical 
applications. Adv Mater 2011;23:H41-56. 
191. Marklein RA, Burdick JA. Spatially controlled hydrogel mechanics to modulate 
stem cell interactions. Soft Matter 2010;6:136-43. 
192. Chung C, Burdick JA. Influence of three-dimensional hyaluronic acid 
microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng Part A 
2009;15:243-54. 
193. Serban MA, Prestwich GD. Modular extracellular matrices: solutions for the 
puzzle. Methods 2008;45:93-8. 
 
172 
194. Fedorovich NE, Oudshoorn MH, van Geemen D, Hennink WE, Alblas J, Dhert 
WJ. The effect of photopolymerization on stem cells embedded in hydrogels. 
Biomaterials 2009;30:344-53. 
195. Ananthanarayanan B, Kim Y, Kumar S. Elucidating the mechanobiology of 
malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. 
Biomaterials 2011;32:7913-23. 
196. Amini AA, Nair LS. Injectable hydrogels for bone and cartilage repair. Biomed 
Mater 2012;7:024105. 
197. Liu X, Jin X, Ma PX. Nanofibrous hollow microspheres self-assembled from star-
shaped polymers as injectable cell carriers for knee repair. Nat Mater 2011;10:398-406. 
198. Nicodemus GD, Bryant SJ. The role of hydrogel structure and dynamic loading 
on chondrocyte gene expression and matrix formation. J Biomech 2008;41:1528-36. 
199. Elbert DL, Pratt AB, Lutolf MP, Halstenberg S, Hubbell JA. Protein delivery 
from materials formed by self-selective conjugate addition reactions. J Control Release 
2001;76:11-25. 
200. Khetan S, Burdick J. Cellular encapsulation in 3D hydrogels for tissue 
engineering. J Vis Exp 2009. 
201. Lutolf MP, Hubbell JA. Synthesis and physicochemical characterization of end-
linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. 
Biomacromolecules 2003;4:713-22. 
202. Nair DP, Podgórski M, Chatani S, Gong T, Xi W, Fenoli CR, Bowman CN. The 
Thiol-Michael Addition Click Reaction: A Powerful and Widely Used Tool in Materials 
Chemistry. Chemistry of Materials 2013;26:724-44. 
 
173 
203. Chung C, Mesa J, Randolph MA, Yaremchuk M, Burdick JA. Influence of gel 
properties on neocartilage formation by auricular chondrocytes photoencapsulated in 
hyaluronic acid networks. J Biomed Mater Res A 2006;77:518-25. 
204. Weng L, Chen X, Chen W. Rheological characterization of in situ crosslinkable 
hydrogels formulated from oxidized dextran and N-carboxyethyl chitosan. 
Biomacromolecules 2007;8:1109-15. 
205. Li T, Ci T, Chen L, Yu L, Ding J. Salt-induced reentrant hydrogel of 
poly(ethylene glycol)-poly(lactide-co-glycolide) block copolymers. Polym Chem 
2014;5:979-91. 
206. Ngwuluka N, Choonara Y, Kumar P, Modi G, Toit L, Pillay V. A Hybrid 
Methacrylate-Sodium Carboxymethylcellulose Interpolyelectrolyte Complex: Rheometry 
and in Silico Disposition for Controlled Drug Release. Materials 2013;6:4284-308. 
207. Yucel T, Cebe P, Kaplan DL. Vortex-Induced Injectable Silk Fibroin Hydrogels. 
Biophys J 2009;97:2044-50. 
208. Nuernberger S, Cyran N, Albrecht C, Redl H, Vecsei V, Marlovits S. The 
influence of scaffold architecture on chondrocyte distribution and behavior in matrix-
associated chondrocyte transplantation grafts. Biomaterials 2011;32:1032-40. 
209. Annabi N, Nichol JW, Zhong X, Ji C, Koshy S, Khademhosseini A, Dehghani F. 
Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue 
Eng Part B Rev 2010;16:371-83. 
210. Lien SM, Ko LY, Huang TJ. Effect of pore size on ECM secretion and cell 




211. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC, Thomas CH, Nuber GW, 
Glorieux FH, Travers R, Sprague SM. Engineering bone regeneration with bioabsorbable 
scaffolds with novel microarchitecture. Tissue Eng 1999;5:35-51. 
212. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and 
characterization of a model extracellular matrix that induces partial regeneration of adult 
mammalian skin. Proc Natl Acad Sci U S A 1989;86:933-7. 
213. Segura T, Anderson BC, Chung PH, Webber RE, Shull KR, Shea LD. 
Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. 
Biomaterials 2005;26:359-71. 
214. Brigham MD, Bick A, Lo E, Bendali A, Burdick JA, Khademhosseini A. 
Mechanically robust and bioadhesive collagen and photocrosslinkable hyaluronic acid 
semi-interpenetrating networks. Tissue Eng Part A 2009;15:1645-53. 
215. Eng D, Caplan M, Preul M, Panitch A. Hyaluronan scaffolds: a balance between 
backbone functionalization and bioactivity. Acta Biomater 2010;6:2407-14. 
216. Jeong CG, Hollister SJ. Mechanical and biochemical assessments of three-
dimensional poly(1,8-octanediol-co-citrate) scaffold pore shape and permeability effects 
on in vitro chondrogenesis using primary chondrocytes. Tissue Eng Part A 2010;16:3759-
68. 
217. Smeds KA, Pfister-Serres A, Miki D, Dastgheib K, Inoue M, Hatchell DL, 
Grinstaff MW. Photocrosslinkable polysaccharides for in situ hydrogel formation. J 
Biomed Mater Res 2001;54:115-21. 












Figure B.1. Alizarin Red staining on controls (A) PAH, (B) TMV-PAH, and (C) RGD-
PAH without BMSCs showed lighter color (pink) compared to the cultured hydrogels. 




APPENDIX C – TMV-FLUORESCEIN
 
 











Figure C.3. Fluorescence spectroscopy calibration with linear fitting curve and equation 
for quantification of fluorescein-modified wild-type TMV.
y = 280.43x - 0.0249 

















APPENDIX D – TWO DIMENSIONAL CONSTRUCTS OF BONE EXCISES 
 
 
Figure D.1. Two dimensional constructs of bone excises from rats with PAH, TMV-
PAH, and RGD-PAH implanted.   
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APPENDIX E – REPRESENTATIVE 
1





H NMR spectra of methacrylated HA with 10% (A), 38% (B), and 100% 






APPENDIX F – TEM ELECTRON MICROGRAPH OF TMV-1CYS 
 
 




APPENDIX G – AFM IMAGE OF WILD-TYPE TMV 
 
 
Figure G.1. Atomic force microscopy of wild-type TMV.  
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APPENDIX H – STANDARD CURVE FOR DYE DIFFUSION STUDY 
 
 
Figure H.1. Fluorescence spectroscopy calibration with linear fitting curve and equation 
for quantification of fluorescein amine isomer I. 
 
